National [[regulation of therapeutic goods|regulatory authorities]] have granted emergency use authorizations for twenty-five [[COVID-19 vaccine]]s.

Eight vaccines have been approved for emergency or full use by at least one [[List of stringent regulatory authorities|stringent regulatory authority]] recognized by the [[World Health Organization]] (WHO): [[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]], [[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]], [[Sinopharm BIBP COVID-19 vaccine|Sinopharm BIBP]], [[Moderna COVID-19 vaccine|Moderna]], [[Janssen COVID-19 vaccine|Janssen]], [[CoronaVac]], [[Covaxin]] and [[Novavax COVID-19 vaccine|Novavax]]. Five others are under assessment by the WHO: [[Sputnik V COVID-19 vaccine|Sputnik V]], [[Sinopharm WIBP COVID-19 vaccine|Sinopharm WIBP]], [[Convidecia]], [[Sanofi–GSK COVID-19 vaccine|Sanofi–GSK]] and [[SCB-2019]].<ref name="WHO status">{{#invoke:Cite web||title=Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process|url=https://extranet.who.int/pqweb/key-resources/documents/status-covid-19-vaccines-within-who-eulpq-evaluation-process|publisher=[[World Health Organization]] (WHO)}}</ref>

Specific versions of five vaccines have been authorised by the [[European Medicines Agency]] (EMA): [[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]], [[Janssen COVID-19 vaccine|Janssen]], [[Novavax COVID-19 vaccine|Novavax]], [[Moderna COVID-19 vaccine|Moderna]] and [[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]].<ref>{{cite web |title=COVID-19 vaccines: authorised |url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised |website=[[European Medicines Agency]] (EMA)}}</ref> Specific versions of another five vaccines are under evaluation by the EMA: [[Sputnik V COVID-19 vaccine|Sputnik V]], [[CoronaVac]], [[Sanofi–GSK COVID-19 vaccine|Sanofi–GSK]] and [[Valneva COVID-19 vaccine|Valneva]].<ref name="ema.europa.eu">{{cite web |title=COVID-19 vaccines: under evaluation |url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-under-evaluation |website=[[European Medicines Agency]] (EMA)}}</ref>

{{Horizontal TOC}}

== Overview maps ==
{| class=center
|
<gallery mode="nolines" widths="400" heights="300">
File:COVID-19 RNA and DNA vaccines authorization map.svg|<div style="text-align:left">[[RNA vaccine]]s and [[DNA vaccine]]s{{Legend|#800080|[[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]]}}{{Legend|#008800|[[Moderna COVID-19 vaccine|Moderna]]}}{{Legend|#008CFF|[[ZyCoV-D]]}}</div>
File:COVID-19 adenovirus vaccines authorization map.svg|<div style="text-align:left">[[Viral vector vaccine|Adenovirus vector vaccines]]{{Legend|#000088|[[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]]}}{{Legend|#008800|[[Janssen COVID-19 vaccine|Janssen]]}}{{Legend|#880000|[[Sputnik V COVID-19 vaccine|Sputnik V]]}}{{Legend|#FF008C|[[Sputnik Light]]}}{{Legend|#888800|[[Convidecia]]}}</div>
</gallery>

<gallery mode="nolines" widths="400" heights="300">
File:COVID-19 inactivated vaccines authorization map.svg|<div style="text-align:left">[[Inactivated vaccine|Inactivated virus vaccines]]{{Legend|#008888|[[Sinopharm BIBP COVID-19 vaccine|Sinopharm BIBP]]}}{{Legend|#888800|[[CoronaVac]]}}{{Legend|#800080|[[BBV152|Covaxin]]}}{{Legend|#FF8C00|[[Sinopharm WIBP COVID-19 vaccine|Sinopharm WIBP]]}}{{Legend|#666666|Others}}</div>
File:COVID-19 subunit and VLP vaccines authorization map.svg|<div style="text-align:left">[[Subunit vaccine]]s{{Legend|#008CFF|[[w:Abdala (vaccine)|Abdala]]}}{{Legend|#8C00FF|[[ZF2001]]}}{{Legend|#008888|[[EpiVacCorona]]}}{{Legend|#FF8C00|[[w:Novavax COVID-19 vaccine|Novavax]]}}{{Legend|#00FF8C|[[w:Soberana 02|Soberana 02]]}}{{Legend|#666666|Others}}</div>
</gallery>
|}

== Oxford–AstraZeneca ==
<section begin="oxfordauthmap"/>
{{infobox
| image            = {{Graph:Map|scale=80|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=dodgerblue|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=dodgerblue|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=dodgerblue|CF=dodgerblue|CG=dodgerblue|CI=dodgerblue|CK=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=dodgerblue
|FI=dodgerblue|FJ=dodgerblue|FK=dodgerblue|FM=dodgerblue|FR=dodgerblue
|GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GG=dodgerblue|GH=dodgerblue|GM=dodgerblue|GN=dodgerblue|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GY=dodgerblue
|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IM=dodgerblue|IN=dodgerblue|IQ=dodgerblue|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue
|JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=dodgerblue|LI=dodgerblue|LK=dodgerblue|LR=dodgerblue|LS=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MR=dodgerblue|MS=dodgerblue|MT=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue
|OM=dodgerblue
|PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PN=dodgerblue|PS=dodgerblue|PT=dodgerblue|PY=dodgerblue
|QA=dodgerblue
|RO=dodgerblue|RS=dodgerblue|RW=dodgerblue
|SA=dodgerblue|SB=dodgerblue|SC=dodgerblue|SD=dodgerblue|SE=dodgerblue|SG=dodgerblue|SH=dodgerblue|SI=dodgerblue|SK=darkred|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=dodgerblue|SV=dodgerblue|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue
|TD=limegreen|TG=dodgerblue|TH=dodgerblue|TJ=dodgerblue|TL=dodgerblue|TM=dodgerblue|TN=dodgerblue|TO=dodgerblue|TT=dodgerblue|TV=dodgerblue|TW=dodgerblue
|UA=dodgerblue|UG=dodgerblue|UY=dodgerblue|UZ=dodgerblue
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=dodgerblue
|WF=dodgerblue|WS=limegreen
|XK=dodgerblue
|YE=dodgerblue
|ZA=darkred|ZM=dodgerblue|ZW=dodgerblue
}}
| caption          = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
{{leftlegend|darkred|Usage stopped}}
}}
<section end="oxfordauthmap"/>
The [[Oxford–AstraZeneca COVID-19 vaccine]], sold under the brand names Vaxzevria<ref name="Vaxzevria EPAR">{{cite web | title=Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR | publisher=[[European Medicines Agency]] (EMA) | url=https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca }}</ref> and Covishield,<ref>{{cite news|date=4 March 2021|title=Covishield and Covaxin: What we know about India's Covid-19 vaccines|work=BBC News|url=https://www.bbc.com/news/world-asia-india-55748124|access-date=8 March 2021|archive-date=7 March 2021|archive-url=https://web.archive.org/web/20210307222320/https://www.bbc.com/news/world-asia-india-55748124|url-status=live}}</ref> is a [[viral vector vaccine]]<ref name="NCT044008383">{{#invoke:Cite web||date=26 May 2020|title=Investigating a Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04400838|url-status=live|archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04400838}}</ref> produced by the British [[University of Oxford]], British-Swedish company [[AstraZeneca]], and the [[Coalition for Epidemic Preparedness Innovations|Coalition for Epidemic Preparedness Innovations<wbr />]].<ref name="NCT044008383"/><ref name="EudraCT-2020-001228-322">{{#invoke:Cite web||date=21 April 2020|title=A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|url-status=live|archive-url=https://web.archive.org/web/20201005201654/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|archive-date=5 October 2020|access-date=3 August 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001228-32}}</ref><ref name="ISRCTN899514242">{{cite journal|last1=O'Reilly|first1=Peter|date=26 May 2020|title=A Phase III study to investigate a vaccine against COVID-19|doi=10.1186/ISRCTN89951424|id=ISRCTN89951424|doi-access=free|website=ISRCTN|name-list-style=vanc}}</ref> Denmark and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder.<ref>{{cite web | title=Denmark continues its vaccine rollout without the COVID-19 vaccine from AstraZeneca | website=Danish Health Authority | date=14 April 2021  | url=https://www.sst.dk/en/english/news/2021/denmark-continues-its-vaccine-rollout-without-the-covid-19-vaccine-from-astrazeneca | access-date=31 July 2021 | quote=That is why it is important to emphasise that it is still an approved vaccine. }}</ref><ref>{{cite news |last1=Peltier |first1=Elian |title=Denmark says it's permanently stopping use of the AstraZeneca vaccine. |url=https://www.nytimes.com/2021/04/14/world/europe/denmark-astrazeneca-vaccine.html |work=The New York Times |date=14 April 2021}}</ref><ref>{{#invoke:Cite web||last=omsorgsdepartementet|first=Helse-og|date=12 May 2021|title=AstraZeneca-vaksinen tas ut av koronavaksinasjons-programmet|url=https://www.regjeringen.no/no/aktuelt/astrazeneca-vaksinen-tas-ut-av-koronavaksinasjonsprogrammet/id2849494/|access-date=12 May 2021|website=Regjeringen.no|language=no}}</ref> Slovakia suspended its use after the death of a predisposed recipient.<ref>{{cite news |title=Slovakia suspends use of AstraZeneca COVID-19 vaccine as a recipient dies |url=https://www.reuters.com/business/healthcare-pharmaceuticals/slovakia-halting-use-astrazeneca-covid-vaccine-first-doses-2021-05-11/ |access-date=23 June 2021 |date=11 May 2021 |work=Reuters |location=Prague}}</ref> South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant [[SARS-CoV-2 Beta variant|Beta variant]].<ref>{{cite news |title=South Africa sells AstraZeneca COVID-19 vaccines to other African countries |url=https://www.reuters.com/article/us-health-coronavirus-safrica-vaccine-idUSKBN2BD0K4 |access-date=23 June 2021 |work=Reuters |date=21 March 2021 |location=Johannesburg}}</ref> Japan approved the vaccine for emergency use in May 2021, but doesn't plan to use them immediately because of rare cases of a blood clotting disorder reported overseas.<ref>{{cite news | title = Japan to donate millions more AstraZeneca vaccine doses across Asia | date = 2021-06-25 | url = https://english.kyodonews.net/news/2021/06/082ff96b4bdb-japan-to-donate-millions-more-astrazeneca-vaccines-across-asia.html | work = Kyodo News }}</ref> Later, Japan started to use the vaccine for people aged 40 or over  to mitigate the surge of the [[SARS-CoV-2 Delta variant|Delta variant]] in August.<ref>{{Cite web|date=2021-08-04|title=Japan to give COVID-19 emergency areas AstraZeneca vaccine|url=https://www.japantimes.co.jp/news/2021/08/04/national/japan-give-covid-19-emergency-areas-astrazeneca-vaccine/|access-date=2021-08-28|website=The Japan Times|language=en-US}}</ref>

;Full (<section begin="Oxford–AstraZeneca_FN"/>3<section end="Oxford–AstraZeneca_FN"/>)
# Australia<ref>{{cite news|date=16 February 2021|title=AstraZeneca coronavirus vaccine approved for use in Australia by TGA|newspaper=[[ABC News (Australia)|ABC News]] (Australia)|url=https://www.abc.net.au/news/2021-02-16/coronavirus-astrazeneca-vaccine-approved-for-use-in-australia/13115784|access-date=16 February 2021}}</ref><ref>{{#invoke:Cite web||date=16 February 2021|title=TGA provisionally approves AstraZeneca's COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-astrazenecas-covid-19-vaccine|access-date=16 February 2021|publisher=[[Therapeutic Goods Administration]] (TGA)}}</ref>
# Brazil<ref>{{cite news|date=12 March 2021|title=Brazil grants full approval to Oxford vaccine, orders Sputnik|publisher=[[France 24]]|agency=[[Agence France-Presse]]|location=Brasilia|url=https://www.france24.com/en/live-news/20210312-brazil-grants-full-approval-to-oxford-vaccine-orders-sputnik|access-date=13 March 2021}}</ref>
#Canada<ref>{{#invoke:Cite web||date=26 February 2021|title=Regulatory Decision Summary – AstraZeneca COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00772|access-date=26 February 2021|website=[[Health Canada]]}}</ref><ref name="hcapps">{{#invoke:Cite web||date=9 December 2020|title=Drug and vaccine authorizations for COVID-19: List of applications received|url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref><ref name=":13">{{Cite news|last=Osman|first=Laura|date=2021-09-16|title=Goodbye Pfizer, hello Comirnaty: Top COVID-19 vaccines given brand names in Canada|work=CBC News|url=https://www.cbc.ca/news/health/vaccine-name-change-canada-1.6178484|access-date=2021-09-16}}</ref>
{{-}}

;Emergency (<section begin="Oxford–AstraZeneca_EN" />172<section end="Oxford–AstraZeneca_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref>{{cite news|last=Sediqi|first=Abdul Qadir|date=7 February 2021|title=First doses of COVID-19 vaccine arrive in Afghanistan from India|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-afghanistan-vaccine-idUSKBN2A707M|access-date=24 February 2021}}</ref><ref>{{#invoke:Cite web||title=India donates 500,000 COVID vaccines to Afghanistan|url=https://www.aljazeera.com/news/2021/2/8/afghanistan-gets-first-doses-of-covid-19-vaccine-from-india|access-date=24 February 2021|publisher=Al Jazeera}}</ref>
# Albania<ref name=":0" />
# Algeria<ref>{{#invoke:Cite web||last=Kreo|title=البلاد الوطني / وزارة الصناعات الصيدلانية ترخص باستعمال لقاح "أسترا زينيكا -أوكسفورد " المضاد لكورونا|url=http://elbilad.net/article/detail?id=113247|access-date=1 April 2021|website=elbilad.net|language=AR}}</ref>
# Andorra<ref name="Andorra vaccines" />
# Angola<ref>{{#invoke:Cite web||last=AfricaNews|date=3 March 2021|time=CET13:13:37+01:00|title=Angola begins Covid immunization fight with COVAX vaccines|url=https://www.africanews.com/2021/03/03/angola-begins-covid-immunization-fight-with-covax-vaccines/|access-date=14 April 2021|website=Africanews}}</ref>
# Argentina<ref>{{cite news|date=30 December 2020|title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P|access-date=30 December 2020|publisher=Reuters}}</ref>
# Armenia<ref>{{cite web |title=Armenia Scraps Restrictions For AstraZeneca Vaccine |url=https://www.azatutyun.am/a/31226006.html |website=«Ազատ Եվրոպա/Ազատություն» ռադիոկայան |language=hy}}</ref>
# Azerbaijan<ref name="cdctracker"/>
# Bahrain<ref>{{#invoke:Cite web||date=25 January 2021|title=Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India|url=http://saudigazette.com.sa/article/602862|access-date=30 January 2021|website=Saudigazette}}</ref>
# Bangladesh<ref>{{#invoke:Cite web||title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use|url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381|access-date=6 January 2021|website=[[The Daily Star (Bangladesh)|The Daily Star]]|date=4 January 2021}}</ref><ref>{{#invoke:Cite web||title=Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine|url=https://www.aa.com.tr/en/asia-pacific/bangladesh-approves-oxford-astrazeneca-covid-19-vaccine/2099147|access-date=6 January 2021|website=aa.com.tr}}</ref>
# Benin<ref name="cdctracker"/>
# Bhutan<ref>{{#invoke:Cite web||title=Bhutan receives 400,000 doses of COVID-19 vaccine from India |url=http://www.xinhuanet.com/english/asiapacific/2021-03/22/c_139827645.htm|access-date=1 April 2021|publisher=Xinhuanet}}</ref><ref>{{#invoke:Cite web||title=Bhutan begins biggest vaccination drive against COVID-19|url=https://www.channelnewsasia.com/news/asia/bhutan-begins-biggest-covid-19-vaccination-drive-astrazeneca-14504644|access-date=1 April 2021|website=CNA}}</ref>
# Bolivia<ref name="cdctracker"/>
# Bosnia and Herzegovina<ref name=":3" />
# Botswana<ref>{{#invoke:Cite web||title=Botswana starts COVID-19 vaccine rollout |url=http://www.xinhuanet.com/english/2021-03/26/c_139838942.htm|access-date=1 April 2021|publisher=Xinhuanet}}</ref>
# Brunei<ref name="auto"/>
# Burkina Faso<ref name="whotracker"/>
# Cambodia<ref name="cdctracker"/>
# Cameroon<ref name="cdctracker"/>
# Cape Verde<ref>{{#invoke:Cite web||title=COVID-19 vaccines sent by COVAX arrive in Cabo Verde |url=https://reliefweb.int/report/cabo-verde/covid-19-vaccines-sent-covax-arrive-cabo-verde|access-date=17 April 2021|website=ReliefWeb}}</ref>
# Central African Republic<ref name="whotracker"/>
# Chile<ref>{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-la-tercera-vacuna-para-combatir-covid-19/|access-date=1 April 2021|language=es}}</ref>
# Colombia<ref>{{cite news|title=Colombia approves emergency use of AstraZeneca coronavirus vaccine |url=https://www.reuters.com/article/us-health-coronavirus-colombia-idUSKBN2AO01A|publisher=Reuters|access-date=22 March 2021|location=Bogotá|date=23 February 2021}}</ref>
# Comoros<ref name="cdctracker"/>
# Congo, DR<ref>{{#invoke:Cite web||title=More than 1.7 million COVID-19 vaccines arrive in the Democratic Republic of Congo|url=https://www.unicef.org/press-releases/more-17-million-covid-19-vaccines-arrive-democratic-republic-congo|access-date=25 April 2021|website=www.unicef.org}}</ref>
# Congo, Rep. of the<ref name="cdctracker"/>
# Costa Rica<ref>{{cite web |title=Costa Rica approves use of AstraZeneca's COVID-19 vaccine |url=https://qcostarica.com/costa-rica-approves-use-of-astrazenecas-covid-19-vaccine/ |website=Q COSTA RICA |date=9 April 2021}}</ref>
# Djibouti<ref name="cdctracker"/>
# Dominican Republic<ref>{{cite news|date=31 December 2020|title=La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19|language=es|work=Agencia EFE|url=https://www.efe.com/efe/america/sociedad/la-republica-dominicana-aprueba-vacuna-de-astrazeneca-contra-covid-19/20000013-4431079}}</ref>
# East Timor<ref>{{#invoke:Cite web||date=April 1, 2021|title=First vaccines for East Timor arrive in Dili on Monday – LUSA|url=https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|url-status=live|archive-url=https://web.archive.org/web/20210402144040/https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|archive-date=April 2, 2021|website=COVID-19 Timor-Leste Dashboard}}</ref>
# Ecuador<ref>{{cite news|date=24 January 2021|title=Ecuador approves use of AstraZeneca vaccine for COVID-19|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-ecuador-astrazeneca-idUSL1N2JZ0HC|access-date=30 January 2021}}</ref>
# Egypt<ref name="Gulf News"/>
# El Salvador<ref>{{cite news|date=30 December 2020|title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ}}</ref>
# Eswatini<ref>{{#invoke:Cite web||title=Eswatini launches nationwide COVID-19 vaccination campaign|url=https://www.afro.who.int/news/eswatini-launches-nationwide-covid-19-vaccination-campaign|access-date=1 April 2021|publisher=[[World Health Organization]] (WHO) }}</ref>
# Ethiopia<ref>{{#invoke:Cite web||title=Ethiopia begins COVID-19 vaccine rollout|url=https://www.aa.com.tr/en/africa/ethiopia-begins-covid-19-vaccine-rollout/2174904|access-date=19 March 2021|website=aa.com.tr}}</ref><ref>{{#invoke:Cite web||title=Ethiopia introduces COVID-19 vaccine in a national launching ceremony|url=https://www.afro.who.int/news/ethiopia-introduces-covid-19-vaccine-national-launching-ceremony|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref><ref>{{cite news|date=9 February 2021|title=Ethiopia says it has secured 9 million doses of COVID-19 vaccines till April|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-ethiopia-idUSKBN2A916S|access-date=19 March 2021}}</ref>
# Fiji<ref name="cdctracker"/>
# Gambia<ref>{{#invoke:Cite web||title=The Arrival of COVAX vaccines Raises Hope in The Gambia|url=https://www.afro.who.int/news/arrival-covax-vaccines-raises-hope-gambia|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref>
# Georgia<ref>{{#invoke:Cite web||title=Georgia to receive first doses of COVID-19 vaccine in early March instead of February|url=https://agenda.ge/en/news/2021/477|access-date=22 March 2021|website=Agenda.ge}}</ref>
# Ghana<ref>{{#invoke:Cite web||title=Welcome to Ghana Food And Drug Authority |url=http://fdaghana.gov.gh/news-media.php?page=78|access-date=1 April 2021|website=fdaghana.gov.gh}}</ref>
# Guatemala<ref name="auto3"/>
# Guinea<ref name="whotracker"/>
# Guinea-Bissau<ref>{{cite web |title=Today, 28,800 doses of COVID-19 vaccine arrive in Bissau |url=https://www.unicef.org/guineabissau/press-releases/today-28800-doses-covid-19-vaccine-arrive-bissau |website=www.unicef.org}}</ref>
# Honduras<ref name="cdctracker"/>
# Hungary<ref>{{#invoke:Cite web||date=22 March 2021|title=Hungary approves two more vaccines not authorised by EU regulator|url=https://www.euronews.com/2021/03/22/covid-19-vaccine-hungary-approves-two-more-jabs-not-authorised-by-eu-regulator|access-date=1 April 2021|website=euronews}}</ref>
# India<ref name="NYT India">{{cite news|last1=Schmall|first1=Emily|last2=Yasir|first2=Sameer|date=3 January 2021|title=India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other|website=The New York Times|url=https://www.nytimes.com/2021/01/03/world/asia/india-covid-19-vaccine.html|access-date=3 January 2021|name-list-style=vanc}}</ref>
# Indonesia<ref>{{#invoke:Cite web||title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca|url=https://nasional.kompas.com/read/2021/03/09/12124611/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-astrazeneca|access-date=10 February 2021|website=Kompas.com}}</ref>
# Iran<ref>{{Cite web |date=17 February 2021|title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official|url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19|access-date=1 April 2021|website=IRNA English}}</ref>
# Iraq<ref name="bignewsnetwork.com">{{#invoke:Cite web||title=Iraq approves Sinopharm, AstraZeneca vaccines|url=https://www.bignewsnetwork.com/news/267583081/iraq-approves-sinopharm-astrazeneca-vaccines|access-date=30 January 2021|website=Big News Network.com}}</ref>
# Ivory Coast<ref>{{cite news|date=1 March 2021|title=Covax: Ivory Coast and Ghana begin mass Covid vaccination rollouts|work=BBC News|url=https://www.bbc.com/news/world-africa-56239136|access-date=19 March 2021}}</ref>
# Japan<ref name="jp">{{cite news | title=Japan Approves Moderna, AstraZeneca Coronavirus Vaccines | website=Bloomberg | date=20 May 2021 | url=https://www.bloomberg.com/news/articles/2021-05-20/japan-approves-moderna-astra-covid-shots-report-says | access-date=2 July 2021}}</ref>
# Jordan<ref>{{#invoke:Cite web||title=COVAX roll-out - Jordan|url=https://www.gavi.org/covax-vaccine-roll-out/jordan|access-date=14 May 2021|website=www.gavi.org}}</ref>
# Kenya<ref>{{#invoke:Cite web||title=Kenya Receives 1M Vaccine Doses, Will Distribute to Health Workers First |url=https://www.voanews.com/covid-19-pandemic/kenya-receives-1m-vaccine-doses-will-distribute-health-workers-first|access-date=19 March 2021|publisher=Voice of America}}</ref>
# Kiribati<ref name="whotracker"/>
# Kosovo<ref>{{#invoke:Cite web||date=29 March 2021|title=Kosovo receives first COVID-19 vaccines through Covax scheme|url=https://www.euronews.com/2021/03/29/kosovo-receives-first-covid-19-vaccines-through-covax-programme|access-date=14 April 2021|website=euronews}}</ref><ref>{{#invoke:Cite web||title=Kosovo PM Becomes Nation's First Person To Receive COVID-19 Vaccine|url=https://www.rferl.org/a/kosovo-covid-vaccines-immunization-last-europe-astrazeneca-covax/31174048.html|access-date=14 April 2021|website=RadioFreeEurope/RadioLiberty}}</ref>
# Kuwait<ref>{{#invoke:Cite web||last=Godinho|first=Varun|date=31 January 2021|title=Kuwait authorises emergency use of Oxford-AstraZeneca Covid-19 vaccine|url=https://gulfbusiness.com/kuwait-authorises-emergency-use-of-oxford-astrazeneca-covid-19-vaccine/|access-date=1 April 2021|website=Gulf Business}}</ref>
# Kyrgyzstan<ref name="whotracker"/>
# Laos<ref name="whotracker"/>
# Lebanon<ref>{{#invoke:Cite web||title=Lebanon Received 33600 Doses of The AstraZeneca Vaccine as First Batch|url=https://www.moph.gov.lb/en/Drugs/index/0/48177/page:3/sort:Drug.brand_name/direction:ASC|website=Ministry of Public Health of Lebanon}}</ref>
# Lesotho<ref>{{#invoke:Cite web||title=Lesotho receives 1st batch of COVID-19 vaccines|url=https://www.aa.com.tr/en/africa/lesotho-receives-1st-batch-of-covid-19-vaccines/2164388|access-date=19 March 2021|website=aa.com.tr}}</ref>
# Liberia<ref>{{#invoke:Cite web||title=96,000 Doses of COVID-19 Vaccine Arrives in Liberia|url=https://www.afro.who.int/news/96000-doses-covid-19-vaccine-arrives-liberia|access-date=11 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref>
# Libya<ref name="auto4">{{#invoke:Cite web||title=Libya kicks off delayed COVID-19 vaccination drive|url=https://www.aljazeera.com/news/2021/4/10/libya-launches-covid-19-vaccination-drive-after-delays|access-date=25 April 2021|website=Al Jazeera}}</ref><ref name="auto5">{{#invoke:Cite web||title=57,600 COVID-19 vaccine doses received today in Tripoli, Libya|url=https://reliefweb.int/report/libya/57600-covid-19-vaccine-doses-received-today-tripoli|access-date=25 April 2021|website=ReliefWeb}}</ref>
# Madagascar<ref name="cdctracker"/>
# Malawi<ref>{{#invoke:Cite web||title=Malawi to receive COVID-19 vaccines in late February – Xinhua |url=http://www.xinhuanet.com/english/2021-02/02/c_139716241.htm|access-date=19 March 2021|publisher=Xinhuanet}}</ref><ref>{{#invoke:Cite web||title=Malawi Sticks to AstraZeneca Despite Concerns Over Efficacy |url=https://www.voanews.com/covid-19-pandemic/malawi-sticks-astrazeneca-despite-concerns-over-efficacy|access-date=19 March 2021|publisher=Voice of America}}</ref>
# Malaysia<ref name="MYS approves">{{cite news|last1=Sipalan|first1=Joseph|last2=Donovan|first2=Kirsten|date=3 March 2021|title=Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use|agency=Reuters|url=https://www.msn.com/en-au/lifestyle/wellbeing/malaysia-approves-sinovac-astrazeneca-covid-19-vaccines-for-use/ar-BB1e9q01|access-date=7 March 2021}}</ref>
# Maldives<ref>{{#invoke:Cite web||title=Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua |url=http://www.xinhuanet.com/english/2021-01/23/c_139691718.htm|access-date=19 February 2021|publisher=Xinhuanet}}</ref>
# Mali<ref>{{#invoke:Cite web||last=AfricaNews|date=6 March 2021 |title=Mali receives first batch of COVID-19 vaccines|url=https://www.africanews.com/2021/03/06/mali-receives-first-batch-of-covid-19-vaccines/|access-date=1 April 2021|website=Africanews}}</ref>
# Mauritania<ref name="whotracker"/>
# Mauritius<ref>{{#invoke:Cite web||last=AfricaNews|date=26 January 2021|title=Mauritius begins vaccinating frontline health workers against covid-19|url=https://www.africanews.com/2021/01/26/mauritius-begins-vaccinating-frontline-health-workers-against-covid-19/|access-date=24 February 2021|website=Africanews}}</ref>
# Mexico<ref>{{cite news|date=5 January 2021|title=Mexico approves AstraZeneca COVID-19 vaccine, minister says|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKBN29A04O|access-date=14 January 2021}}</ref>
# Micronesia<ref name="whotracker"/>
# Moldova<ref name=":2" />
# Mongolia<ref name="news.mn">{{#invoke:Cite web||date=11 January 2021|title=Mongolia approved three Covid-19 vaccines |url=https://news.mn/en/795048/|access-date=1 April 2021|website=News.MN}}</ref>
# Montenegro<ref name="cdctracker"/>
# Morocco<ref>{{Cite news|date=7 January 2021|title=Morocco approves AstraZeneca/Oxford COVID-19 vaccine – Minister|publisher=Reuters|url=https://www.reuters.com/article/uk-health-coronavirus-morocco-idUSKBN29C0QA|access-date=22 March 2021}}</ref>
# Mozambique<ref name="cdctracker"/>
# Myanmar<ref>{{cite news|date=27 January 2021|title=Myanmar launches nationwide COVID-19 vaccination program|website=Xinhua News|url=http://www.xinhuanet.com/english/2021-01/27/c_139700809.htm}}</ref>
# Namibia<ref name="mhss.gov.na">{{Cite web|url=https://mhss.gov.na/documents/119527/775250/SKM_36721030413220.pdf/7a4534bb-022f-46e4-9113-571432290194|title=Importation of COVID-19 Vaccines into Namibia for Public Use and Guidance on Administration of Vaccines by Private Health Care Providers|date=2021-03-31|website=Republic of Namibia Ministry of Health and Social Services|others=Public Notice No.: 05/032021}}</ref>
# Nauru<ref name=Reliefweb>{{#invoke:Cite web||title=Samoa receives 24,000 doses of COVID-19 vaccines through the COVAX facility - Samoa|url=https://reliefweb.int/report/samoa/samoa-receives-24000-doses-covid-19-vaccines-through-covax-facility|access-date=7 June 2021|website=ReliefWeb}}</ref>
# Nepal<ref>{{cite news|date=15 January 2021|title=Nepal approves AstraZeneca COVID vaccine for emergency use – government statement|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal/nepal-approves-astrazeneca-covid-vaccine-for-emergency-use-government-statement-idUSKBN29K140}}</ref>
# New Zealand<ref name="whotracker"/>
# Nicaragua<ref name="cdctracker"/>
# Niger<ref name="cdctracker"/>
# Nigeria<ref>{{cite news|title=Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria|publisher=BBC News Pidgin|url=https://www.bbc.com/pidgin/media-56084858|access-date=24 February 2021}}</ref>
# North Macedonia<ref>{{cite web |title=Сѐ за вакцините |url=https://kovid19vakcinacija.mk/za-vakcinite/ |website=Официјална веб-страница за вакцинација против КОВИД19 |language=mk-MK}}</ref>
# Oman<ref name="cdctracker"/>
# Pakistan<ref>{{cite news|date=16 January 2021|title=Pakistan approves AstraZeneca COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/us-health-coronavirus-pakistan-astrazene/pakistan-approves-astrazeneca-covid-19-vaccine-for-emergency-use-idUKKBN29L0DO}}</ref>
# Palestine<ref name="cdctracker"/>
# Panama<ref name="cdctracker"/>
# Papua New Guinea<ref>{{#invoke:Cite web||date=30 March 2021|title=PNG prime minister first to be vaccinated with Australian-supplied doses 'to show it's safe'|url=http://www.theguardian.com/world/2021/mar/30/png-prime-minister-first-to-be-vaccinated-with-australian-supplied-doses-to-show-its-safe|access-date=1 April 2021|website=The Guardian}}</ref><ref>{{#invoke:Cite web||date=17 March 2021|title=Australia gives Covid-19 vaccine doses to hard-hit Papua New Guinea|url=https://www.france24.com/en/asia-pacific/20210317-australia-gives-covid-19-vaccine-doses-to-hard-hit-papua-new-guinea|access-date=1 April 2021|publisher=France 24}}</ref>
# Paraguay<ref name="whotracker"/>
# Peru<ref>{{cite web |title=DIGEMID |url=http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 |website=www.digemid.minsa.gob.pe |language=es}}</ref>
# Philippines<ref>{{cite news|date=28 January 2021|title=Philippine regulator approves emergency use of AstraZeneca vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-philippines-vaccin-idUSKBN29X0CY|access-date=28 January 2021}}</ref>
# Qatar<ref name="whotracker"/>
# Rwanda<ref>{{#invoke:Cite web||title=Rwanda receives COVID-19 Vaccines through COVAX|url=https://www.afro.who.int/news/rwanda-receives-covid-19-vaccines-through-covax|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref>
# Samoa<ref name=Reliefweb />
# São Tomé and Príncipe<ref name="cdctracker"/>
# Saudi Arabia<ref name="gulfnews.com" />
# Senegal<ref name="whotracker"/>
# Serbia<ref>{{cite news|date=21 February 2021|title=Serbia receives first shipment of AstraZeneca COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-serbia-vaccines-idUSL1N2KR03M|access-date=19 March 2021}}</ref>
# Seychelles<ref>{{Cite news|last=Bhattacherjee|first=Kallol|date=22 January 2021|title=Coronavirus {{!}} Myanmar, Mauritius, Seychelles receive Covishield vaccine|work=The Hindu|url=https://www.thehindu.com/news/national/coronavirus-myanmar-mauritius-seychelles-receive-covishield-vaccine/article33638057.ece|access-date=1 April 2021}}</ref>
# Sierra Leone<ref>{{#invoke:Cite web||title=COVID-19 vaccines shipped by COVAX arrive in Sierra Leone|url=https://www.afro.who.int/news/covid-19-vaccines-shipped-covax-arrive-sierra-leone|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref>
# Singapore<ref name="channelnewsasia.com">{{#invoke:Cite web||title=Those who opt for Sinovac, other vaccines under WHO emergency list to be considered fully vaccinated |url=https://www.channelnewsasia.com/singapore/sinovac-vaccine-covid19-sinopharm-astrazeneca-fully-vaccinated-2096576 |access-date=6 August 2021 |work=CNA |date=6 August 2021}}</ref> ''(restricted)''
# Solomon Islands<ref name="cdctracker"/>
# Somalia<ref>{{#invoke:Cite web||title=Somalia Receives Its First Batch of COVID-19 Vaccines |url=https://www.voanews.com/covid-19-pandemic/somalia-receives-its-first-batch-covid-19-vaccines|access-date=1 April 2021|publisher=Voice of America}}</ref>
# South Korea<ref>{{cite news|last1=Kim|first1=Han-joo|date=10 February 2021|title=S. Korea approves AstraZeneca's COVID-19 vaccine for all adults|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210210006351320|access-date=10 February 2021}}</ref><ref>{{cite news|last1=Maresca|first1=Thomas|date=10 February 2021|title=South Korea approves AstraZeneca COVID-19 vaccine|publisher=United Press International|url=https://www.upi.com/Top_News/World-News/2021/02/10/South-Korea-approves-AstraZeneca-COVID-19-vaccine/4231612945438/|access-date=10 February 2021}}</ref>
# South Sudan<ref>{{#invoke:Cite web||title=COVID-19 vaccination kicks-off in South Sudan|url=https://www.afro.who.int/news/covid-19-vaccination-kicks-south-sudan|access-date=14 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref>
# Sri Lanka<ref>{{#invoke:Cite web||date=22 January 2021|title=Sri Lanka approves vaccine amid warnings of virus spread|url=https://apnews.com/article/sri-lanka-coronavirus-pandemic-340488c48ab372050825e70e057dd294|access-date=22 January 2021|publisher=Associated Press}}</ref>
# Sudan<ref>{{#invoke:Cite web||title=COVID-19 vaccination in Sudan|url=https://www.unicef.org/sudan/stories/covid-19-vaccination-sudan|access-date=19 March 2021|website=[[UNICEF]]}}</ref><ref>{{#invoke:Cite web||title=Sudan receives first delivery of COVID-19 vaccines with over 800,000 doses|url=https://www.unicef.org/press-releases/sudan-receives-first-delivery-covid-19-vaccines-over-800000-doses|access-date=19 March 2021|website=[[UNICEF]]}}</ref>
# Syria<ref name="whotracker"/>
# Taiwan<ref>{{cite news|date=20 February 2021|title=Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-taiwan-idUSKBN2AK05R|access-date=13 March 2021|publisher=Reuters}}</ref>
# Tajikistan<ref>{{#invoke:Cite web||title=Tajikistan becomes first country in Central Asia to receive COVID-19 vaccine through COVAX Facility|url=https://www.unicef.org/tajikistan/press-releases/tajikistan-becomes-first-country-central-asia-receive-covid-19-vaccine-through-0|access-date=14 April 2021|website=unicef.org}}</ref>
# Thailand<ref>{{#invoke:Cite web||date=23 January 2021|title=Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca|url=https://www.pattayamail.com/thailandnews/thai-food-and-drug-registers-covid-19-vaccine-developed-by-astrazeneca-341186|website=Pattaya Mail}}</ref>
# Togo<ref>{{#invoke:Cite web||last=First|first=Togo|title=Covid-19: First vaccination campaign to soon begin|url=https://www.togofirst.com/en/health/1602-7300-covid-19-first-vaccination-campaign-to-soon-begin|access-date=19 March 2021|website=togofirst.com}}</ref>
# Tonga<ref>{{#invoke:Cite web||title=Over 500 people given first COVID-19 vaccine shot in Tonga – Xinhua |url=http://www.xinhuanet.com/english/asiapacific/2021-04/16/c_139885080.htm|access-date=25 April 2021|website=www.xinhuanet.com}}</ref><ref>{{#invoke:Cite web||date=16 April 2021|title=Tonga's Princess takes the lead on Covid-19 vaccination|url=https://www.rnz.co.nz/international/pacific-news/440580/tonga-s-princess-takes-the-lead-on-covid-19-vaccination|access-date=25 April 2021|website=RNZ}}</ref><ref>{{#invoke:Cite web||title=Kingdom of Tonga receives 24,000 doses of COVID-19 vaccines through the COVAX facility|url=https://www.who.int/westernpacific/about/how-we-work/pacific-support/news/detail/31-03-2021-kingdom-of-tonga-receives-24-000-doses-of-covid-19-vaccines-through-the-covax-facility|access-date=25 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref>
# Tunisia<ref name="whotracker"/>
# Turkmenistan<ref name="whotracker">{{cite web |title=WHO Coronavirus (COVID-19) Dashboard |url=https://covid19.who.int/ |publisher=[[World Health Organization]] (WHO) }}</ref>
# Tuvalu<ref name="Reliefweb"/>
# Uganda<ref>{{#invoke:Cite web||last=AfricaNews|date=10 March 2021|title=Uganda starts COVID-19 vaccinations|url=https://www.africanews.com/2021/03/10/uganda-starts-covid-19-vaccinations/|access-date=19 March 2021|website=Africanews}}</ref>
# Ukraine<ref>{{#invoke:Cite web||title=COVID-19: AstraZeneca vaccine certified for use in Ukraine|url=https://covid.unian.info/covid-19-astrazeneca-vaccine-certified-for-use-in-ukraine-11330906.html|access-date=10 March 2021|website=covid.unian.info}}</ref>
# United Arab Emirates<ref name="cdctracker"/>
# United Kingdom<ref>{{#invoke:Cite web||date=30 December 2020|title=Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref><ref>{{cite press release|title=Oxford University/AstraZeneca vaccine authorised by UK medicines regulator|url=https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator|publisher=Department of Health and Social Care|access-date=30 December 2020|date=30 December 2020}}</ref><ref>{{#invoke:Cite web||date=30 December 2020|title=Conditions of Authorisation for COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref>
# Uruguay<ref name="cdctracker"/>
# Uzbekistan<ref name="cdctracker"/>
# Vanuatu<ref name="whotracker"/>
# Vietnam<ref>{{#invoke:Cite web||title=Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress|url=https://www.channelnewsasia.com/news/asia/vietnam-approves-astrazeneca-vaccine-reports-34-new-covid-19-14074712|access-date=5 February 2021|website=CNA}}</ref>
# Yemen<ref>{{#invoke:Cite web||title=Yemen receives 360,000 COVID-19 vaccine doses through the COVAX Facility|url=https://www.unicef.org/press-releases/yemen-receives-360000-covid-19-vaccine-doses-through-covax-facility|access-date=7 June 2021|website=www.unicef.org}}</ref>
# Zambia<ref name=":5">{{Cite news|date=25 March 2021|title=Zambia sets out plans to vaccinate all people over 18 against COVID-19|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-zambia-vaccine-idUSKBN2BH2NS|access-date=17 April 2021}}</ref><ref name=":6">{{#invoke:Cite web||title=Zambia launches the COVID-19 vaccination|url=https://reliefweb.int/report/zambia/zambia-launches-covid-19-vaccination|access-date=17 April 2021|website=ReliefWeb}}</ref><ref name=":8">{{#invoke:Cite web||title=Zambia gets 1st 228,000 vaccine doses from COVAX|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/zambia-gets-1st-228-000-vaccine-doses-from-covax/2206521|access-date=17 April 2021|website=aa.com.tr}}</ref>
# Zimbabwe<ref name="whotracker"/>
'''{{nowrap|[[European Medicines Agency|EMA countries]]}}'''<ref name="Vaxzevria EPAR" /><ref name="EU Marketing authorisation" />
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-oxford">{{cite web |title=CARPHA Issues its First Emergency Use Recommendation for a COVID-19 Vaccine |url=https://www.carpha.org/More/Media/Articles/ArticleID/435/CARPHA-Issues-its-First-Emergency-Use-Recommendation-for-a-COVID-19-Vaccine |website=Caribbean Public Health Agency}}</ref>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines
# Suriname<ref>{{cite news|date=23 February 2021|title=Suriname begins coronavirus vaccination campaign with donated doses|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-suriname-vaccine-idUSKBN2AN2AT|access-date=28 February 2021}}</ref>
# Trinidad and Tobago
<!-- not counted --><br />
'''[[ISO 3166-1#Current codes|Non-country entities]]'''
* Anguilla{{efn|name=carphance|via CARPHA authorization<ref name="carpha-oxford"/>}}
* Aruba{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Curaçao{{efn|name=carphance}}
* Cook Islands<ref name="cdctracker"/>
* Falkland Islands<ref name="cdctracker"/>
* French Polynesia<ref name="cdctracker"/>
* Guadeloupe<ref name="whotracker"/>
* Guernsey<ref name="cdctracker"/>
* Isle of Man<ref name="cdctracker"/>
* Jersey<ref name="cdctracker"/>
* Montserrat{{efn|name=carphance}}
* Northern Cyprus<ref name=":4">{{#invoke:Cite web||last=Psyllides|first=George|title=Coronavirus: 10,000 vaccines handed over to north |url=https://cyprus-mail.com/2021/03/31/coronavirus-10000-vaccines-handed-over-to-north/|access-date=17 April 2021|website=cyprus-mail.com/}}</ref>
* Pitcairn<ref name="whotracker"/>
* Saint Helena, Ascension and Tristan da Cunha<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Turks and Caicos Islands{{efn|name=carphance}}
* Wallis and Futuna<ref name="cdctracker"/>
* ''[[World Health Organization]]''<ref name="WHO status" /><ref>{{#invoke:Cite web||title=Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca|url=https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1|access-date=27 February 2021|publisher=[[World Health Organization]] (WHO)}}</ref><ref>{{cite news|title=AstraZeneca/Oxford Covid-19 Vaccine Gets Emergency Approval From WHO|website=Forbes|url=https://www.forbes.com/sites/alisondurkee/2021/02/15/astrazeneca-oxford-covid-19-vaccine-gets-emergency-approval-from-who/|access-date=16 February 2021}}</ref><ref>{{cite web | title=WHO Recommendation AstraZeneca/SKBio - COVID-19 Vaccine (ChAdOx1-S [recombinant]) | website=[[World Health Organization]] (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant | access-date=8 May 2021}}</ref><ref>{{cite web | title=WHO recommendation Serum Institute of India Pvt Ltd - COVID-19 Vaccine (ChAdOx1-S [recombinant]) - Covishield | website=[[World Health Organization]] (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant-covishield | access-date=8 May 2021}}</ref>
</div>

== Pfizer–BioNTech ==
<section begin="pfizerauthmap"/>
{{infobox|image={{Graph:Map|scale=80|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AT=dodgerblue|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue
|BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BH=dodgerblue|BJ=limegreen|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=limegreen|CF=limegreen|CG=limegreen|CH=blueviolet|CI=limegreen|CK=dodgerblue|CL=dodgerblue|CM=limegreen|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=dodgerblue|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=limegreen
|FI=dodgerblue|FJ=limegreen|FM=blueviolet|FO=dodgerblue|FR=dodgerblue
|GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GH=limegreen|GI=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue
|HK=dodgerblue|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue
|IL=dodgerblue|IM=dodgerblue|IN=limegreen|IQ=dodgerblue|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue
|JE=dodgerblue|JM=dodgerblue|JO=dodgerblue|JP=dodgerblue
|KE=dodgerblue|KG=limegreen|KH=limegreen|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=dodgerblue|LB=limegreen|LC=dodgerblue|LI=dodgerblue|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=dodgerblue|MD=dodgerblue|ME=dodgerblue|MH=blueviolet|MK=dodgerblue|ML=limegreen|MM=limegreen|MN=dodgerblue|MO=dodgerblue|MP=dodgerblue|MQ=dodgerblue|MR=limegreen|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=limegreen|NC=dodgerblue|NE=limegreen|NG=dodgerblue|NI=limegreen|NL=dodgerblue|NO=dodgerblue|NP=limegreen|NR=limegreen|NU=dodgerblue|NZ=blueviolet
|OM=dodgerblue
|PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=blueviolet|PY=dodgerblue
|QA=dodgerblue
|RO=dodgerblue|RS=dodgerblue|RW=dodgerblue
|SA=blueviolet|SB=limegreen|SD=dodgerblue|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SM=dodgerblue|SN=limegreen|SO=limegreen|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=limegreen|SZ=limegreen
|TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=limegreen|TK=dodgerblue|TL=limegreen|TN=dodgerblue|TO=limegreen|TR=dodgerblue|TT=dodgerblue|TV=limegreen|TW=dodgerblue
|UA=dodgerblue|UG=limegreen|US=blueviolet|UY=dodgerblue|UZ=dodgerblue
|VA=dodgerblue|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=limegreen
|WS=limegreen
|XK=dodgerblue
|YE=limegreen
|ZA=dodgerblue|ZM=limegreen|ZW=limegreen
}}
|caption=
{{leftlegend|blueviolet|Бүрин зүбшөөрэл}}
{{leftlegend|dodgerblue|Аварийна зүбшөөрэл}}
{{leftlegend|limegreen|Зүйтэй [[COVAX]]-ай абагша}}
}}
<section end="pfizerauthmap"/>
The [[Pfizer–BioNTech COVID-19 vaccine]], also known as Comirnaty,<ref name="Comirnaty EPAR">{{#invoke:Cite web||title=Comirnaty EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|access-date=23 December 2020|publisher=[[European Medicines Agency]] (EMA)}}</ref> is an [[mRNA vaccine]]<ref name="hcreg">{{#invoke:Cite web||date=9 December 2020|title=Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref> produced by the German company [[BioNTech]] and the American company [[Pfizer]].<ref name="hcreg"/><ref name="NCT04368728">{{#invoke:Cite web||date=30 April 2020|title=Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults|url=https://clinicaltrials.gov/ct2/show/NCT04368728|url-status=live|archive-url=https://web.archive.org/web/20201011084828/https://clinicaltrials.gov/ct2/show/NCT04368728/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368728}}</ref><ref name="EudraCT-2020-001038-36">{{#invoke:Cite web||date=14 April 2020|title=A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|url-status=live|archive-url=https://web.archive.org/web/20200422111024/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|archive-date=22 April 2020|access-date=22 April 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001038-36}}</ref> In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by [[Fosun Pharma]].<ref>{{#invoke:Cite web||title=BioNTech and China partner, not Pfizer, to produce HK shots|url=https://www.thestandard.com.hk/section-news/section/11/225661/BioNTech-and-China-partner,-not-Pfizer,-to-produce-HK-shots|website=The Standard}}</ref><ref>{{#invoke:Cite web||title=Pfizer and BioNTech's overlooked third partner will distribute the vaccine in China – and it's facing some resistance |url=https://fortune.com/2021/01/09/covid-vaccine-china-fosun-pfizer-biontech/|access-date=18 April 2021}}</ref><ref>{{Cite news|last=Burger|first=Ludwig|date=16 March 2020|title=BioNTech in China alliance with Fosun over potential coronavirus vaccine|work=Reuters|url=https://www.reuters.com/article/us-biontech-fosunpharma-vaccine-collabor-idUKKBN2130O5|access-date=18 April 2021}}</ref><ref>{{Cite news|date=25 November 2020|title=BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-biontech-fosunphar-idUSKBN2850ZZ|access-date=18 April 2021}}</ref><ref name="RTHK 20210711" /><ref name="BioNTech PR 20210712" />

;Full (<section begin="Pfizer-BioNTech_FN"/>10<section end="Pfizer-BioNTech_FN"/>)
# Australia<ref>{{#invoke:Cite web||title=Comirnaty|url=https://www.tga.gov.au/apm-summary/comirnaty|date=25 January 2021|access-date=25 January 2021|publisher=[[Therapeutic Goods Administration]] (TGA)}}</ref><ref>{{cite report | url=https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | title=Australian Public Assessment Report for BNT162b2 (mRNA) | publisher=[[Therapeutic Goods Administration]] (TGA) | access-date=25 January 2021}}</ref>
# Brazil<ref name="Brazil approves full vaccine">{{#invoke:Cite web||url=https://g1.globo.com/bemestar/vacina/noticia/2021/02/23/anvisa-concede-registro-definitivo-a-vacina-da-pfizer.ghtml|title=Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil|publisher=G1|date=23 February 2021|access-date=23 February 2021|language=pt-br}}</ref>
#Canada<ref>{{cite web|date=August 23, 2021|title=U.S. gives Pfizer COVID-19 vaccine full approval - CityNews Toronto|url=https://toronto.citynews.ca/2021/08/23/us-pfizer-covid-19-vaccine-full-approval/|access-date=August 23, 2021|website=CityNews Toronto}}</ref><ref>{{cite web|author1=The Associated Press|date=August 23, 2021|title=U.S. regulators give full approval of Pfizer-BioNTech's COVID-19 vaccine|url=https://www.cbc.ca/news/health/us-pfizer-fda-approval-1.6149959|access-date=August 23, 2021|website=CBC News}}</ref><ref name=":13" />
# Marshall Islands{{efn|name=CFA}}{{efn|name=useua|Full approval only for those aged 16+. EUA still applies for recipients aged 12-15.}}
# Micronesia{{efn|name=CFA}}{{efn|name=useua}}
# New Zealand<ref>{{#invoke:Cite web||date=3 February 2021|title=Robust assessment ahead of Medsafe approval of vaccine|url=https://www.health.govt.nz/news-media/media-releases/robust-assessment-ahead-medsafe-approval-vaccine|access-date=6 February 2021|work=Ministry of Health}}</ref>
# Palau{{efn|name=CFA|via United States authorization through [[Compact of Free Association]]<ref>{{cite press release | title=Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines | publisher=[[United States Department of the Interior]] (DOI) | date=12 December 2020 | url=https://www.doi.gov/oia/press/interior-applauds-inclusion-insular-areas-through-operation-warp-speed-receive-covid-19 | access-date=13 January 2021}} {{PD-notice}}</ref><ref>{{cite news|url=https://www.hawaiipublicradio.org/post/asia-minute-palau-administers-vaccines-keep-country-free-covid#stream/0|publisher=[[Hawaii Public Radio]]|title=Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID|first=Bill|last=Dorman|date=6 January 2021|access-date=13 January 2021|name-list-style=vanc}}</ref>}}{{efn|name=useua}}
# Saudi Arabia<ref>{{#invoke:Cite web||date=10 December 2020|title=Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use|url=https://english.alarabiya.net/en/coronavirus/2020/12/10/Coronavirus-Saudi-Arabia-approves-Pfizer-COVID-19-vaccine-for-use|access-date=10 December 2020|website=Al Arabiya English}}</ref><ref name="NYT vaccine tracker">{{cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|title=Coronavirus Vaccine Tracker|work=[[The New York Times]]|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|name-list-style=vanc}}</ref>
# Switzerland<ref name="Swiss authorization">{{cite press release|title=Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland|url=https://www.bag.admin.ch/bag/en/home/das-bag/aktuell/medienmitteilungen.msg-id-81761.html|publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]]|date=19 December 2020|access-date=19 December 2020}}</ref><ref>{{#invoke:Cite web||title=Comirnaty Product information|url=https://www.swissmedicinfo.ch/ShowText.aspx?textType=FI&lang=DE&authNr=68225|access-date=31 January 2021|language=DE|trans-quote=Due to incomplete clinical data at the time of the assessment of the authorization application, the Comirnaty medicinal product is authorized for a limited period (Art. 9a Medicinal Products Act).}}</ref>
# United States{{efn|name=useua}}<ref>{{cite press release|title=FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine|publisher=U.S. [[Food and Drug Administration]] (FDA)|date=11 December 2020|url=https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19|access-date=11 December 2020}} {{PD-notice}}</ref><ref name="Pfizer-BioNTech COVID-19 Vaccine EUA fact sheet">{{#invoke:Cite web||date=25 February 2021|title=Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers|url=https://www.fda.gov/media/144413/download|access-date=25 February 2021|publisher=Pfizer|format=PDF}}</ref><ref name="FDA PR 20210823">{{Cite press release |title=FDA Approves First COVID-19 Vaccine |date=23 August 2021 |publisher=U.S. [[Food and Drug Administration]] (FDA) |url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine |access-date=23 August 2021 |archive-url=https://web.archive.org/web/20210823143040/https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine |archive-date=23 August 2021 |url-status=live}}</ref>
{{-}}
;Emergency (<section begin="Pfizer-BioNTech_EN"/>122<section end="Pfizer-BioNTech_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref name="cdctracker"/>
# Albania<ref>{{#invoke:Cite web||title=Albania to start COVID-19 immunisation with Pfizer vaccine in January – report|url=https://seenews.com/news/albania-to-start-covid-19-immunisation-with-pfizer-vaccine-in-jan-report-726470|website=Seenews}}</ref>
# Algeria<ref>{{Cite web|date=2021-05-05|title=Canada allows Pfizer COVID-19 vaccine for children aged 12-15|url=https://www.reuters.com/world/americas/canada-authorizes-pfizer-covid-19-vaccine-children-aged-12-15-2021-05-05/|access-date=2021-08-19|website=Reuters|language=en}}</ref>
# Andorra<ref>{{#invoke:Cite web||title=Andorra COVID-19|url=https://www.govern.ad/covid19_newsletter/en/|access-date=19 February 2021|website=govern.ad}}</ref>
# Argentina<ref>{{cite news|title=Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer|url=https://www.lanacion.com.ar/sociedad/coronavirus-argentina-anmat-aprobo-uso-emergencia-vacuna-nid2548852|access-date=23 December 2020|website=La Nación|language=es}}</ref>
# Armenia<ref>{{#invoke:Cite web||date=June 30, 2021|title=Dashboard: Vaccinating Eurasia- June|url=https://eurasianet.org/dashboard-vaccinating-eurasia-june|url-status=live|access-date=August 4, 2021|website=[[Eurasianet]]}}</ref>
# Azerbaijan<ref name="whotracker"/>
# Bahrain<ref>{{#invoke:Cite web||title=Bahrain becomes second country to approve Pfizer COVID-19 vaccine|url=https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine|access-date=5 December 2020|publisher=[[Al Jazeera]]}}</ref><ref>{{cite web | title=The Pfizer-BioNTech COVID-19 Vaccine Was Granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) & Bahrain National Health Regulatory Authority (NHRA) | website=cvdvaccine | url=https://www.cvdvaccine-bh.com/ | access-date=18 April 2021}}</ref>
# Bangladesh<ref>{{#invoke:Cite web||title=Bangladesh approves Pfizer Covid-19 vaccine for emergency use|date=27 May 2021|url=https://www.dhakatribune.com/bangladesh/2021/05/27/bangladesh-approves-pfizer-covid-19-vaccine-for-emergency-use|access-date=27 May 2021|publisher=[[Dhaka Tribune]]}}</ref>
# Bhutan<ref name="whotracker"/>
# Bolivia<ref name="cdctracker"/>
# Bosnia and Herzegovina<ref name=":3">{{#invoke:Cite web||title=Pfizer/BioNTech COVID-19 vaccines shipped by COVAX arrive in Bosnia and Herzegovina|url=https://bosniaherzegovina.un.org/en/123137-pfizerbiontech-covid-19-vaccines-shipped-covax-arrive-bosnia-and-herzegovina|access-date=14 April 2021|publisher=United Nations}}</ref>
# Botswana<ref>{{Cite news|title=Botswana expects to welcome multiple COVID-19 vaccines |url=http://www.xinhuanet.com/english/africa/2021-02/27/c_139771113.htm|access-date=1 April 2021|publisher=Xinhuanet}}</ref>
# Brunei<ref name="auto">{{#invoke:Cite web||title=COVID-19: Brunei to begin mass vaccination on April 3 |url=https://thescoop.co/2021/04/02/covid-19-brunei-to-begin-mass-vaccination-on-april-3/|access-date=6 April 2021|website=TheScoop|date=2 April 2021}}</ref>
# Cape Verde<ref name="cdctracker"/>
# Chile<ref name="chile">{{#invoke:Cite web||date=17 December 2020|title=Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use|url=https://www.straitstimes.com/world/chile-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use|access-date=17 December 2020|website=The Straits Times}}</ref>
# Colombia<ref>{{cite news|date=6 January 2021|title=Colombia regulator approves Pfizer-BioNTech vaccine for emergency use|publisher=[[Reuters]]|url=https://www.reuters.com/article/health-coronavirus-colombia-vaccine/colombia-regulator-approves-pfizer-biontech-vaccine-for-emergency-use-idINL1N2JH00P/|access-date=6 January 2021}}</ref>
# Costa Rica<ref name="costa">{{#invoke:Cite web||date=16 December 2020|title=Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine|url=https://ticotimes.net/2020/12/16/costa-rica-authorizes-pfizer-biontech-coronavirus-vaccine|access-date=16 December 2020|website=The Tico Times}}</ref>
# Djibouti<ref name="whotracker"/>
# Dominican Republic<ref>[https://covid-19pharmacovigilance.paho.org/pfizer-biontech Pfizer-BioNTech COVID-19 vaccine]. Pan American Health Organization.</ref>
# Ecuador<ref name="ecuador">{{#invoke:Cite web||title=Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-ingreso-al-pais-de-vacuna-pfizer-biontech-para-el-covid-19/|access-date=17 December 2020|language=es}}</ref>
# Egypt<ref name="whotracker"/>
# El Salvador<ref name="cdctracker"/><ref>{{#invoke:Cite web||last=McGwin|first=Kevin|date=30 December 2020|title=Greenland to begin new year with COVID vaccinations|url=https://www.arctictoday.com/greenland-to-begin-new-year-with-covid-vaccinations/|access-date=21 March 2021|website=ArcticToday}}</ref>
# Georgia<ref name="whotracker"/>
# Guatemala<ref name="auto3">{{cite web |title=COVID-19 Information |url=https://gt.usembassy.gov/alert-covid-19-2/ |website=U.S. Embassy in Guatemala |date=25 February 2020}}</ref>
# Guinea<ref name="whotracker"/>
# Honduras<ref name="whotracker"/>
# Indonesia<ref>{{cite news|url=https://www.cnnindonesia.com/nasional/20210715145336-20-668159/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-pfizer|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin COVID-19 Pfizer|work=CNN Indonesia|date=15 July 2021|accessdate=15 July 2021|language=id}}</ref>
#Iran<ref>{{Cite web|date=September 22, 2021|title=Iran says to buy 2 million doses of Pfizer vaccine|url=https://mb.com.ph/2021/09/22/iran-says-to-buy-2-million-doses-of-pfizer-vaccine/|url-status=live|access-date=October 4, 2021|website=[[Manila Bulletin]]}}</ref>
# Iraq<ref>{{#invoke:Cite web||title=Iraq grants emergency approval for Pfizer COVID-19 vaccine|url=https://www.msn.com/en-ae/news/other/iraq-grants-emergency-approval-for-pfizer-covid-19-vaccine/ar-BB1cgvD6|access-date=27 December 2020|publisher=MSN}}</ref>
# Israel<ref>{{#invoke:Cite web||title=Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine|url=https://www.jpost.com/breaking-news/fda-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use-nyt-651871|access-date=28 December 2020|website=The Jerusalem Post}}</ref>
# Japan<ref name="jp" /><ref>{{cite news|date=14 February 2021|title=Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use|work=[[Nikkei Asia]]|url=https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use|access-date=14 February 2021|name-list-style=vanc}}</ref><ref>{{#invoke:Cite web||last=Tsukimori|first=Osamu|date=15 February 2021|title=Japan gives OK to Pfizer coronavirus vaccine, with rollout to begin this week|url=https://www.japantimes.co.jp/news/2021/02/15/national/science-health/pfizer-vaccine-approval-japan/|access-date=1 April 2021|website=The Japan Times}}</ref>
# Jordan<ref>{{#invoke:Cite web||date=15 December 2020|title=Jordan approves Pfizer-BioNTech Covid vaccine|url=https://www.france24.com/en/live-news/20201215-jordan-approves-pfizer-biontech-covid-vaccine|access-date=15 December 2020|publisher=France 24}}</ref>
# Kenya<ref>{{#invoke:Cite news||date=2021-08-02|title=Kenya Approves J&J, Pfizer Covid-19 Vaccines as Cases Surge|language=en|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-08-02/kenya-approves-j-j-pfizer-covid-19-vaccines-as-cases-surge|access-date=2021-09-24}}</ref>
# Kosovo<ref name="whotracker"/>
# Kuwait<ref>{{#invoke:Cite web||date=13 December 2020|title=Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine|url=https://arab.news/427j9|access-date=15 December 2020|website=Arab News}}</ref>
# Laos<ref name="whotracker"/>
# Lebanon<ref>{{#invoke:Cite web||date=14 February 2021|title=Lebanon starts Covid-19 vaccination campaign|url=https://www.france24.com/en/middle-east/20210214-lebanon-starts-covid-19-vaccination-campaign|access-date=16 March 2021|publisher=France 24}}</ref>
# Libya<ref name="cdctracker"/>
# Malawi<ref>{{Cite web|title=Malawi Ministry of Health on Facebook|url=https://www.facebook.com/login/?next&#61;https%253A%252F%252Fwww.facebook.com%252Fmalawimoh%252Fposts%252F4098884300167054|access-date=2021-09-14|website=Facebook|language=en}}</ref>
# Malaysia<ref>{{cite news|last=Lim|first=Ida|date=8 January 2021|title=Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted|work=[[The Malay Mail]]|url=https://www.msn.com/en-my/news/national/khairy-malaysia-can-use-pfizer-e2-80-99s-covid-19-vaccine-now-as-conditional-registration-granted/ar-BB1czVUU|access-date=8 January 2021|name-list-style=vanc}}</ref>
# Maldives<ref>{{#invoke:Cite web||date=15 March 2021|title=Sinopharm & Pfizer approved for use in Maldives|url=https://timesofaddu.com/2021/03/15/breaking-sinopharm-pfizer-approved-for-use-in-maldives/|access-date=1 April 2021|website=The Times of Addu}}</ref>
# Mexico<ref>{{cite news|date=12 December 2020|title=Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges|publisher=Bloomberg|url=https://www.bloomberg.com/news/articles/2020-12-12/mexico-approves-pfizer-vaccine-for-emergency-use-as-covid-surges|access-date=12 December 2020}}</ref><ref>{{cite news|date=12 December 2020|title=Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccine|website=The Economic Times|url=https://economictimes.indiatimes.com/news/international/world-news/mexico-authorizes-emergency-use-of-pfizer-biontech-coronavirus-vaccine/articleshow/79696221.cms|access-date=14 January 2021}}</ref>
# Moldova<ref name=":2">{{cite news|last=Foundation|first=Thomson Reuters|title=Moldova approves Russia's Sputnik V vaccine as political row simmers|url=https://news.trust.org/item/20210227162136-o0jx5/|access-date=1 April 2021|website=news.trust.org}}</ref>
# Monaco<ref>{{#invoke:Cite web||title=First Vaccines Arrive in Monaco – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco|url=https://en.gouv.mc/Policy-Practice/Coronavirus-Covid-19/Actualites/FIRST-VACCINES-ARRIVE-IN-MONACO-COVID-19-vaccination-campaign-begins-tomorrow|access-date=19 February 2021|website=en.gouv.mc}}</ref>
# Mongolia<ref>{{#invoke:Cite web||title=Mongolia will receive 300,000 doses of COVID-19 vaccine developed by China|url=https://akipress.com/news:654794:Mongolia_will_receive_300,000_doses_of_COVID-19_vaccine_developed_by_China/|access-date=19 March 2021|website=AKIpress News Agency
}}</ref>
# Montenegro<ref name="whotracker"/>
# Morocco<ref name="whotracker"/>
# Nigeria<ref>{{#invoke:Cite web||date=2021-04-30|title=NAFDAC approves Pfizer Biotech Vaccine for emergency use authorisation|url=https://editor.guardian.ng/news/nafdac-approves-pfizer-biotech-vaccine-for-emergency-use-authorisation/|access-date=2021-07-21|website=The Guardian Nigeria News - Nigeria and World News|language=en-US}}</ref>
# North Macedonia<ref>{{#invoke:Cite web||title=North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts|url=https://www.rferl.org/a/north-macedonia-kicks-off-covid-19-vaccinations/31108206.html|access-date=19 February 2021|website=RadioFreeEurope/RadioLiberty}}</ref>
# Oman<ref name="oman">{{cite news|date=15 December 2020|title=Oman issues licence to import Pfizer BioNTech Covid vaccine – TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-oman-vaccine-int-idUSKBN28P1RA|access-date=16 December 2020}}</ref>
# Pakistan<ref>{{cite web |title=DRAP gives emergency approval for Pfizer's coronavirus vaccine |url=https://www.geo.tv/latest/352816-drap-gives-emergency-approval-for-pfizers-coronavirus-vaccine |website=www.geo.tv }}</ref>
# Palestine<ref name="cdctracker"/>
# Panama<ref name="panama">{{#invoke:Cite web||title=Panama approves Pfizer's COVID-19 vaccine – health ministry|url=https://finance.yahoo.com/news/panama-approves-pfizers-covid-19-010942802.html|access-date=16 December 2020|publisher=Yahoo! Finance}}</ref>
# Papua New Guinea<ref>{{#invoke:Cite web||date=2021-08-12|title=Vaccination is not compulsory, Prime Minister tells Parliament|url=https://covid19.info.gov.pg/vaccination-is-not-compulsory-prime-minister-tells-parliament/|access-date=2021-09-24|website=PNG &#124; COVID 19|language=en-US}}</ref>
# Paraguay<ref>{{#invoke:Cite web||title=DNVS otorga registro sanitario de emergencia a Pfizer - MSPBS Py|url=https://www.mspbs.gov.py/portal/23306/dnvs-otorga-registro-sanitario-de-emergencia-a-pfizer.html|url-status=live}}</ref><ref>{{#invoke:Cite web||title=Pfizer: la nueva vacuna que compró Paraguay. MSPBS Paraguay|url=https://www.mspbs.gov.py/portal/23192/pfizer-la-nueva-vacuna-que-compro-paraguay.html|url-status=live}}</ref>
# Peru<ref>{{#invoke:Cite web||title=Peru regulators approve Pfizer vaccine against COVID-19: filing|url=https://news.yahoo.com/peru-regulators-approve-pfizer-vaccine-173719455.html|access-date=31 March 2021|publisher=Yahoo! News}}</ref>
# Philippines<ref>{{#invoke:cite news||date=14 January 2021|title=PH authorizes Pfizer's COVID-19 vaccine for emergency use|publisher=CNN Philippines|url=https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html|access-date=14 January 2021}}</ref>
# Qatar<ref>{{#invoke:cite news||title=Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-qatar/qatar-oman-to-receive-pfizer-biontech-covid-19-vaccine-this-week-idUSKBN28U0VE|access-date=24 December 2020}}</ref>
# Rwanda<ref name="cdctracker"/>
# San Marino<ref name="cdctracker"/>
# Serbia<ref>{{#invoke:cite news||date=21 December 2020|title=Serbia leads region in expecting COVID-19 vaccines within days|work=BalkanInsight|url=https://balkaninsight.com/2020/12/21/serbia-leads-region-in-expecting-covid-19-vaccines-within-days/|access-date=26 December 2020}}</ref><ref>{{cite news|date=22 December 2020|title=First shipment of Pfizer-BioNTech vaccine arrives in Serbia|work=Serbian government website|url=https://www.srbija.gov.rs/vest/en/165409/first-shipment-of-pfizer-biontech-vaccine-arrives-in-serbia.php|access-date=26 December 2020}}</ref>
# Singapore<ref>{{#invoke:Cite web||date=14 December 2020|title=Singapore approves use of Pfizer's COVID-19 vaccine|url=https://apnews.com/article/science-singapore-coronavirus-pandemic-lee-hsien-loong-coronavirus-vaccine-5bf8461b9d2d32ec08d56fcf5958317a|access-date=15 December 2020|publisher=Associated Press}}</ref>
# South Africa<ref>{{#invoke:Cite web||title=South Africa approves Pfizer Covid-19 vaccine for emergency use|url=https://businesstech.co.za/news/trending/476360/south-africa-approves-pfizer-covid-19-vaccine-for-emergency-use/|access-date=18 March 2021}}</ref><ref>{{#invoke:Cite web||last=https://www.timeslive.co.za/authors/unathi-nkanjeni|title=Pfizer-BioNTec approved for emergency use in SA: here is what you need to know about the vaccine|url=https://www.timeslive.co.za/news/south-africa/2021-03-18-pfizer-biontec-approved-for-emergency-use-in-sa-here-is-what-you-need-to-know-about-the-vaccine/|access-date=19 March 2021|website=TimesLIVE}}</ref>
# South Korea<ref>{{cite news|last1=Lee|first1=Kyung-eun|date=27 February 2021|title=S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program|work=Arirang News|url=https://www.arirang.com/news/News_View.asp?nseq=273056|access-date=28 February 2021}}</ref><ref>{{cite news|last1=Kim|first1=Han-joo|date=5 March 2021|title=S. Korea approves Pfizer's COVID-19 vaccine amid immunization push|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210305001500320|access-date=5 March 2021}}</ref>
# Sri Lanka<ref>{{cite web |title=Sri Lanka approves Pfizer COVID vaccine for emergency use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/sri-lanka-approves-pfizer-covid-vaccine-emergency-use-2021-05-08/ |website=Reuters |date=8 May 2021}}</ref>
# Sudan<ref name="cdctracker"/>
# Taiwan<ref name="RTHK 20210711">{{cite web | last=Kemp | first=Robert | title=Fosun says it has struck deal to send Taiwan vaccines | website=RTHK | date=11 July 2021 | url=https://news.rthk.hk/rthk/en/component/k2/1600277-20210711.htm? | access-date=11 July 2021}}</ref><ref name="BioNTech PR 20210712">{{cite press release | title=10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region | website=BioNTech | date=12 July 2021 | url=https://investors.biontech.de/news-releases/news-release-details/10-million-doses-mrna-based-covid-19-vaccine-be-supplied-taiwan | access-date=18 July 2021}}</ref>
# Thailand<ref>{{cite news | title = Thailand approves Pfizer-Biontech vaccine for emergency use | date = 24 June 2021 | url = https://www.reuters.com/world/asia-pacific/thailand-approves-pfizer-biontech-vaccine-emergency-use-2021-06-24/ | work = Reuters }}</ref>
# Tunisia<ref name="NYT vaccine tracker" />
# Turkey<ref>{{cite web |author=Gözde Bayar |date=18 March 2021 |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-to-receive-45m-doses-of-pfizer-vaccine-this-month/2179702 |title=Turkey to receive 4.5M doses of Pfizer vaccine this month |publisher=Anadolu Agency}}</ref>
# Ukraine<ref>{{#invoke:Cite web||title=Наказ МОЗ України від 22.02.2021 № 308 "Про державну реєстрацію лікарського засобу (медичного імунобіологічного препарату) для екстреного медичного застосування"|url=https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-22022021--308-pro-derzhavnu-reestraciju-likarskogo-zasobu-medichnogo-imunobiologichnogo-preparatu-dlja-ekstrenogo-medichnogo-zastosuvannja|access-date=19 March 2021|website=moz.gov.ua}}</ref>
# United Arab Emirates<ref>{{#invoke:Cite web||date=23 December 2020|title=Dubai approves the Pfizer-BioNTech vaccine which will be free of charge|url=https://emirateswoman.com/dubai-approves-the-pfizer-biontech-vaccine-for-free/|access-date=28 December 2020|website=Emirates Woman}}</ref>
# United Kingdom<ref name="ukgov12-2">{{#invoke:Cite web||date=2 December 2020|title=UK medicines regulator gives approval for first UK COVID-19 vaccine|url=https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine|access-date=2 December 2020|publisher=Medicines and Healthcare Products Regulatory Agency, Government of the UK}}</ref><ref name="MHRA 2020-12-08">{{#invoke:Cite web||date=8 December 2020|title=Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}</ref><ref>{{#invoke:Cite web||date=3 December 2020|title=Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}</ref>
# Uruguay<ref>{{cite web |title=Uruguay acquired Pfizer and Sinovac vaccines; details will be announced Saturday |url=https://en.mercopress.com/2021/01/23/uruguay-acquired-pfizer-and-sinovac-vaccines-details-will-be-announced-saturday |website=MercoPress }}</ref>
#Uzbekistan<ref>{{Cite web|date=September 12, 2021|title=U.S. Donates Over 1.2 million COVID-19 Pfizer Vaccines to Uzbekistan|url=https://uz.usembassy.gov/u-s-donates-over-1-2-million-covid-19-pfizer-vaccines-to-uzbekistan/|url-status=live|access-date=October 4, 2021|website=<nowiki>[[U.S. Embassy in Uzbekistan</nowiki>}}</ref>
# Vatican City<ref>{{cite news|last=McElwee|first=Joshua J.|date=11 December 2020|title=Vatican to offer coronavirus vaccine to residents and staff in early 2021|publisher=[[National Catholic Reporter]]|url=https://www.ncronline.org/news/coronavirus/vatican-offer-coronavirus-vaccine-residents-and-staff-early-2021|access-date=9 February 2021}}</ref><ref>{{cite press release|url=https://www.vaticannews.va/it/vaticano/news/2020-12/in-vaticano-parte-il-piano-vaccinale-anticovid.html|title=In Vaticano parte il piano vaccinale anticovid|date=11 December 2020|access-date=9 February 2021|first=Massimiliano|last=Menichetti|website=vatican.va}}</ref>
# Vietnam<ref>{{Cite news|last=Le|first=Nga|date=12 June 2021|title=Vietnam approves Pfizer Covid vaccine for emergency use|work=[[VnExpress]]|url=https://e.vnexpress.net/news/news/vietnam-approves-pfizer-covid-vaccine-for-emergency-use-4293267.html}}</ref>
'''{{nowrap|[[European Medicines Agency|EMA countries]]}}'''<ref name="Comirnaty EPAR" /><ref name="EU Marketing authorisation" />
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-pfizer">{{cite web | title=Caribbean Public Health Agency > Who We Are > Member States | website=The Caribbean Public Health Agency (CARPHA) | url=https://www.carpha.org/Who-We-Are/Member-States | access-date=7 April 2021}}</ref><ref>{{#invoke:Cite web||date=6 January 2021|title=Pfizer vaccine approved for region but Health Ministry wants more info|url=https://newsday.co.tt/2021/01/06/pfizer-vaccine-approved-for-region-but-health-ministry-wants-more-info/|access-date=24 February 2021|website=Trinidad and Tobago Newsday}}</ref>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines
# Suriname
# Trinidad and Tobago
<!-- not counted --><br />
'''[[ISO 3166-1#Current codes|Non-country entities]]'''
* Anguilla{{efn|name=carphance}}
* American Samoa<ref name="whotracker"/>
* Aruba{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Cook Islands<ref name="whotracker"/>
* Curaçao{{efn|name=carphance}}
* Faroe Islands<ref>{{#invoke:Cite web||last=Nielsdóttir|first=Alda|date=30 December 2020|title=First Covid-19 vaccines administered in the Faroe Islands|url=https://local.fo/first-covid-19-vaccines-administered-in-the-faroe-islands/|access-date=29 March 2021|website=Local.fo}}</ref>
* French Polynesia<ref name="whotracker"/>
* Gibraltar<ref name="cdctracker"/>
* Greenland<ref>{{#invoke:Cite web||last1=Sevunts|first1=Levon|last2=International|first2=Radio Canada|date=4 January 2021|title=Greenland launches COVID-19 vaccination campaign|url=https://www.rcinet.ca/eye-on-the-arctic/2021/01/04/greenland-launches-covid-19-vaccination-campaign-1/|access-date=21 March 2021|website=Eye on the Arctic}}</ref>
* Guadeloupe<ref name="whotracker"/>
* Guam<ref name="whotracker"/>
* Guernsey<ref name="cdctracker"/>
* Hong Kong<ref>{{#invoke:Cite web||date=25 January 2021|title=Use of vaccine approved|url=https://www.news.gov.hk/eng/2021/01/20210125/20210125_175428_123.html|access-date=15 February 2021|publisher=Government of Hong Kong}}</ref>
* Isle of Man<ref name="cdctracker"/>
* Jersey<ref name="cdctracker"/>
* Macau<ref>{{#invoke:cite web||title=Local BioNTech vaccination to resume on April 5 |url=https://www.macaubusiness.com/local-biontech-vaccination-to-resume-on-april-5/ |website=macaubusiness.com |access-date=15 April 2021}}</ref>
* Martinique<ref name="whotracker"/>
* Montserrat{{efn|name=carphance}}
* New Caledonia<ref name="cdctracker"/>
* Niue<ref name="whotracker"/>
* Northern Cyprus<ref name=":4" />
* Northern Mariana Islands<ref name="whotracker"/>
* Puerto Rico<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Tokelau<ref name="whotracker"/>
* Turks and Caicos Islands{{efn|name=carphance}}
* ''[[World Health Organization]]''<ref name="WHO status">{{#invoke:Cite web||title=Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process|url=https://extranet.who.int/pqweb/key-resources/documents/status-covid-19-vaccines-within-who-eulpq-evaluation-process|publisher=[[World Health Organization]] (WHO)}}</ref><ref>{{cite press release|title=WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access|website=[[World Health Organization]] (WHO)|url=https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access|date=31 December 2020|access-date=6 January 2021}}</ref><ref>{{cite web | title=WHO recommendation Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) – Comirnaty | website=[[World Health Organization]] (WHO) | date=31 December 2020 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty | access-date=8 May 2021}}</ref>
</div>

== Moderna ==
<section begin="modernaauthmap" />
{{infobox|image={{Graph:Map|scale=80|defaultValue=gainsboro
|AD=dodgerblue|AE=dodgerblue|AF=limegreen|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=limegreen|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AU=blueviolet|AT=dodgerblue|AW=dodgerblue|AZ=limegreen
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BH=dodgerblue|BJ=limegreen|BM=dodgerblue|BN=dodgerblue|BO=limegreen|BQ=dodgerblue|BR=dodgerblue|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue
|CA=blueviolet|CD=limegreen|CF=limegreen|CG=dodgerblue|CH=blueviolet|CI=limegreen|CL=limegreen|CM=limegreen|CO=dodgerblue|CR=limegreen|CV=limegreen|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=limegreen|DK=dodgerblue|DM=dodgerblue|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=limegreen|EG=limegreen|ES=dodgerblue|ET=limegreen
|FI=dodgerblue|FJ=dodgerblue|FM=dodgerblue|FO=dodgerblue|FR=dodgerblue
|GB=blueviolet|GD=dodgerblue|GE=limegreen|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=limegreen|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue
|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IL=dodgerblue|IN=dodgerblue|IQ=limegreen|IR=limegreen|IS=dodgerblue|IT=dodgerblue
|JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=limegreen|KH=limegreen|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=limegreen|LB=limegreen|LC=dodgerblue|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=limegreen|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=limegreen|MC=limegreen|MD=dodgerblue|ME=limegreen|MH=dodgerblue|MK=limegreen|ML=limegreen|MM=limegreen|MN=dodgerblue|MP=dodgerblue|MR=limegreen|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=dodgerblue|NI=limegreen|NL=dodgerblue|NO=dodgerblue|NP=limegreen|NR=limegreen|NZ=limegreen
|OM=limegreen
|PA=limegreen|PE=dodgerblue|PG=limegreen|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=dodgerblue|PY=dodgerblue
|QA=dodgerblue
|RO=dodgerblue|RS=limegreen|RW=dodgerblue
|SA=dodgerblue|SB=limegreen|SD=limegreen|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SN=limegreen|SO=limegreen|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=limegreen|SZ=limegreen
|TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=dodgerblue|TL=limegreen|TN=dodgerblue|TO=limegreen|TT=dodgerblue|TV=limegreen|TW=dodgerblue
|UA=dodgerblue|UG=limegreen|US=dodgerblue|UY=limegreen|UZ=dodgerblue
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VU=limegreen|VN=dodgerblue
|WF=dodgerblue|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=limegreen|ZM=limegreen|ZW=limegreen
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="modernaauthmap" />
The [[Moderna COVID-19 vaccine]], also known as Spikevax,<ref name="COVID-19 Vaccine Moderna EPAR" /> is an [[RNA vaccine|mRNA vaccine]]<ref name="NCT04283461">{{#invoke:Cite web||date=16 March 2020|title=Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)|url=https://clinicaltrials.gov/ct2/show/NCT04283461|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04283461}}</ref> produced by the American company [[Moderna]], the U.S. [[National Institute of Allergy and Infectious Diseases]], the U.S. [[Biomedical Advanced Research and Development Authority]], and the [[Coalition for Epidemic Preparedness Innovations]].<ref name="NCT044704272">{{#invoke:Cite web||date=14 July 2020|title=A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04470427|url-status=live|archive-url=https://web.archive.org/web/20201011084833/https://clinicaltrials.gov/ct2/show/NCT04470427/|archive-date=11 October 2020|access-date=27 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04470427}}</ref><ref name="palca2">{{cite news|last1=Palca|first1=Joe|date=27 July 2020|title=COVID-19 vaccine candidate heads to widespread testing in U.S.|publisher=NPR|url=https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people|url-status=live|access-date=27 July 2020|archive-url=https://web.archive.org/web/20201011084836/https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people/|archive-date=11 October 2020|name-list-style=vanc}}</ref>

;Full (<section begin="Moderna_FN" />4<section end="Moderna_FN" />)
# Australia<ref>{{#invoke:Cite web||date=9 August 2021|title=TGA provisionally approves Moderna’s COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-modernas-covid-19-vaccine-0|url-status=live|website=Therapeutic Goods Administration}}</ref>
# Canada<ref name="hc-moderna12-23">{{cite web|date=23 December 2020|title=Regulatory Decision Summary – Moderna COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00736|access-date=23 December 2020|publisher=Health Canada, Government of Canada}}</ref><ref name="hcapps" /><ref name=":13" />
# Switzerland<ref>{{cite press release|title=Swissmedic grants authorisation for the COVID-19 vaccine from Moderna |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zulassung-covid-19-impfstoff-moderna.html |publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]] |date=12 January 2020 |access-date=12 January 2020}}</ref>
# United Kingdom<ref>{{#invoke:Cite web||date=1 April 2021|title=Information for Healthcare Professionals on COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna|access-date=6 April 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref><ref>{{#invoke:Cite web||date=19 February 2021|title=Summary of the Public Assessment Report for COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/summary-of-the-public-assessment-report-for-covid-19-vaccine-moderna|access-date=6 April 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref>
{{-}}
;Emergency (<section begin="Moderna_EN" />97<section end="Moderna_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Andorra<ref name="Andorra vaccines" />
# Argentina<ref>{{#invoke:Cite web||date=July 17, 2021|title=United States donates 3.5 million Moderna vaccines to Argentina|url=https://batimes.com.ar/news/argentina/us-donates-35-million-moderna-vaccines-to-argentina.phtml|url-status=live|access-date=August 3, 2021|website=[[Buenos Aires Times]]}}</ref>
# Bahrain<ref name="whotracker" />
# Bangladesh<ref>{{cite web |title=Moderna gets emergency use authorisation in Bangladesh|url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/moderna-gets-emergency-use-authorisation-bangladesh-2120677 |website=[[The Daily Star (Bangladesh)|The Daily Star]] |date=29 June 2021|access-date=30 June 2021}}</ref>
# Bhutan<ref name="whotracker"/>
# Botswana<ref>{{cite press release |title=Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine |url=https://www.businesswire.com/news/home/20210603005629/en/Moderna-Announces-Agreement-to-Supply-the-Republic-of-Botswana-with-its-COVID-19-Vaccine |publisher=Moderna|via=Business Wire |date=3 June 2021}}</ref>
# Brazil<ref name="Agência Brasil"/>
# Brunei<ref name="whotracker"/>
# Colombia<ref>{{Cite web|url=https://www.elespectador.com/salud/colombia-autoriza-el-uso-de-la-vacuna-de-moderna-para-el-coronavirus/|title=ELESPECTADOR.COM|first=El|last=Espectador|date=June 25, 2021|website=ELESPECTADOR.COM}}</ref>
# Congo, Rep. of the<ref name="cdctracker"/>
# El Salvador<ref name="whotracker"/>
# Fiji<ref name="whotracker"/>
# Ghana<ref>{{Cite web|title=Farmacovigilancia de vacunas para COVID-19 - Moderna|url=https://covid-19pharmacovigilance.paho.org/|access-date=2021-09-24|website=Farmacovigilancia de vacunas para COVID-19|language=en}}</ref>
# Guatemala<ref name="auto3" />
# Honduras<ref>{{cite web |title=Honduras a la zaga de la vacunación en Centroamérica |url=https://proceso.hn/honduras-a-la-zaga-en-vacunacion-en-ca/ |website=Proceso Digital |language=es |date=10 April 2021}}</ref>
# India<ref>{{cite news |last1=Kaul |first1=Rhythma |title=Moderna's Covid vaccine approved for use in India |url=https://www.hindustantimes.com/india-news/modernas-covid-vaccine-approved-for-use-in-india-101624990937539.html |work=Hindustan Times |date=29 June 2021 }}</ref>
# Indonesia<ref>{{cite news |author= Friski Riana |editor= Laila Afifa|title=BPOM Issues Emergency Use Authorization for Moderna Vaccine |url=https://en.tempo.co/read/1478877/bpom-issues-emergency-use-authorization-for-moderna-vaccine |work=Tempo.co |date=2 July 2021 }}</ref>
# Israel<ref name="israelmoderna">{{cite web |title= Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel|url=https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use|publisher=modernatx.com |access-date=4 January 2021|date=4 January 2021}}</ref>
# Japan<ref name="jp" /><ref>{{cite press release | title=Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan | publisher=Takeda | via=Business Wire | date=21 May 2021 | url=https://www.businesswire.com/news/home/20210520006154/en/Takeda-Announces-Approval-of-Moderna%E2%80%99s-COVID-19-Vaccine-in-Japan | access-date=2 July 2021}}</ref>
# Jordan<ref name="whotracker"/>
# Kenya<ref name=":10">{{Cite news|title=Kenya approves Moderna Sinopharm vaccines amid fourth wave|url=https://www.bloomberg.com/news/articles/2021-08-19/kenya-approves-moderna-sinopharm-vaccines-amid-fourth-wave|url-status=live|access-date=2021-08-28|newspaper=Bloomberg.com|date = 19 August 2021}}</ref>
# Kuwait<ref>{{cite web |title=COVID-19: Kuwait unlikely to import Sputnik V |url=https://gulfnews.com/world/gulf/kuwait/covid-19-kuwait-unlikely-to-import-sputnik-v-1.78388637 |website=gulfnews.com |access-date=21 April 2021 }}</ref>
# Libya<ref name="cdctracker"/>
# Malaysia<ref>{{cite web |author1=New Straits Times |title=DCA grants conditional approval for Moderna vaccine |url=https://www.nst.com.my/news/nation/2021/08/715318/dca-grants-conditional-approval-moderna-vaccine |date=8 August 2021}}</ref>
# Maldives<ref>{{cite web |author1=Maldives Food and Drug Agency |title=Approval to use of COVID-19 vaccine Moderna dispersion for injection |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(382).pdf |date=6 June 2021}}</ref>
# Marshall Islands{{efn|name=CFA}}
# Malawi<ref>{{Cite web|title=Malawi Ministry of Health on Facebook|url=https://www.facebook.com/login/?next&#61;https%253A%252F%252Fwww.facebook.com%252Fmalawimoh%252Fposts%252F4098884300167054|access-date=2021-09-14|website=Facebook|language=en}}</ref>
# Mexico<ref>{{cite web |title=Comité de Moléculas Nuevas y Subcomité emiten opinión favorable para vacuna Moderna
|url=https://www.gob.mx/cofepris/articulos/comite-de-moleculas-nuevas-y-subcomite-emiten-opinion-favorable-para-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title=COFEPRIS emite autorización para uso de emergencia a vacuna Moderna
|url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}</ref>
# Micronesia{{efn|name=CFA}}
# Moldova<ref name="msmps.gov.md">{{cite web |title=Membrii NITAG au venit cu recomandări privind utilizarea vaccinurilor împotriva COVID-19 în Republica Moldova |url=https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/ |website=Ministerul Sănătății, Muncii și Protecţiei Sociale |language=ro |date=3 March 2021}}</ref>
# Mongolia<ref name="news.mn" />
# Nigeria<ref>{{#invoke:Cite web||date=2021-07-15|title=NAFDAC approves emergency use of three additional Covid-19 vaccines for Nigeria|url=https://editor.guardian.ng/news/nafdac-approves-emergency-use-of-three-additional-covid-19-vaccines-for-nigeria/|access-date=2021-07-21|website=The Guardian Nigeria News - Nigeria and World News|language=en-US}}</ref>
# Pakistan<ref name="whotracker"/>
# Palau{{efn|name=CFA}}
# Palestine<ref name="cdctracker">{{cite web |title=COVID Data Tracker |url=https://covid.cdc.gov/covid-data-tracker/#global-vaccinations |website=U.S. [[Centers for Disease Control and Prevention]] (CDC) |date=28 March 2020}}</ref>
# Paraguay<ref name="whotracker"/>
#Peru<ref>{{Cite web|date=September 17, 2021|title=Gobierno suscribió acuerdo con Moderna por 20 millones de dosis contra la COVID-19|url=https://rpp.pe/peru/actualidad/gobierno-suscribio-acuerdo-con-moderna-por-20-millones-de-vacunas-contra-la-covid-19-noticia-1358438?ref=rpp|url-status=live|access-date=October 4, 2021|website=[[RPP Noticias]]}}</ref>
# Philippines<ref>{{cite news |author1=Galvez, Daphne |title=Moderna COVID-19 vaccine gets emergency use authorization |url=https://newsinfo.inquirer.net/1427462/moderna-covid-19-vaccine-gets-emergency-use-authorization |publisher=Philippine Daily Inquirer |date=5 May 2021}}</ref>
# Qatar<ref name="Aljazeera">{{#invoke:Cite web||title=Qatar approves emergency use of Moderna's COVID-19 vaccine|url=https://www.aljazeera.com/news/2021/2/10/qatar-approves-emergency-use-for-modernas-covid-19-vaccine|website=Al Jazeera|access-date=31 March 2021}}</ref>
# Rwanda<ref name="cdctracker" />
# Saudi Arabia<ref name="gulfnews.com">{{#invoke:Cite web||title=AstraZeneca and Moderna vaccines to be administered in Saudi Arabia|url=https://gulfnews.com/world/gulf/saudi/astrazeneca-and-moderna-vaccines-to-be-administered-in-saudi-arabia-1.76573439|access-date=19 January 2021|website=Gulf News}}</ref>
# Singapore<ref>{{cite news|date=3 February 2021|title=Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-singapore/singapore-becomes-first-in-asia-to-approve-modernas-covid-19-vaccine-idUSKBN2A30ZM|access-date=3 February 2021|publisher=Reuters}}</ref>
# South Korea<ref>{{Cite news |last1=Kim |first1=Han-joo |date=21 May 2021|title=Moderna COVID-19 vaccine gets final nod in S. Korea |url=https://en.yna.co.kr/view/AEN20210521005500320|access-date=21 May 2021|work=Yonhap News Agency}}</ref>
# Sri Lanka<ref name="whotracker"/>
# Taiwan<ref>{{#invoke:Cite web||date=5 May 2021|title=莫德納疫苗獲緊急授權 自費AZ疫苗供應不間斷|url=https://www.cna.com.tw/news/firstnews/202105050200.aspx|website=Central News Agency}}</ref>
# Tajikistan<ref>{{#invoke:Cite web||date=July 26, 2021|title=1.5 million doses of Moderna Vaccines arrive in Tajikistan|url=https://www.unicef.org/tajikistan/press-releases/15-million-doses-moderna-vaccines-arrive-tajikistan|url-status=live|access-date=August 4, 2021|website=[[UNICEF]]}}</ref>
# Thailand<ref>{{cite news | title = Thai FDA approves Moderna vaccine | date = 2021-05-13 | url = https://www.bangkokpost.com/thailand/general/2115195/thai-fda-approves-moderna-vaccine | work = Bangkok Post }}</ref>
# Tunisia<ref name="whotracker"/>
# Ukraine<ref>{{#invoke:Cite web||date=July 19, 2021|title=U.S. Donates 2 Million Coronavirus Vaccine Doses To Ukraine|url=https://www.rferl.org/a/us-vaccine-ukraine-covid/31365604.html|url-status=live|access-date=August 4, 2021|website=[[RadioFreeEurope]]}}</ref>
# United Arab Emirates<ref>{{cite news | title = Coronavirus latest: Moderna vaccine approved for emergency use by UAE | date = 2021-07-04 | url = https://www.thenationalnews.com/coronavirus/2021/07/03/coronavirus-latest-updates-uae-cases-vaccine-covid-test/ | work = The National }}</ref>
# United States<ref name="FDA PR 20201218">{{cite press release | title=FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine | publisher=U.S. [[Food and Drug Administration]] (FDA) | url=https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid | access-date=18 December 2020}}</ref><ref name="CDC ACIP Moderna COVID-19 Vaccine">{{cite journal|vauthors=Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K|display-authors=6|date=December 2020|title=The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine – United States, December 2020|url=https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm695152e1-H.pdf|journal=MMWR. Morbidity and Mortality Weekly Report|volume=69|issue=5152|pages=1653–56|doi=10.15585/mmwr.mm695152e1|pmid=33382675|s2cid=229945697|doi-access=free}}</ref>
# Uzbekistan<ref>{{#invoke:Cite web||date=July 30, 2021|title=U.S. Government Provides 3 Million of the Moderna COVID-19 Vaccine to Uzbekistan|url=https://uz.usembassy.gov/u-s-government-provides-3-million-doses-of-the-moderna-covid-19-vaccine-to-uzbekistan/|url-status=live|access-date=August 4, 2021|website=}}</ref>
# Vietnam<ref>{{Cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=[[Vietnam Television]]|url=https://vtv.vn/suc-khoe/bo-y-te-phe-duyet-co-dieu-kien-vaccine-covid-19-moderna-20210629110122178.htm}}</ref><ref>{{Cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=Vietnam Government Portal|url=http://baochinhphu.vn/Hoat-dong-Bo-nganh/Bo-Y-te-phe-duyet-co-dieu-kien-vaccine-COVID19-Moderna/436244.vgp}}</ref>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="COVID-19 Vaccine Moderna EPAR">{{cite web|title=Spikevax (previously COVID-19 Vaccine Moderna) EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-moderna|url-status=live|website=[[European Medicines Agency]] (EMA)}}</ref><ref name="EU Marketing authorisation" />
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-pfizer"/><ref name="COVID-19 Vaccine Information"/>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines
# Suriname
# Trinidad and Tobago
<!-- not counted --><br />
'''[[ISO 3166-1#Current codes|Non-country entities]]'''
* American Samoa<ref name="whotracker"/>
* Anguilla{{efn|name=carphance}}
* Aruba{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Curaçao{{efn|name=carphance}}
* Faroe Islands<ref name="cdctracker"/>
* Greenland<ref name="cdctracker"/>
* Guadeloupe<ref name="whotracker"/>
* Guam<ref name="whotracker"/>
* Guernsey<ref name="cdctracker"/>
* Jersey<ref name="cdctracker"/>
* Montserrat{{efn|name=carphance}}
* Northern Mariana Islands<ref name="whotracker"/>
* Puerto Rico<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Turks and Caicos Islands{{efn|name=carphance}}
* Wallis and Futuna<ref name="whotracker"/>
* ''[[World Health Organization]]''<ref>{{cite news |title=WHO lists anti-COVID Moderna vaccine for emergency use |url=https://newsinfo.inquirer.net/1425841/who-lists-anti-covid-moderna-vaccine-for-emergency-use |work=Agence France-Presse |publisher=Philippine Daily Inquirer |date=1 May 2021}}</ref><ref>{{cite web | title=WHO Recommendation COVID-19 mRNA Vaccine (nucleoside modified) | website=[[World Health Organization]] (WHO) | date=30 April 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-mrna-vaccine-nucleoside-modified | access-date=8 May 2021}}</ref>
</div>

== Janssen ==
<section begin="janssenauthmap"/>
{{infobox|image={{Graph:Map|scale=80|defaultValue=gainsboro
|AD=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=limegreen|AO=limegreen|AR=limegreen|AS=dodgerblue|AT=dodgerblue|AU= violet|AW=dodgerblue|AZ=limegreen
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BH=dodgerblue|BJ=limegreen|BM=dodgerblue|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=dodgerblue|BT=limegreen|BW=dodgerblue|BZ=dodgerblue
|CA=darkred|CD=limegreen|CF=limegreen|CG=limegreen|CH=blueviolet|CI=limegreen|CL=dodgerblue|CM=limegreen|CO=dodgerblue|CR=limegreen|CV=limegreen|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue
|DE=dodgerblue|DJ=dodgerblue|DK=darkred|DM=dodgerblue|DO=limegreen|DZ=limegreen
|EC=limegreen|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=limegreen
|FI=darkred|FJ=limegreen|FM=dodgerblue|FO=dodgerblue|FR=dodgerblue
|GB=dodgerblue |GD=dodgerblue|GE=limegreen|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GR=dodgerblue|GT=limegreen|GU=dodgerblue|GY=dodgerblue
|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue
|ID=dodgerblue|IE=dodgerblue|IN=dodgerblue|IQ=limegreen|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue
|JM=dodgerblue|JO=dodgerblue
|KE=dodgerblue|KG=limegreen|KH=dodgerblue|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue
|LA=dodgerblue|LB=limegreen|LC=dodgerblue|LI=dodgerblue|LK=limegreen|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=limegreen|MH=dodgerblue|MK=limegreen|ML=limegreen|MM=limegreen|MN=limegreen|MP=dodgerblue|MR=limegreen|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=limegreen|MX=dodgerblue|MY=dodgerblue|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=dodgerblue|NI=limegreen|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue
|OM=limegreen
|PA=limegreen|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=limegreen|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=dodgerblue|PY=limegreen
|QA=dodgerblue
|RO=dodgerblue|RS=limegreen|RW=limegreen
|SA=dodgerblue|SB=limegreen|SD=dodgerblue|SE=dodgerblue|SG=limegreen|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SN=limegreen|SO=dodgerblue|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=limegreen|SX=dodgerblue|SY=dodgerblue|SZ=limegreen
|TC=dodgerblue|TD=limegreen|TH=dodgerblue|TG=limegreen|TJ=limegreen|TL=limegreen|TN=dodgerblue|TO=limegreen|TT=dodgerblue|TV=limegreen|TW=dodgerblue|TZ=dodgerblue
|UA=dodgerblue|UG=limegreen|US=dodgerblue|UY=limegreen|UZ=limegreen
|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=limegreen
|WS=limegreen
|XK=limegreen
|YE=dodgerblue
|ZA=dodgerblue|ZM=dodgerblue|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|violet|Full authorization, not used}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
{{leftlegend|darkred|Usage stopped}}
}}
<section end="janssenauthmap"/>
The [[Janssen COVID-19 vaccine]]<ref>{{cite web | title=Janssen COVID-19 Emergency Use Authorization (EUA) Official Website | website=Janssen | date=28 February 2021 | url=https://www.janssencovid19vaccine.com/hcp.html | access-date=28 February 2021}}</ref> is a [[viral vector vaccine]]<ref>{{cite techreport|type=Briefing|date=26 February 2021|title=Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19|publisher=U.S. [[Food and Drug Administration]] (FDA)|url=https://www.fda.gov/media/146217/download|page=6|access-date=6 March 2021|quote=The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein.}}</ref> produced by [[Janssen Pharmaceutica]] (a subsidiary of [[Johnson & Johnson]]) and [[Beth Israel Deaconess Medical Center]].<ref name=":22">{{#invoke:Cite web||date=4 August 2020|title=A Study of Ad26.COV2.S in Adults|url=https://clinicaltrials.gov/ct2/show/NCT04436276|url-status=live|archive-url=https://web.archive.org/web/20200916063346/https://clinicaltrials.gov/ct2/show/NCT04436276|archive-date=16 September 2020|access-date=23 August 2020|website=[[ClinicalTrials.gov]]}}</ref><ref name=":32">{{#invoke:Cite web||title=A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants|url=https://clinicaltrials.gov/ct2/show/NCT04505722|url-status=live|archive-url=https://web.archive.org/web/20200926145744/https://clinicaltrials.gov/ct2/show/NCT04505722|archive-date=26 September 2020|website=[[ClinicalTrials.gov]]|publisher=US National Library of Medicine}}</ref> It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen.<ref name="COVID-19 Vaccine Janssen EPAR">{{#invoke:Cite web||date=5 March 2021|title=COVID-19 Vaccine Janssen EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen|access-date=16 March 2021|publisher=[[European Medicines Agency]] (EMA)}}</ref> Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder.<ref>{{cite web |title=The Danish COVID-19 vaccine rollout continues without the COVID-19 vaccine from Johnson & Johnson |url=https://www.sst.dk/en/english/news/2021/the-danish-covid-19-vaccine-rollout-continues-without-the-covid-19-vaccine-from-johnson-johnson |website=www.sst.dk }}</ref> Canada never started deploying the Janssen Vaccine after issues with doses sent from the [[Emergent BioSolutions]] Manufacturing Plant. After 300,000 doses were rejected, no Canadian Province has requested the Janssen Vaccine.<ref>{{Cite news|last=Tasker|first=John Paul|date=29 June 2021|title=Johnson & Johnson COVID-19 vaccine is in limbo with no additional Canadian shipments planned|work=[[CBC News]]|url=https://www.cbc.ca/news/politics/johnson-johnson-no-shipments-planned-1.6084140|access-date=31 July 2021}}</ref>

;Full (<section begin="Janssen_FN"/>2<section end="Janssen_FN"/>)
# Australia (not used)<ref>{{cite web | title= COVID-19 Vaccine Janssen | website=Therapeutic Goods Administration | date=25 June 2021 | url=https://www.tga.gov.au/apm-summary/covid-19-vaccine-janssen | access-date=26 June 2021 }}</ref><ref>{{#invoke:Cite web||last=Administration|first=Australian Government Department of Health Therapeutic Goods|date=25 June 2021|title=TGA grants third provisional approval to COVID-19 vaccine: Janssen|url=https://www.tga.gov.au/media-release/tga-grants-third-provisional-approval-covid-19-vaccine-janssen|access-date=28 June 2021|website=Therapeutic Goods Administration (TGA)}}</ref>
# Switzerland<ref>{{cite news|agency=Keystone-SDA/Reuters/sb|title=Johnson & Johnson Covid vaccine approved for use in Switzerland|url=https://www.swissinfo.ch/eng/johnson---johnson-covid-vaccine-approved-for-use-in-switzerland/46469458|access-date=1 April 2021|website=SWI swissinfo.ch}}</ref><ref>{{cite news | title=Swissmedic regulator approves Johnson & Johnson COVID-19 vaccine | publisher=Reuters | date=22 March 2021 | url=https://www.reuters.com/article/health-coronavirus-swiss-johnsonjohnson-idUSZ8N2K8003 | access-date=3 April 2021}}</ref>

{{-}}
;Emergency (<section begin="Janssen_EN"/>103<section end="Janssen_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref name="whotracker"/>
# Andorra<ref name="Andorra vaccines">{{cite news|title=Informació en relació amb la vacunació contra la COVID-19|publisher=Govern d'Andorra|url=https://www.govern.ad/vacunacio/faqs/FAQS_Vacunacio_COVID19.pdf|access-date=14 March 2021 | language=ca }}</ref>
# Bahrain<ref>{{cite news | title=Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use | publisher=Reuters | date=25 February 2021 | url=https://www.reuters.com/article/health-coronavirus-bahrain-idUSS8N2I4021 | access-date=25 February 2021}}</ref><ref>{{cite news | title=Bahrain becomes 1st nation to grant J&J shot emergency use | website=ABC News (United States) | date=25 February 2021 | url=https://abcnews.go.com/International/wireStory/bahrain-1st-nation-grant-jj-shot-emergency-76112143 | access-date=25 February 2021}}</ref>
# Bangladesh<ref>{{cite news | title=Bangladesh approves Johnson & Johnson's Covid-19 vaccine for emergency use| publisher=Dhaka Tribune | date=15 June 2021| url=https://www.dhakatribune.com/bangladesh/2021/06/15/johnson-johnson-s-covid-19-vaccine-approved-for-emergency-use | access-date=15 June 2021}}</ref><ref>{{cite news |url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/single-dose-covid-19-vaccine-janssen-gets-emergency-use-authorization-bangladesh-2111557| title=Single-dose Covid-19 vaccine Janssen gets emergency use authorization in Bangladesh| website=[[The Daily Star (Bangladesh)|The Daily Star]]| date=15 June 2021|access-date=15 June 2021}}</ref>
# Bolivia<ref name="whotracker" />
# Botswana<ref>{{cite web |title=COVID-19 Vaccines Approved by BoMRA |url=https://www.bomra.co.bw/index.php/news-updates/177-covid-19-vaccines-approved-by-bomra |website=www.bomra.co.bw}}</ref>
# Brazil<ref>{{cite news |date=31 March 2021 |title=Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine |url=https://www.reuters.com/article/health-coronavirus-brazil-janssen/brazil-health-regulator-approves-emergency-use-of-johnson-johnson-covid-19-vaccine-idUSL1N2LT2PS |publisher=Reuters |location=Rio de Janeiro |access-date=1 April 2021}}</ref>
# Brunei<ref name="whotracker"/>
# Cambodia<ref name="whotracker"/>
# Canada<ref>{{cite news|title=Johnson & Johnson COVID-19 vaccine becomes 4th to receive Health Canada approval|publisher=CBC News|url=https://www.cbc.ca/news/politics/johnson-johnson-covid19-vaccine-approved-1.5937900|access-date=5 March 2021}}</ref>
# Chile<ref>{{cite web |title=Chile authorizes emergency use of Johnson & Johnson's Janssen vaccine through COVAX|url=https://www.ispch.cl/noticia/isp-valida-uso-de-emergencia-de-la-vacuna-janssen-de-johnson-johnson-a-traves-de-mecanismo-covax/|publisher=Public Health Institute, [[Ministry of Health (Chile)|Ministry of Health of Chile]]|date=10 June 2021}}</ref>
# Colombia<ref>{{cite news|last=Acosta|first=Luis Jaime|location=Bogotá|title=Colombia grants emergency use for J&J coronavirus vaccine |url=https://www.reuters.com/article/health-coronavirus-colombia/colombia-grants-emergency-use-for-jj-coronavirus-vaccine-idUSL1N2LO01O |access-date=25 March 2021 |publisher=Reuters |date=25 March 2021}}</ref>
# Djibouti<ref name="whotracker"/>
# Egypt<ref name="whotracker"/>
# Ghana<ref>{{#invoke:cite web ||title=Johnson & Johnson COVID-19 vaccine to be available in Ghana by August |url=https://www.graphic.com.gh/news/general-news/johnson-johnson-covid-19-vaccine-to-be-available-in-ghana-by-august.html |website=Graphic Online}}</ref>
# Guinea<ref name="whotracker"/>
# Honduras<ref name="cdctracker"/>
# India<ref>{{#invoke:Cite web||date=2021-08-07|title=India approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/world/india/india-approves-jj-covid-19-vaccine-emergency-use-2021-08-07/|access-date=2021-08-07|website=Reuters}}</ref>
# Indonesia<ref name="auto6">{{Cite web|last=|first=|date=2021-09-07|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 Produksi Johnson & Johnson dan Cansino|url=https://nasional.kompas.com/read/2021/09/07/18330171/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-produksi-johnson|url-status=live|access-date=2021-09-07|website=KOMPAS.com|language=id}}</ref>
# Iran<ref name="whotracker"/>
# Jordan<ref name="whotracker"/>
# Kenya<ref>{{#invoke:Cite news||date=2021-08-02|title=Kenya Approves J&J, Pfizer Covid-19 Vaccines as Cases Surge|language=en|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-08-02/kenya-approves-j-j-pfizer-covid-19-vaccines-as-cases-surge|access-date=2021-09-24}}</ref>
# Kuwait<ref>{{cite web |title=Kuwait authorises emergency use of Johnson & Johnson vaccine |url=https://www.kuna.net.kw/ArticleDetails.aspx?id=2980741&language=en |publisher=Kuwait News Agency (KUNA) |date=8 June 2021}}</ref>
# Laos<ref name="whotracker"/>
# Libya<ref name="cdctracker"/>
# Malaysia<ref>{{cite news|date=15 June 2021|title=Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines|url= https://www.reuters.com/business/healthcare-pharmaceuticals/malaysia-grants-conditional-approval-cansino-jj-covid-19-vaccines-2021-06-15/|work=[[Reuters]]|access-date= 15 June 2021}}</ref>
# Maldives<ref>{{cite web |title=Approval to use of Covid-19 vaccine Janssen |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(381).pdf |publisher=Maldives Food and Drug Authority |date=6 June 2021}}</ref>
# Marshall Islands{{efn|name=CFA}}
# Mexico<ref>{{cite web |title= El Comité de Moléculas Nuevas de COFEPRIS informa sobre los resultados de votación para la vacuna COVID-19 (Ad26.COV2-S [Recombinante]) |url=https://www.gob.mx/cofepris/articulos/el-comite-de-moleculas-nuevas-de-cofepris-informa-sobre-los-resultados-de-votacion-para-la-vacuna-covid-19-ad26-cov2-s-recombinante |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title= COFEPRIS emite autorización para uso de emergencia a vacuna contra COVID-19 Ad26.COV2.S de Janssen (Johnson & Johnson) |url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-contra-covid-19-ad26-cov2-s-de-janssen-johnson-johnson |website=www.gob.mx/cofepris |language=es}}</ref>
# Micronesia{{efn|name=CFA}}
# Moldova<ref name="msmps.gov.md"/>
# Morocco<ref name="whotracker"/>
# Nepal<ref>{{#invoke:Cite web||title=1.5 million doses of J&J vaccine arrive in Nepal|url=https://kathmandupost.com/health/2021/07/12/1-5-million-doses-of-j-j-vaccine-arrive-in-nepal|access-date=12 July 2021|website=kathmandupost}}</ref>
# New Zealand<ref name="whotracker"/>
# Nigeria<ref>{{#invoke:Cite web||date=20 April 2021|title=905m COVID-19 shots administered worldwide – Report|url=https://www.premiumtimesng.com/health/456360-905m-covid-19-shots-administered-worldwide-report.html|access-date=7 June 2021}}</ref>
# Palau{{efn|name=CFA}}
# Palestine<ref name="whotracker"/>
# Papua New Guinea<ref name="whotracker"/>
# Peru<ref>{{#invoke:Cite web||date=July 9, 2021|title=Peru authorizes use of Johnson & Johnson COVID-19 vaccine|url=https://andina.pe/ingles/noticia-peru-authorizes-use-of-johnson-johnson-covid19-vaccine-852510.aspx|url-status=live|access-date=August 3, 2021|website=[[ATV (Peruvian TV channel)|Andina]]}}</ref>
# Philippines<ref>{{#invoke:Cite web||url=https://cnnphilippines.com/news/2021/4/19/covaxin-janssen-emergency-use-authorization.html|title=Covaxin, Janssen approved for emergency use in PH |work=CNN Philippines|date=19 April 2021}}</ref>
# Qatar<ref name="whotracker"/>
# Saudi Arabia<ref name="whotracker"/>
# Singapore<ref name="channelnewsasia.com"/>''(restricted)''
# Somalia<ref name="whotracker"/>
# South Africa<ref>{{cite news|url=https://www.bbc.com/news/world-africa-55675806|title=Coronavirus: South Africa rolls out vaccination programme|date=17 February 2021|access-date=19 February 2021|work=BBC News}}</ref>
# South Korea<ref>{{cite news |last1=Lardieri |first1=Alexa |title=South Korea Approves Johnson & Johnson Vaccine |url=https://www.usnews.com/news/health-news/articles/2021-04-07/south-korea-grants-conditional-approval-to-johnson-johnson-coronavirus-vaccine |access-date=8 April 2021 |work=U.S. News & World Report |date=7 April 2021}}</ref>
# Sudan<ref name="whotracker"/>
# Syria<ref name="whotracker"/>
# Taiwan<ref>{{Cite news|date=10 June 2021|title=嬌生疫苗通過我緊急使用授權 BNT僅「有條件通過」|publisher=The Liberty Times|url=https://news.ltn.com.tw/news/life/breakingnews/3565594}}</ref>
# Tanzania<ref name="whotracker"/>
# Thailand<ref>{{Cite news|date=25 March 2021|title=Thailand approves Johnson & Johnson's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand-idUSKBN2BH1L7|access-date=1 April 2021}}</ref>
# Tunisia<ref>{{cite news |title=Tunisia approve Johnson & Johnson COVID-19 vaccine |url=https://www.reuters.com/article/uk-health-coronavirus-tunisia/tunisia-approve-johnson-johnson-covid-19-vaccine-idUSKBN2BV1SQ |website=Reuters |date=8 April 2021}}</ref>
# Ukraine<ref name="whotracker"/>
# United Kingdom<ref>{{cite news |title=Janssen single-dose Covid vaccine approved by UK |url=https://www.bbc.com/news/health-57283837 |publisher=BBC News |date=28 May 2021}}</ref>
# United States<ref name="FDA PR 20210227">{{cite press release | title=FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine | publisher=U.S. [[Food and Drug Administration]] (FDA) | date=27 February 2021 | url=https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine | access-date=27 February 2021}}</ref><ref name="FDA EUA">{{Cite web|url=https://www.fda.gov/media/146303/download|title=Janssen COVID-19 Vaccine EUA Letter of Authorization 06102021|date=2021-06-10|website=U.S. Food & Drug Administration}}</ref>
# Vietnam<ref name=ldo1507>{{Cite news|date=15 July 2021|title=Việt Nam phê duyệt khẩn cấp vaccine COVID-19 của Johnson & Johnson|work=Lao Động|url=https://laodong.vn/y-te/viet-nam-phe-duyet-khan-cap-vaccine-covid-19-cua-johnson--johnson-930853.ldo}}</ref><ref name=vnp1507>{{Cite news|date=15 July 2021|title=Bộ Y tế phê duyệt vaccine phòng COVID-19 Janssen của Johnson & Johnson|work=Vietnam+|url=https://www.vietnamplus.vn/bo-y-te-phe-duyet-vaccine-phong-covid19-janssen-cua-johnson-johnson/726931.vnp}}</ref>
# Yemen<ref name="whotracker"/>
# Zambia<ref name=":5" /><ref name=":6" /><ref name=":8" />
# Zimbabwe<ref>{{#invoke:Cite web||date=2021-07-28|title=Zimbabwe approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/business/healthcare-pharmaceuticals/zimbabwe-approves-jj-covid-19-vaccine-emergency-use-2021-07-28/|access-date=2021-08-23|website=Reuters|language=en}}</ref>
'''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="EU Marketing authorisation">{{#invoke:Cite web||title=Marketing authorisation|url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation|access-date=23 March 2021|publisher=[[European Medicines Agency]] (EMA)}}</ref>'''
# Austria
# Belgium
# Bulgaria
# Croatia
# Cyprus
# Czech Republic
# Denmark
# Estonia
# Finland
# France
# Germany
# Greece
# Hungary
# Iceland
# Ireland
# Italy
# Latvia
# Liechtenstein
# Lithuania
# Luxembourg
# Malta
# Netherlands
# Norway
# Poland
# Portugal
# Romania
# Slovakia
# Slovenia
# Spain
# Sweden
'''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="COVID-19 Vaccine Information">{{cite web |title=COVID-19 Vaccine Information |url=https://www.carpha.org/What-We-Do/Public-Health/Novel-Coronavirus/COVID-19-Vaccine-Information |website=www.carpha.org}}</ref>
# Antigua and Barbuda
# Bahamas
# Barbados
# Belize
# Dominica
# Grenada
# Guyana
# Haiti
# Jamaica
# Saint Kitts and Nevis
# Saint Lucia
# Saint Vincent and the Grenadines<ref name="auto2"/>
# Suriname
# Trinidad and Tobago
<!-- not counted -->
<!-- not counted --><br />
'''[[ISO 3166-1#Current codes|Non-country entities]]'''
* Anguilla{{efn|name=carphance}}
* American Samoa<ref name="whotracker"/>
* Aruba{{efn|name=carphance}}
* Bermuda{{efn|name=carphance}}
* British Virgin Islands{{efn|name=carphance}}
* Caribbean Netherlands{{efn|name=carphance}}
* Cayman Islands{{efn|name=carphance}}
* Curaçao{{efn|name=carphance}}
* French Polynesia<ref name="whotracker"/>
* Greenland<ref name="NYT vaccine tracker" />
* Guam<ref name="whotracker"/>
* Montserrat{{efn|name=carphance}}
* Northern Mariana Islands<ref name="whotracker"/>
* Puerto Rico<ref name="whotracker"/>
* Sint Maarten{{efn|name=carphance}}
* Turks and Caicos Islands{{efn|name=carphance}}
* ''Africa Regulatory Taskforce''<ref>{{#invoke:Cite web||title=UPDATE: Statement to Member States regarding thromboembolic events after vaccination with Janssen COVID-19 vaccine (Johnson & Johnson)|url=https://africacdc.org/news-item/update-statement-to-member-states-regarding-thromboembolic-events-after-vaccination-with-janssen-covid-19-vaccine-johnson-johnson/|access-date=7 June 2021|website=Africa CDC}}</ref>
* ''[[World Health Organization]]''<ref>{{cite news |title=WHO approves J&J's COVID-19 vaccine for emergency listing |url=https://www.channelnewsasia.com/news/world/covid-19-who-approves-johnson-jj-vaccine-emergency-listing-14394654 |access-date=13 March 2021 |publisher=Channel NewsAsia |date=13 March 2021}}</ref><ref>{{cite web | title=WHO recommendation Janssen–Cilag International NV (Belgium) COVID-19 Vaccine (Ad26.COV2-S [recombinant]) | website=[[World Health Organization]] (WHO) | date=12 March 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-janssen-cilag-international-nv-belgium-covid-19-vaccine-ad26cov2-s | access-date=8 May 2021}}</ref>
</div>

== Sinopharm-BBIBP ==
<section begin="bbibpauthmap"/>
{{infobox|image={{Graph:Map|scale=80|defaultValue=gainsboro
|AD=limegreen|AE=blueviolet|AF=dodgerblue|AG=dodgerblue|AL=limegreen|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AZ=limegreen
|BA=limegreen|BB=dodgerblue|BD=dodgerblue|BF=limegreen|BH=blueviolet|BJ=limegreen|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=dodgerblue|BW=limegreen|BY=dodgerblue|BZ=dodgerblue
|CD=limegreen|CF=limegreen|CG=dodgerblue|CI=dodgerblue|CL=limegreen|CM=dodgerblue|CN=blueviolet|CO=limegreen|CR=limegreen|CU=dodgerblue|CV=limegreen
|DJ=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue
|EC=limegreen|EG=dodgerblue|ET=dodgerblue
|FJ=limegreen|FM=limegreen
|GA=dodgerblue|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=dodgerblue|GN=dodgerblue|GQ=dodgerblue|GT=limegreen|GW=dodgerblue|GY=dodgerblue
|HN=limegreen|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IN=limegreen|IQ=dodgerblue|IR=dodgerblue
|JM=limegreen|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=limegreen|KM=dodgerblue|KN=limegreen|KP=dodgerblue|KR=limegreen|KW=dodgerblue|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=limegreen|LK=dodgerblue|LR=limegreen|LS=limegreen|LY=dodgerblue
|MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=dodgerblue|MO=blueviolet|MR=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue
|NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=limegreen|NP=dodgerblue|NR=limegreen|NZ=limegreen
|OM=limegreen
|PA=limegreen|PE=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PY=dodgerblue
|QA=dodgerblue
|RS=dodgerblue|RW=dodgerblue
|SA=dodgerblue|SB=dodgerblue|SC=blueviolet|SD=dodgerblue|SG=dodgerblue|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=limegreen|SV=limegreen|SY=dodgerblue|SZ=limegreen
|TD=dodgerblue|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TT=dodgerblue|TV=limegreen
|UA=limegreen|UG=limegreen|UY=limegreen|UZ=limegreen
|VC=limegreen|VE=dodgerblue|VN=dodgerblue|VU=dodgerblue
|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=limegreen|ZM=dodgerblue|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
}}
<section end="bbibpauthmap"/>
The [[Sinopharm BIBP COVID-19 vaccine]],is an [[inactivated vaccine|inactivated virus vaccine]] produced by the [[China National Pharmaceutical Group]] (Sinopharm) and its Beijing Institute of Biological Products.<ref name="ChiCTR20000347802">{{cite journal|last1=Chen|first1=Wei|last2=Al Kaabi|first2=Nawal|date=18 July 2020|title=A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)|url=http://www.chictr.org.cn/showprojen.aspx?proj=56651|journal=Chinese Clinical Trial Registry|access-date=15 August 2020|name-list-style=vanc}}</ref><ref name=":02">{{cite journal|display-authors=6|vauthors=Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X|date=October 2020|title=Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial|journal=The Lancet. Infectious Diseases|volume=21|issue=1|pages=39–51|doi=10.1016/s1473-3099(20)30831-8|pmc=7561304|pmid=33069281}}</ref>

;Full (<section begin="Sinopharm-BBIBP_FN"/>4<section end="Sinopharm-BBIBP_FN"/>)
# Bahrain<ref>{{#invoke:cite web||title=Bahrain approves China's Sinopharm coronavirus vaccine |url=https://www.arabianbusiness.com/healthcare/455832-bahrain-approves-chinas-sinopharm-coronavirus-vaccine |website=Arabian Business Industries |date=13 December 2020}}</ref>
# China<ref>{{#invoke:cite news||last1=Kuo |first1=Lily |title=China approves Sinopharm coronavirus vaccine, the country's first for general use |url=https://www.washingtonpost.com/world/asia_pacific/coronavirus-vaccine-china-sinopharm/2020/12/30/1cc4be9e-4a62-11eb-97b6-4eb9f72ff46b_story.html |work=The Washington Post| name-list-style=vanc}}</ref>
# Seychelles<ref>{{#invoke:Cite web||title=President Ramkalawan and First Lady receives second dose SinoPharm Vaccine|url=http://www.statehouse.gov.sc/news/5090/president-ramkalawan-and-first-lady-receives-second-dose-sinopharm-vaccine|access-date=5 February 2021|website=statehouse.gov.sc}}</ref>
# United Arab Emirates<ref name="nyt-uae-wee-dec-12-2020">{{#invoke:cite news||last1=Wee |first1=Sui-Lee |title=Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl |url=https://www.nytimes.com/2020/12/09/business/china-coronavirus-vaccine-united-arab-emirates.html |access-date=12 December 2020 |work=[[The New York Times]] |date=9 December 2020| name-list-style=vanc}}</ref><ref>{{#invoke:Cite web||title=Coronavirus: UAE authorises emergency use of vaccine for frontline workers|url=https://www.thenationalnews.com/uae/health/coronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680|access-date=24 November 2020|website=The National|date=14 September 2020}}</ref>
{{-}}

;Emergency (<section begin="Sinopharm-BBIBP_EN" />93<section end="Sinopharm-BBIBP_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Afghanistan<ref>{{#invoke:Cite web||title=China 'to provide 400,000 COVID vaccine doses' to Afghanistan|url=https://www.aljazeera.com/news/2021/3/1/china-to-provide-400000-covid-vaccine-doses-to-afghanistan|access-date=22 March 2021|publisher=Al Jazeera}}</ref>
# Algeria<ref>{{#invoke:Cite web||last=Presse|first=AFP-Agence France|title=Algeria Receives 200,000 Coronavirus Jabs From China|url=https://www.barrons.com/news/algeria-receives-200-000-coronavirus-jabs-from-china-01614270916|access-date=22 March 2021|website=Barrons}}</ref>
# Angola<ref>{{#invoke:Cite web||date=25 March 2021|title=Angola recebeu doação chinesa de 200 mil doses de vacinas Sinopharm|url=https://www.noticiasaominuto.com/mundo/1718180/angola-recebeu-doacao-chinesa-de-200-mil-doses-de-vacinas-sinopharm|access-date=14 April 2021|website=Notícias ao Minuto|language=pt}}</ref>
# Antigua and Barbuda<ref>{{#invoke:Cite web||date=14 July 2021|title=SPUTNIK V VACCINE APPROVED FOR USE IN ANTIGUA AND BARBUDA – SINOPHARM ROLL OUT TO BEGIN THIS WEEK|url=https://antiguaobserver.com/sputnik-v-vaccine-approved-for-use-in-antigua-and-barbuda-sinopharm-roll-out-to-begin-this-week/|access-date=15 July 2021|website=Antigua Observer Newspaper}}</ref>
# Argentina<ref>{{#invoke:cite news||last1=Biannchi|first1=Walter|date=21 February 2021|title=Argentina approves Sinopharm COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-argentina-vaccine-idUSKBN2AL0P9|access-date=23 February 2021}}</ref>
# Armenia<ref name="whotracker"/>
# Bangladesh<ref>{{#invoke:cite news||date=29 April 2021|title=Bangladesh approves emergency use of China's Sinopharm vaccine amid supply squeeze|publisher=[[bdnews24.com]]|url=https://bdnews24.com/bangladesh/2021/04/29/bangladesh-approves-emergency-use-of-chinas-sinopharm-vaccine-amid-supply-squeeze|access-date=29 April 2021}}</ref>
# Barbados<ref>{{#invoke:Cite web||last=Rollock|first=Melissa|date=23 June 2021|title=China's Sinopharm Vaccines To Arrive On Friday|url=https://gisbarbados.gov.bb/blog/chinas-sinopharm-vaccines-to-arrive-on-friday/|url-status=live|access-date=28 June 2021|website=Barbados Government Information System}}</ref>
# Belarus<ref>{{#invoke:Cite web||date=15 March 2021|title=Belarus begins COVID-19 vaccinations with Chinese shots|url=https://eng.belta.by/society/view/belarus-begins-covid-19-vaccinations-with-chinese-shots-138222-2021/|access-date=16 March 2021|publisher=Belta}}</ref>
# Belize<ref name="cdctracker"/>
# Bhutan<ref>{{#invoke:Cite web||title=Bhutan receives 500,000 doses of COVID-19 vaccines through COVAX|url=https://www.unicef.org/rosa/press-releases/bhutan-receives-500000-doses-covid-19-vaccines-through-covax|access-date=15 July 2021|website=www.unicef.org}}</ref>
# Bolivia<ref>{{#invoke:Cite web||title=Bolivia begins inoculation with Sinopharm jabs |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/26/bolivia-begins-inoculation-with-sinopharm-jabs|access-date=28 February 2021|website=The Star|location=Malaysia}}</ref>
# Bosnia and Hergezovina<ref>{{Cite web|url=https://www.sarajevotimes.com/finalized-contract-for-the-procurement-of-half-a-million-doses-of-sinopharm-vaccine/|title=Finalized Contract for the Procurement of half a Million Doses of Sinopharm Vaccine|date=July 2, 2021}}</ref>
# Brazil<ref name="Agência Brasil">{{#invoke:cite news||title=Covid-19: aumenta para sete o número de vacinas autorizadas no Brasil |url=https://agenciabrasil.ebc.com.br/radioagencia-nacional/saude/audio/2021-05/aumenta-para-sete-o-numero-de-vacinas-autorizadas-no-brasil |work=Agência Brasil |date=7 May 2021 |language=pt-br}}</ref>
# Brunei<ref>{{#invoke:Cite web||title=Vaccine donation from China arrives |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/12/vaccine-donation-from-china-arrives|access-date=22 March 2021|website=The Star|location=Malaysia}}</ref>
# Cambodia<ref>{{#invoke:Cite web||last1=Rinith|first1=Taing|date=4 February 2021|title=Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine|url=https://www.khmertimeskh.com/50810677/health-ministry-grants-emergency-use-authorization-to-chinas-sinopharm-vaccine/|access-date=4 February 2021|work=Khmer Times|name-list-style=vanc}}</ref>
# Cameroon<ref name="cdctracker"/>
# Chad<ref>{{#invoke:Cite web||last=AfricaNews|date=6 June 2021|title=Chadians line up for Sinopharm as COVID-19 vaccination campaign begins|url=https://www.africanews.com/2021/06/06/chadians-line-up-for-sinopharm-as-covid-19-vaccination-campaign-begins/|access-date=6 June 2021|website=Africanews}}</ref>
# Comoros<ref name="cdctracker"/>
# Congo<ref name="cdctracker"/>
#Cuba<ref>{{Cite web|date=2021-08-28|title=Cuba aplicará vacuna china Sinopharm junto a inoculaciones de desarrollo local|url=https://es.euronews.com/2021/08/28/salud-coronavirus-cuba-china|access-date=2021-08-29|website=euronews|language=es}}</ref>
# Djibouti<ref name="cdctracker"/>
# Dominica<ref>{{#invoke:Cite web||date=4 March 2021|title=Dominica: Melissa Skerrit receives the Sinopharm COVID-19 vaccine|url=https://wicnews.com/caribbean/dominica-melissa-skerrit-receives-the-sinopharm-covid-19-vaccine-522633184/|access-date=7 March 2021|publisher=WIC News}}</ref>
# Dominican Republic<ref>{{#invoke:cite web||title=Ministro de Salud recibe su primera dosis de la vacuna Sinovac; asegura que el biológico es confiable |url=https://www.msp.gob.do/web/?p=11563 |website=Ministerio de Salud Pública |language=es |date=3 May 2021}}</ref>
# Egypt<ref>{{#invoke:Cite web||title=Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister – Xinhua |url=http://xinhuanet.com/english/2021-01/03/c_139637781.htm|publisher=Xinhuanet}}</ref>
# Equatorial Guinea<ref>{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/02/17/equatorial-guinea-president-receives-1st-dose-of-chinese-covid-19-vaccine/|access-date=22 March 2021|website=dailynewsegypt.com}}</ref>
# Ethiopia<ref>{{#invoke:Cite news||date=29 March 2021|title=Ethiopia to get 300,000 doses of Sinopharm COVID-19 shot, health minister says|publisher=Reuters|url=https://www.reuters.com/article/uk-healthcare-coronavirus-ethiopia-idUSKBN2BL1TE|access-date=14 April 2021}}</ref>
# Gabon<ref>{{#invoke:Cite web||date=12 March 2021|title=Gabon receives 100,000 doses of Sinopharm's vaccine from China|url=https://gabon24.ga/en/news/gabon-receives-100000-doses-of-sinopharms-vaccine-from-china/5155/|access-date=15 March 2021|publisher=Gabon 24}}</ref>
# Gambia<ref name="whotracker"/>
# Georgia<ref>{{#invoke:Cite web||date=4 May 2021|title=Georgia Starts COVID-19 Vaccination with Sinopharm|url=https://civil.ge/archives/417469|access-date=9 May 2021|website=Civil.ge}}</ref>
# Guinea<ref name="whotracker"/>
# Guinea-Bissau<ref name="cdctracker"/>
# Guyana<ref>{{#invoke:Cite web||date=6 March 2021|title=Sinopharm vaccine rollout starts this weekend|url=https://www.stabroeknews.com/2021/03/06/news/guyana/sinopharm-vaccine-rollout-starts-this-weekend/|access-date=7 March 2021|publisher=Stabroek News}}</ref>
# Hungary<ref>{{#invoke:Cite web||title=Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU|url=https://nationalpost.com/pmn/health-pmn/hungary-signs-deal-for-chinese-sinopharms-covid-19-vaccine-first-in-eu|website=National Post}}</ref><ref name="WashPost Hungary" />
# Indonesia<ref>{{#invoke:Cite web||title=Indonesia approves Sinopharm COVID-19 vaccine for emergency use|url=https://english.kontan.co.id/news/indonesia-approves-sinopharm-covid-19-vaccine-for-emergency-use|website=Kontan|date=30 April 2021|access-date=30 April 2021}}</ref>
# Iran<ref>{{#invoke:Cite web||date=22 February 2021|title=Iran Launches Phase Two of Mass Inoculation Campaign|url=https://financialtribune.com/articles/national/107614/iran-launches-phase-two-of-mass-inoculation-campaign|access-date=23 February 2021|website=Financial Tribune}}</ref>
# Iraq<ref name="bignewsnetwork.com" />
# Ivory Coast<ref name="whotracker"/>
# Jordan<ref>{{#invoke:Cite web||title=First batch of Chinese Sinopharm vaccine arrives in Jordan|url=https://en.royanews.tv/news/24716/2021-01-10|access-date=9 January 2021|publisher=Roya News}}</ref>
# Kazakhstan<ref>{{#invoke:Cite web||last=Satubaldina|first=Assel|date=30 April 2021|title=Three Vaccines to Become Available to Kazakh Citizens|url=https://astanatimes.com/2021/04/three-vaccines-to-become-available-to-kazakh-citizens/|access-date=1 May 2021|website=The Astana Times}}</ref>
# Kenya<ref name=":10" />
# Kuwait<ref name="whotracker"/>
# Kyrgyzstan<ref>{{#invoke:Cite web||last=Kharizov|first=Ruslan|date=19 March 2021|title=150,000 doses of Sinopharm coronavirus vaccine delivered to Kyrgyzstan|url=https://24.kg/english/187138_150000_doses_of_Sinopharm_coronavirus_vaccine_delivered_to_Kyrgyzstan/|access-date=22 March 2021|website=24.kg}}</ref>
# Laos<ref name="auto1" />
# Lebanon<ref>{{#invoke:Cite web||last1=Crean|first1=Rosabel|title=China donates 50,000 doses of Sinopharm vaccine to Lebanon|url=http://www.dailystar.com.lb/News/Lebanon-News/2021/Mar-01/517953-china-donates-50000-doses-of-sinopharm-vaccine-to-lebanon.ashx|access-date=2 March 2021|work=[[The Daily Star (Bangladesh)|The Daily Star]]}}</ref>
# Libya<ref>{{#invoke:Cite web||date=August 2, 2021|title=Libya gets 2 million Sinopharm doses with more expected|url=https://www.africanews.com/2021/08/02/libya-gets-2-million-sinopharm-doses-with-more-expected/|url-status=live|access-date=August 5, 2021|website=[[Africanews]]}}</ref>
# Malaysia<ref>{{#invoke:Cite news||last=Latiff|first=Rozanna|date=16 July 2021|title=Malaysia approves China's Sinopharm vaccine for emergency use|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-malaysia-vaccine-idUSL4N2OS18D|access-date=16 July 2021}}</ref>
# Malawi<ref name=":11">{{Cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|date=2020-06-10|title=Coronavirus Vaccine Tracker|language=en-US|work=The New York Times|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|access-date=2021-08-29|issn=0362-4331}}</ref>
# Maldives<ref>{{#invoke:Cite web||last1=Rasheed|first1=Aishath Hanaan Hussain|title=MFDA approves Pfizer, Sinopharm Covid-19 vaccines for emergency use|url=https://raajje.mv/96801|access-date=16 March 2021|publisher=raajje.mv}}</ref>
# Mauritania<ref>{{#invoke:Cite web||title=Mauritania begins COVID-19 vaccination campaign|url=https://www.aa.com.tr/en/africa/mauritania-begins-covid-19-vaccination-campaign/2189322|access-date=29 March 2021|website=aa.com.tr}}</ref>
# Mauritius<ref name="cdctracker"/>
# Mexico<ref>{{cite web |title= Comité de Moléculas Nuevas emite opiniones favorables por unanimidad sobre remdesivir y vacuna Sinopharm 
|url=https://www.gob.mx/cofepris/es/articulos/comite-de-moleculas-nuevas-emite-opiniones-favorables-por-unanimidad-sobre-remdesivir-y-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title= Cofepris emite autorización para uso de emergencia a vacuna Sinopharm 
|url=https://www.gob.mx/cofepris/es/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}</ref>
# Moldova<ref>{{#invoke:Cite web||last=Cristina|date=19 March 2021|title=O mie de studenți și medici-rezidenți din cadrul USMF vor fi imunizați anti-COVID cu vaccinul BBIBP-CorV, produs de către Sinopharm Beijing Institute of Biological Products|url=https://www.zdg.md/stiri/stiri-sociale/o-mie-de-studenti-si-medici-rezidenti-din-cadrul-usmf-vor-fi-imunizati-anti-covid-cu-vaccinul-bbibp-corv-produs-de-catre-sinopharm-beijing-institute-of-biological-products/|access-date=19 March 2021|website=Ziarul de Gardă|language=ro-RO}}</ref>
# Mongolia<ref>{{#invoke:Cite web||title=Deputy PM and City Governor get the first dose of Sinopharm vaccine|url=https://www.montsame.mn/en/read/256205|access-date=15 March 2021|publisher=Montsame}}</ref>
# Montenegro<ref>{{#invoke:Cite web||title=Montenegro receives 30,000 doses of China's COVID-19 vaccine|url=http://seenews.com/news/montenegro-receives-30000-doses-of-chinas-covid-19-vaccine-733151|access-date=22 March 2021|website=seenews.com}}</ref>
# Morocco<ref>{{#invoke:Cite web||title=Covid-19: Morocco authorizes use of the Sinopharm vaccine|url=https://en.yabiladi.com/articles/details/104807/covid-19-morocco-authorizes-sinopharm-vaccine.html|website=en.yabiladi.com}}</ref>
# Mozambique<ref>{{#invoke:cite news||date=6 March 2021|title=Mozambique expects to vaccinate 16 million against coronavirus by 2022|url=https://www.reuters.com/article/health-coronavirus-mozambique/mozambique-expects-to-vaccinate-16-million-against-coronavirus-by-2022-idUSL5N2L35GH|access-date=7 March 2021|publisher=Reuters}}</ref>
# Myanmar<ref>{{#invoke:Cite web||title=Myanmar to use China-donated Sinopharm Covid vaccine|url=https://elevenmyanmar.com/news/myanmar-to-use-china-donated-sinopharm-covid-vaccine|access-date=20 June 2021|website=Eleven Media Group Co., Ltd}}</ref>
# Namibia<ref>{{#invoke:Cite web||last=Namibian|first=The|title=Khomas, Erongo first to get vaccinated|url=https://www.namibian.com.na/index.php?page=read&id=99946|access-date=17 March 2021|website=The Namibian}}</ref>
# Nepal<ref>{{#invoke:Cite web||last1=Poudel|first1=Arjun|title=China's Shinopharm vaccine gets emergency use authorisation in Nepal|url=https://kathmandupost.com/health/2021/02/17/china-s-shinopharm-vaccine-gets-emergency-use-authorisation-in-nepal|access-date=19 February 2021|work=Kathmandu Post}}</ref>
# Niger<ref>{{#invoke:Cite web||title=China donates 400,000 doses of Sinopharm COVID-19 vaccine to Niger|url=https://www.channelnewsasia.com/news/world/china-donates-400-000-doses-of-sinopharm-covid-19-vaccine-to-14461352|access-date=1 April 2021|website=CNA}}</ref>
# Nigeria<ref>{{Cite web|date=2021-08-24|title=Nigeria approves Sinopharm COVID vaccine, expects 7.7 mln doses|url=https://www.reuters.com/world/africa/nigeria-approves-sinopharm-covid-vaccine-expects-77-mln-doses-2021-08-24/|access-date=2021-08-28|website=Reuters|language=en}}</ref>
# North Korea<ref>{{#invoke:Cite news||last1=Son|first1=Hyemin|last2=Ji|first2=Jeongeun |last3=Lee|first3=Myungchul|title=North Korea Has Been Importing Chinese COVID-19 Vaccines Since Early May |url=https://www.rfa.org/english/news/korea/vax-06152021112903.html |work=[[Radio Free Asia]] |date=15 June 2021}}</ref>
# North Macedonia<ref>{{#invoke:Cite web||last=|first=|title=North Macedonia looks to Chinese vaccine to revive program|url=https://abcnews.go.com/Health/wireStory/north-macedonia-chinese-vaccine-revive-program-77418628|access-date=1 May 2021|website=ABC News}}</ref>
# Pakistan<ref>{{#invoke:Cite news||last1=Shahzad|first1=Asif|date=19 January 2021|title=Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/health-coronavirus-pakistan-sinopharm/pakistan-approves-chinese-sinopharm-covid-19-vaccine-for-emergency-use-idUSKBN29O049|publisher=Reuters|name-list-style=vanc}}</ref>
# Palestine<ref>{{#invoke:Cite web||last=|first=|title=What we know about China's Sinopharm COVID vaccine|url=https://www.thefinancialexpress.com.bd/national/what-we-know-about-chinas-sinopharm-covid-vaccine-1619625832|access-date=1 May 2021|website=The Financial Express}}</ref>
# Papua New Guinea<ref>{{#invoke:Cite web||date=7 May 2021|title=Chinese vaccine to be gazetted|url=https://postcourier.com.pg/chinese-vaccine-to-be-gazetted/|access-date=21 May 2021|website=Post Courier}}</ref>
# Paraguay<ref name="whotracker"/>
# Peru<ref>{{#invoke:Cite news||date=27 January 2021|title=Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine – government sources|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-peru/peru-grants-exceptional-approval-for-sinopharm-covid-19-vaccine-government-sources-idUSKBN29W2TL}}</ref>
# Philippines<ref>{{#invoke:Cite news||author1=Aguilar, Krissy|title=PH approves Sinopharm COVID-19 vaccine for emergency use|url=https://newsinfo.inquirer.net/1442960/ph-approves-sinopharm-covid-19-vaccine-for-emergency-use|publisher=Philippine Daily Inquirer|date=7 June 2021}}</ref>
# Qatar<ref>{{#invoke:Cite news||author1=Arslan|title=Qatar gives conditional approval for Sinopharm Vaccine|url=https://covid19.moph.gov.qa/EN/travel-and-return-policy/Pages/default.asp|publisher=qaziarslantariq|date=1 August 2021}}</ref>
# Rwanda<ref>{{Cite web|date=2021-08-12|title=Rwanda to acquire Sinopharm vaccines next week|url=https://www.newtimes.co.rw/news/rwanda-acquire-sinopharm-vaccines-next-week|access-date=2021-08-28|website=The New Times {{!}} Rwanda|language=en}}</ref>
# Saudi Arabia<ref name=":9">{{Cite web|date=2021-08-25|title=Saudi Arabia approves Sinovac and Sinopharm vaccines|url=https://arab.news/ycuqf|access-date=2021-08-28|website=Arab News|language=en}}</ref>
# Senegal<ref>{{#invoke:Cite web||last1=Asala|first1=Kizzi|title=Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm|url=https://www.africanews.com/2021/02/18/senegal-kicks-off-covid-19-vaccination-campaign-with-china-s-sinopharm/|access-date=23 February 2021|publisher=Africanews}}</ref>
# Serbia<ref>{{#invoke:Cite web||title=Serbia Becomes First European Nation To Use China's Sinopharm Vaccine|url=https://www.rferl.org/a/serbia-covid-vaccine-china-sinopharm/31053091.html|website=RadioFreeEurope/RadioLiberty}}</ref>
# Sierra Leone<ref>{{#invoke:Cite web||last1=Thomas|first1=Abdul Rashid|date=15 March 2021|title=Sierra Leone's President Bio leads the way in taking COVID-19 Vaccine|url=https://www.thesierraleonetelegraph.com/sierra-leones-president-bio-leads-the-way-in-taking-covid-19-vaccine/|access-date=16 March 2021|work=Sierra Leone Telegraph}}</ref>
# Singapore<ref>{{#invoke:Cite web||title=11 Singapore private healthcare providers allowed to bring in Sinopharm COVID-19 vaccine|url=https://www.channelnewsasia.com/news/singapore/sinopharm-covid-19-hsa-special-access-route-vaccine-sinovac-15337454|access-date=2021-07-30|website=CNA|language=en}}</ref> ''(restricted)''
# Solomon Islands<ref>{{#invoke:Cite web||title=Health Ministry Prepares for Sinopharm Roll Out - Solomon Times Online|url=https://www.solomontimes.com/news/health-ministry-prepares-for-sinopharm-roll-out/10856|access-date=21 May 2021|website=SolomonTimes.com}}</ref>
# Somalia<ref>{{#invoke:Cite web||last=|date=15 April 2021|title=Somalia rolls out Sinopharm vaccines to boost fight against COVID-19|url=https://newsghana.com.gh/somalia-rolls-out-sinopharm-vaccines-to-boost-fight-against-covid-19/|access-date=18 April 2021|website=News Ghana}}</ref>
#South Sudan<ref>{{Cite web|date=2021-08-27|title=South Sudan to receive 100,000 doses of Sinopharm vaccines from China|url=https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/|access-date=2021-08-29|website=Juba echo|language=en-US}}</ref>
# Sri Lanka<ref>{{#invoke:Cite web||date=19 March 2021|title=NMRA approves sinopharm vaccine for emergency use|url=https://colombogazette.com/2021/03/19/nmra-approves-sinopharm-vaccine-for-emergency-use/|access-date=29 March 2021|website=Colombo Gazette}}</ref>
# Sudan<ref>{{#invoke:Cite web||title=China To Provide Sudan With 250,000 Doses Of Sinopharm Vaccine On Friday – Ambassador|url=https://www.urdupoint.com/en/world/china-to-provide-sudan-with-250000-doses-of-1203394.html|access-date=14 April 2021|website=UrduPoint}}</ref><ref>{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/03/28/china-donated-sinopharm-covid-19-vaccines-arrive-in-sudan/|access-date=14 April 2021|website=dailynewsegypt.com}}</ref>
# Suriname<ref name="whotracker"/>
# Syria<ref name="whotracker"/>
# Thailand<ref>{{#invoke:cite news|| title = FDA approves use of Sinopharm vaccine | date = 2021-05-28 | url = https://www.bangkokpost.com/thailand/general/2123307/fda-approves-use-of-sinopharm-vaccine | work = [[Bangkok Post]]}}</ref>
# Trinidad and Tobago<ref>{{#invoke:Cite web||title=3,719 get Sinopharm vaccine in two days|url=https://trinidadexpress.com/newsextra/3-719-get-sinopharm-vaccine-in-two-days/article_3ee2e5bc-bbe8-11eb-a881-03217b7b7121.html|access-date=3 June 2021|website=Trinidad Express Newspapers}}</ref>
# Tunisia<ref>{{#invoke:Cite web||title=China's Sinopharm COVID-19 vaccine approved for marketing in Tunisia - Xinhua &#124; English.news.cn|url=http://www.xinhuanet.com/english/africa/2021-07/13/c_1310057298.htm|access-date=2021-07-21|website=www.xinhuanet.com}}</ref>
# Turkmenistan<ref>{{#invoke:Cite web||title=В Туркменистане от COVID бесплатно прививают китайской вакциной, российский "Спутник" можно купить|url=https://rus.azathabar.com/a/31190974.html|access-date=9 May 2021|website=Радио Азатлык|language=ru}}</ref>
# Vanuatu<ref>{{#invoke:Cite web||title=PM to receive Sinopharm jab today|url=https://dailypost.vu/news/pm-to-receive-sinopharm-jab-today/article_353ada2c-cd65-11eb-96db-9308a7cd2ac1.html|access-date=15 June 2021|website=Vanuatu Daily Post}}</ref>
# Venezuela<ref>{{#invoke:cite news||last1=Sequera|first1=Vivian|date=1 March 2021|title=Venezuela approves use of China's Sinopharm coronavirus vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-venezuela-vaccine-idUSKCN2AT3T2|access-date=2 March 2021}}</ref>
# Vietnam<ref>{{#invoke:Cite web||date=4 June 2021|title=Vietnam approves China's Sinopharm vaccine for use against COVID-19|url=https://www.reuters.com/business/healthcare-pharmaceuticals/vietnam-approves-chinas-sinopharm-vaccine-use-against-covid-19-media-2021-06-04/|access-date=4 June 2021|website=Reuters}}</ref>
# Zambia<ref>{{#invoke:Cite web||last=Sachiti|first=Roselyne|title=Zambia to get Sinopharm COVID-19 vaccines|url=https://www.herald.co.zw/zambia-to-get-sinopharm-covid-19-vaccines/|access-date=21 May 2021|website=The Herald}}</ref>
# Zimbabwe<ref>{{#invoke:Cite web||last1=Mutsaka|first1=Farai|date=18 February 2021|title=Zimbabwe starts administering China's Sinopharm vaccines|url=https://www.thestar.com/news/world/africa/2021/02/18/zimbabwe-starts-administering-chinas-sinopharm-vaccines.html|access-date=20 February 2021|work=Toronto Star}}</ref>
<br />'''[[ISO 3166-1#Current codes|Non-country entities]]'''<!-- not counted -->
* Macau<ref>{{#invoke:Cite web||date=7 February 2021|title=Macau receives first batch of COVID-19 vaccines|url=https://www.asgam.com/index.php/2021/02/08/macau-receives-first-batch-of-covid-19-vaccines/|access-date=24 February 2021|website=IAG}}</ref>
* ''[[World Health Organization]]''<ref>{{cite press release | title=WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations | publisher=[[World Health Organization]] (WHO) | date=7 May 2021 | url=https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=7 May 2021}}</ref><ref name=WHOEUA>{{cite news | last=Taylor | first=Adam | title=WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine | website=[[The Washington Post]] | date=7 May 2021 | url=https://www.washingtonpost.com/world/2021/05/07/who-sinopharm-emergency-use/ | access-date=7 May 2021}}</ref>
</div>
{{-}}

== Sputnik V ==
<section begin="sputnikauthmap" />
{{infobox
| image            = {{Graph:Map|scale=80|defaultValue=gainsboro
|AD=silver|AE=dodgerblue|AF=silver|AG=dodgerblue|AL=silver|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=darkgrey|AZ=dodgerblue
|BA=dodgerblue|BB=silver|BD=dodgerblue|BE=darkgrey|BF=silver|BG=darkgrey|BH=dodgerblue|BJ=silver|BN=silver|BO=dodgerblue|BR=dodgerblue|BS=silver|BT=silver|BW=silver|BY=dodgerblue|BZ=silver
|CD=silver|CF=silver|CG=silver|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=silver|CR=silver|CV=silver|CY=darkgrey|CZ=darkgrey
|DE=darkgrey|DJ=dodgerblue|DK=darkgrey|DM=silver|DO=silver|DZ=dodgerblue
|EC=dodgerblue|EE=darkgrey|EG=dodgerblue|ES=darkgrey|ET=silver
|FI=darkgrey|FJ=silver|FM=silver|FR=darkgrey
|GA=dodgerblue|GH=dodgerblue|GM=silver|GN=dodgerblue|GR=darkgrey|GT=dodgerblue|GY=dodgerblue
|HN=dodgerblue|HR=darkgrey|HT=silver|HU=dodgerblue
|ID=dodgerblue|IE=darkgrey|IN=dodgerblue|IQ=dodgerblue|IR=dodgerblue|IT=darkgrey
|JM=silver|JO=dodgerblue
|KE=dodgerblue|KG=dodgerblue|KH=silver|KI=silver|KM=silver|KN=silver|KP=silver|KZ=dodgerblue
|LA=dodgerblue|LB=dodgerblue|LC=silver|LK=dodgerblue|LR=silver|LS=silver|LT=darkgrey|LU=darkgrey|LV=darkgrey|LY=dodgerblue
|MA=dodgerblue|MC=silver|MD=dodgerblue|ME=dodgerblue|MH=silver|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MR=silver|MT=darkgrey|MU=dodgerblue|MV=dodgerblue|MW=silver|MX=dodgerblue|MY=silver|MZ=silver
|NA=dodgerblue|NE=silver|NG=dodgerblue|NI=dodgerblue|NL=darkgrey|NP=dodgerblue|NR=silver|NZ=silver
|OM=dodgerblue
|PA=dodgerblue|PE=dodgerblue|PG=silver|PH=dodgerblue|PK=dodgerblue|PL=darkgrey|PS=dodgerblue|PT=darkgrey|PY=dodgerblue
|RO=darkgrey|RS=dodgerblue|RU=dodgerblue|RW=silver
|SA=silver|SB=silver|SC=dodgerblue|SD=silver|SE=darkgrey|SG=silver|SI=darkgrey|SK=dodgerblue|SL=silver|SM=dodgerblue|SN=silver|SO=silver|SR=silver|SS=silver|ST=silver|SV=silver|SY=dodgerblue|SZ=silver
|TD=silver|TG=silver|TH=silver|TJ=silver|TL=silver|TM=blueviolet|TN=dodgerblue|TO=silver|TR=dodgerblue|TT=silver|TV=silver
|UA=silver|UG=silver|UY=silver|UZ=blueviolet
|VC=dodgerblue|VE=dodgerblue|VN=dodgerblue|VU=silver
|WS=silver
|XK=silver
|YE=silver
|ZA=silver|ZM=silver|ZW=dodgerblue
}}
| caption          = {{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|silver|Eligible [[COVAX]] recipient (ongoing assessment)<ref name="WHO status"/>}}
{{leftlegend|darkgrey|[[European Medicines Agency]] (EMA) review in progress<ref name="ema.europa.eu">{{cite web |title=COVID-19 vaccines: under evaluation |url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-under-evaluation |website=[[European Medicines Agency]] (EMA)}}</ref>}}
}}
<section end="sputnikauthmap" />
The [[Sputnik V COVID-19 vaccine]] is a [[viral vector vaccine]]<ref name="NCT04436471">{{cite journal|date=17 June 2020|title=An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04436471|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04436471}}</ref> produced by the Russian [[Gamaleya Research Institute of Epidemiology and Microbiology]].
;Full (<section begin="Sputnik V_FN" />2<section end="Sputnik V_FN" />)
# Turkmenistan<ref>{{cite news|date=18 January 2021|title=Turkmenistan is the first in Central Asia to have registered 'Sputnik V' vaccine|work=Orient|url=https://orient.tm/en/turkmenistan-is-the-first-in-central-asia-to-have-registered-sputnik-v-vaccine/}}</ref><ref>{{cite news|date=22 January 2021|title=Session of the Cabinet of Ministers of Turkmenistan |work=Turkmenistan today |url=https://tdh.gov.tm/en/post/25815/objectives-of-increasing-national-health-system%E2%80%99s-potential-discussed}}</ref>
# Uzbekistan<ref>{{cite news|date=17 February 2021|title=Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use|publisher=Agence France-Presse (Barron's)|url=https://www.barrons.com/news/uzbekistan-certifies-russia-s-sputnik-vaccine-for-mass-use-01613559912}}</ref>
{{-}}

;Emergency (<section begin="Sputnik V_EN" />73<section end="Sputnik V_EN" />)
<div style="margin-top: 0.3em; column-width: 15em;">
# Albania<ref name=":0" />
# Algeria<ref>{{cite news|date=10 January 2021|title=Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine|work=Algeria Press service|url=https://www.aps.dz/en/health-science-technology/37478-covid19-national-pharmaceuticals-agency-registers-sputnik-v-vaccine}}</ref>
# Angola<ref name="Reuters idUSR4N2K301A" />
# Antigua and Barbuda<ref>{{cite press release|title=Antigua and Barbuda authorizes Sputnik V|url=https://sputnikvaccine.com/newsroom/pressreleases/antigua-and-barbuda-authorizes-sputnik-v/|website=sputnikvaccine.com|date=26 March 2021}}</ref>
# Argentina<ref>{{cite press release|title=Argentina has registered the Sputnik V vaccine based on Russian clinical trial data|url=https://sputnikvaccine.com/newsroom/pressreleases/argentina-has-registered-the-sputnik-v-vaccine-based-on-russian-clinical-trial-data-/|access-date=1 January 2021|publisher=Gamaleya Center}}</ref>
# Armenia<ref>{{cite news|date=1 February 2021|title=Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF|publisher=[[Reuters]]|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-armeni/armenia-approves-russias-sputnik-v-coronavirus-vaccine-russias-rdif-idUSR4N2J304T|access-date=1 February 2021}}</ref>
# Azerbaijan<ref>{{cite news|date=12 March 2021|title=Azerbaijan approves Russia's Sputnik V vaccine for use against COVID-19 -Azeri health ministry|publisher=[[Reuters]]|url=https://www.reuters.com/article/health-coronavirus-russia-azerbaijan/azerbaijan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-azeri-health-ministry-idUSR4N2IW02L}}</ref><ref>{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6524/|access-date=1 April 2021|website=rdif.ru}}</ref>
# Bahrain<ref>{{cite news|date=10 February 2021|title=Bahrain authorises Sputnik V COVID-19 vaccine for emergency use – Bahrain TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-bahrain-vaccine-int-idUSKBN2AA1GW|access-date=19 February 2021}}</ref>
# Bangladesh<ref>{{cite news|date=27 April 2021|title=Bangladesh approves Russia's Sputnik V Covid-19 vaccine for emergency use|publisher=[[Dhaka Tribune]]|url=https://www.dhakatribune.com/bangladesh/2021/04/27/bangladesh-approves-russia-s-sputnik-v-vaccine-for-emergency-use|access-date=27 April 2021}}</ref>
# Belarus<ref>{{cite news|date=21 December 2020|title=Belarus registers Sputnik V vaccine, in first outside Russia – RDIF|publisher=[[Reuters]]|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-belarus/belarus-registers-sputnik-v-vaccine-in-first-outside-russia-rdif-idINKBN28V0ZG|access-date=22 December 2020}}</ref>
# Bolivia<ref>{{cite news|title=Ministerio de Salud de Bolivia – Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19|work=minsalud.gob.bo|url=https://www.minsalud.gob.bo/5114-bolivia-y-rusia-firman-contrato-para-adquirir-5-2-millones-de-dosis-de-la-vacuna-sputnik-v-contra-el-covid-19|access-date=1 January 2021}}</ref>
# Bosnia and Herzegovina<ref name="Tass 20210205">{{#invoke:Cite web||date=5 February 2021|title=Sputnik V vaccine registered in Bosnia and Herzegovina's Republika Srpska|url=https://tass.com/world/1253307|access-date=8 February 2021|agency=TASS}}</ref>
# Brazil<ref name="g1.globo.com">{{cite news |title=Anvisa aprova, com restrições, a importação excepcional de doses da Covaxin e Sputnik V |trans-title=Anvisa approves import of doses of Covaxin and Sputnik V, with restrictions |url=https://g1.globo.com/bemestar/vacina/noticia/2021/06/04/anvisa-covaxin-sputnik-v.ghtml |access-date=4 June 2021 |work=G1 |agency=Globo |date=4 June 2021 |language=Portuguese}}</ref> ''(restricted)''
# Cameroon<ref>{{cite news|date=19 March 2021|title=Cameroon approves Russia's Sputnik V coronavirus vaccine for use – RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-camero-idUSR4N2HG02H}}</ref>
# Chile<ref>{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-sputnik-v/|access-date=2021-07-21}}</ref>
# Congo<ref name="Reuters idUSR4N2K301A" />
# Djibouti<ref name="Reuters idUSR4N2K301A">{{cite news |title=Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine |url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-angola-idUSR4N2K301A |publisher=[[Reuters]] |date=3 March 2021 }}</ref>
# Ecuador<ref>{{cite news|title=Arcsa autoriza el ingreso al Ecuador de vacuna Sputnik V|work=www.controlsanitario.gob.ec|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-el-ingreso-al-ecuador-de-vacuna-sputnik-v/|date=14 May 2021|access-date=15 May 2021}}</ref>
# Egypt<ref name="Gulf News">{{cite news|title=COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs|work=Gulf News|url=https://gulfnews.com/world/mena/covid-19-egypt-authorises-sputnik-v-astrazeneca-virus-jabs-1.1614189861208|access-date=24 February 2021}}</ref>
# Gabon<ref>{{cite press release|title=Sputnik V authorised in Gabon|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-authorized-in-gabon/|access-date=17 February 2021|publisher=Gamaleya Center}}</ref>
# Ghana<ref>{{cite news|date=20 February 2021|title=Ghana approves Russia's Sputnik V vaccine for emergency use – RDIF|agency=[[Reuters]]|url=https://news.trust.org/item/20210220072758-kzlw8/}}</ref>
# Guatemala<ref>{{#invoke:Cite web||title=Guatemala authorizes Sputnik V|url=https://www.pharmiweb.com/press-release/2021-02-26/guatemala-authorizes-sputnik-v|access-date=1 April 2021|website=PharmiWeb.com}}</ref>
# Guinea<ref>{{cite news|date=31 December 2020|title=Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine|work=Africa news|url=https://www.africanews.com/2020/12/31/guinea-begins-administering-russia-s-sputnik-v-covid-19-vaccine/}}</ref>
# Guyana<ref>{{cite news|date=3 March 2021|title=Russia's Sputnik V vaccine expands its reach in Latin America|publisher=CNN|url=https://edition.cnn.com/2021/03/03/americas/sputnik-latin-america-spreads-intl-latam/index.html}}</ref>
# Honduras<ref>{{cite news|date=25 February 2021|title=Honduras approves use of Sputnik V vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-02/25/c_139764745.htm}}</ref>
# Hungary<ref>{{cite news |title=Hungarian drug regulator approves Sputnik V vaccine: website |url=https://www.themoscowtimes.com/2021/02/07/hungary-approves-russias-sputnik-v-vaccine-a72853 |work=The Moscow Times |date=7 February 2021 }}</ref><ref name="Tass 20210205" /><ref name="WashPost Hungary">{{cite news | last=Spike | first=Justin | title=Hungary approves 2 more vaccines from outside EU amid spike |agency=Associated Press |website=ABC News | date=22 March 2021 | url=https://abcnews.go.com/Health/wireStory/hungary-approves-vaccines-eu-amid-spike-76604743 | access-date=14 July 2021 |name-list-style=vanc}}</ref>
# India<ref>{{cite news |title=India approves Russia's 'Sputnik V' COVID-19 vaccine: Economic Times |url=https://www.reuters.com/article/health-coronavirus-india-vaccine/india-approves-russias-sputnik-v-covid-19-vaccine-economic-times-idUSKBN2BZ11Y |publisher=[[Reuters]] |date=12 April 2021 }}</ref>
# Indonesia<ref>{{Cite web|last=|first=|date=2021-08-25|title=BPOM Terbitkan Izin Darurat Vaksin Rusia Sputnik-V|url=https://www.cnnindonesia.com/nasional/20210825111626-20-685041/bpom-terbitkan-izin-darurat-vaksin-rusia-sputnik-v|url-status=live|access-date=2021-08-25|website=CNN Indonesia|language=id-ID}}</ref>
# Iran<ref>{{cite news|date=26 January 2021|title=Iran approves Russian coronavirus vaccine Sputnik V|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-russia-iran/iran-approves-russian-coronavirus-vaccine-sputnik-v-for-use-idUSKBN29V1A8}}</ref>
# Iraq<ref>{{cite press release|title=Sputnik V authorized in Iraq|url=https://www.pharmiweb.com/press-release/2021-03-05/sputnik-v-authorized-in-iraq|publisher=PharmiWeb.com|date=4 March 2021}}</ref>
# Ivory Coast<ref name="whotracker" />
# Jordan<ref>{{cite press release|title=Jordan approves Russia's Sputnik V vaccine for use against COVID-19|url=https://www.reuters.com/article/health-coronavirus-russia-jordan-vaccine/jordan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-idUSL1N2L8241|publisher=Reuters|date=10 March 2021}}</ref>
# Kazakhstan<ref>{{#invoke:Cite web||date=1 February 2021|title=Kazakhstan begins mass vaccination by Russian Sputnik V|url=https://www.neweurope.eu/article/kazakhstan-has-began-mass-vaccination-by-russian-sputnik-v/|access-date=19 February 2021}}</ref>
# Kenya<ref>{{cite news|date=10 March 2021|title=Morocco, Kenya approve Russian coronavirus vaccine for use – RDIF|url=https://www.reuters.com/article/uk-health-coronavirus-vaccine-russia-ken-idUSKBN2B2130|access-date=12 March 2021}}</ref>
# Kyrgyzstan<ref>{{cite press release|title=Sputnik V registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-registered-in-kyrgyzstan/|website=Gamaleya Center|date=23 February 2021}}</ref>
# Laos<ref name="auto1">{{#invoke:Cite web||title=Laos declares Covid-19 vaccinations safe, more to be inoculated next week |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/01/06/laos-declares-covid-19-vaccinations-safe-more-to-be-inoculated-next-week|access-date=19 February 2021|website=The Star|location=Malaysia}}</ref>
# Lebanon<ref>{{cite news|date=5 February 2021|title=Lebanon authorises emergency use of Russia's Sputnik V vaccine|agency=[[Reuters]]|url=https://news.trust.org/item/20210205151526-w0bv2/}}</ref>
# Libya<ref name="auto4" /><ref name="auto5" />
# Maldives<ref>{{cite news|title=Maldives approves Russia's Sputnik V COVID-19 vaccine|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maldiv/maldives-approves-russias-sputnik-v-covid-19-vaccine-idUSR4N2MN00D|website=reuters.com|date=13 May 2021|access-date=May 13, 2021}}</ref>
# Mali<ref>{{cite news|date=30 March 2021|title=Mali approves Russia's Sputnik V vaccine – Russian sovereign wealth fund|publisher=[[Reuters]]|url=https://www.reuters.com/article/uk-health-coronavirus-russia-mali-vaccin/mali-approves-russias-sputnik-v-vaccine-russian-sovereign-wealth-fund-idUSKBN2BM0Y5}}</ref>
# Mauritius<ref>{{cite news|date=22 March 2021|title=Mauritius approves Russia's Sputnik V coronavirus vaccine – Russian RDIF fund|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maurit/mauritius-approves-russias-sputnik-v-coronavirus-vaccine-russian-rdif-fund-idUSR4N2KP01G}}</ref>
# Mexico<ref>{{cite news|date=3 February 2021|title=Mexico, Germany warm to Russia's Sputnik V virus vaccine|work=The Jakarta Post|url=https://www.thejakartapost.com/news/2021/02/03/mexico-germany-warm-to-russias-sputnik-v-virus-vaccine-.html}}</ref>
# Moldova<ref name=":2" />
# Mongolia<ref>{{cite news|date=9 February 2021|title=Mongolia Approves Russia's Sputnik V Coronavirus Vaccine – RDIF|publisher=Urdu Point|url=https://www.urdupoint.com/en/world/mongolia-approves-russias-sputnik-v-coronavi-1163730.html}}</ref>
# Montenegro<ref>{{cite news|date=12 February 2021|title=Montenegro and St. Vincent approve Russia's Sputnik V vaccine – RDIF|publisher=[[Reuters]]|url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-mon/montenegro-and-st-vincent-approve-russias-sputnik-v-vaccine-rdif-idUSKBN2AC0QZ}}</ref>
# Morocco<ref>{{cite news|date=11 March 2021|title=Morocco orders one million doses of Russia's Sputnik V vaccine|publisher=Yabiladi|url=https://en.yabiladi.com/articles/details/107075/morocco-orders-million-doses-russia-s.html}}</ref>
# Myanmar<ref>{{#invoke:Cite web||title=Myanmar registers Russia's Sputnik V COVID-19 vaccine|url=https://tass.com/world/1253415|access-date=19 February 2021|publisher=Tass}}</ref>
# Namibia<ref>{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6520/|access-date=1 April 2021|website=rdif.ru}}</ref>
# Nepal<ref>{{Cite news|author=Reuters Staff|date=20 April 2021|title=Nepal approves Russia's Sputnik V COVID-19 vaccine|work=[[Reuters]]|url=https://www.reuters.com/article/health-coronavirus-nepal-idINL4N2MD3KU|access-date=23 April 2021}}</ref>
# Nicaragua<ref>{{cite news|date=3 February 2021|title=Nicaragua approves Russian COVID-19 vaccine|publisher=AP News|url=https://apnews.com/article/nicaragua-europe-russia-health-coronavirus-pandemic-82f9744bcf62d1689683c56455ecf15a |access-date=2 June 2021}}</ref>
# Nigeria<ref>{{cite news |title=Sputnik V vaccine approved in Nigeria |url=https://rdif.ru/fullNews/6937/ |access-date=18 July 2021 |work=Russian Direct Investment Fund |date=15 July 2021}}</ref>
# North Macedonia<ref>{{#invoke:Cite web||date=7 March 2021|title=NRussia's Sputnik V COVID 19 vaccine registered in North Macedonia|url=https://tass.com/coronavirus-outbreak-in-china/1263509|publisher=[[TASS]]}}</ref>
# Oman<ref name="oman-coronavac-sputnik"/>
# Pakistan<ref>{{cite news|date=24 January 2021|title=Govt okays Russian vaccine for 'emergency use'|work=Dawn|url=https://www.dawn.com/news/1603273}}</ref>
# Palestine<ref>{{cite news|date=11 January 2021|title=Palestine has become the first country in the Middle East to register Sputnik V vaccine|work=RFID|url=https://rdif.ru/Eng_fullNews/6279/}}</ref>
# Panama<ref>{{cite news |title=Panama approves use of Russian vaccine |url=https://www.newsroompanama.com/news/panama-approves-use-of-russian-vaccine |access-date=2 April 2021 |work=Newsroom Panama |date=1 April 2021}}</ref>
# Paraguay<ref>{{cite news|date=15 January 2021|title=Paraguay approves Russia's Sputnik V vaccine: RDIF|publisher=[[Reuters]]|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-paragu/paraguay-approves-russias-sputnik-v-vaccine-rdif-idUSR4N2J303Y|access-date=15 January 2021}}</ref>
# Peru<ref>{{#invoke:Cite web||date=July 20, 2021|title=Perú anuncia acuerdo para compra de 20 millones de dosis de la vacuna Sputnik V|url=https://elperuano.pe/noticia/125005-gobierno-firma-contrato-para-compra-de-20-millones-de-dosis-de-la-vacuna-sputnik-v|url-status=live|access-date=August 5, 2021|website=[[El Peruano]]}}</ref>
# Philippines<ref>{{cite web |url=https://cnnphilippines.com/news/2021/3/19/Russia-Gamaleya-emergency-use-PH.html |title=Russia's Sputnik V approved for emergency use in PH |date=19 March 2021 |website=[[CNN Philippines]] |access-date=19 March 2021}}</ref>
# Russia<ref name="burki">{{cite journal|vauthors=Burki TK|date=November 2020|title=The Russian vaccine for COVID-19|journal=The Lancet. Respiratory Medicine|volume=8|issue=11|pages=e85–e86|doi=10.1016/S2213-2600(20)30402-1|pmc=7837053|pmid=32896274|doi-access=free|title-link=doi}}</ref>
# Saint Vincent and the Grenadines<ref name="auto2">{{#invoke:Cite web||date=11 February 2021|title=Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021|url=https://www.gov.vc/images/pdf_documents/SRO-Public_Health_Emergency_Authorisation_of_Covid-19_Vaccine.pdf|access-date=12 February 2021|website=Government of Saint Vincent and the Grenadines}}</ref>
# San Marino<ref>{{cite news|date=20 February 2021|title=San Marino buys the Sputnik vaccine: "First doses already in the next few days"|work=Unioneonline|url=https://www.unionesarda.it/en/articolo/news/mondo/2021/02/19/san-marino-acquista-il-vaccino-sputnik-prime-dosi-gia-nei-prossim-137-1117575.html}}</ref><ref>{{cite news|date=12 April 2021|title=San Marino reopens thanks to Sputnik covid vaccine from Russia |work=Wanted in Rome|url=https://www.wantedinrome.com/news/san-marino-reopens-thanks-to-sputnik-covid-vaccine-from-russia.html}}</ref>
# Serbia<ref>{{cite news|date=31 December 2020|title=Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju|language=sr-RS|work=N1|url=https://rs.n1info.com/vesti/agencija-odobrila-uvoz-ruske-vakcine-sputnjik-v-u-srbiju/}}</ref>
# Seychelles<ref>{{cite news|date=19 March 2021|title=Sputnik V vaccine approved in Seychelles|agency=[[TASS]]|url=https://tass.com/world/1268131}}</ref>
# Slovakia<ref name="whotracker"/>
# Sri Lanka<ref>{{cite news|date=4 March 2021|title=Sri Lanka approves Russia's Sputnik V vaccine|work=The Hindu|url=https://www.thehindu.com/news/international/sri-lanka-approves-russias-sputnik-v-vaccine/article33987742.ece}}</ref>
# Syria<ref>{{cite news|date=22 February 2021|title=Syria authorizes use of Sputnik-V|publisher=Roya|url=https://en.royanews.tv/news/25728/2021-02-22}}</ref>
# Tunisia<ref>{{cite press release|title=Sputnik V vaccine authorized in Tunisia|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-vaccine-authorized-in-tunisia/|access-date=30 January 2021|publisher=Gamaleya Center}}</ref>
# Turkey<ref>{{Cite news|author=Merve Aydogan|date=30 April 2021|title=Turkey OKs emergency use of Sputnik-V vaccine|work=[[Anadolu Agency]]|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-oks-emergency-use-of-sputnik-v-vaccine/2225824}}</ref>
# United Arab Emirates<ref>{{cite news|date=21 January 2021|title=UAE approves Russia's Sputnik vaccine for emergency use|work=Khaleej Times|url=https://www.khaleejtimes.com/coronavirus-pandemic/uae-approves-russias-sputnik-vaccine-for-emergency-use|access-date=21 January 2021}}</ref>
# Venezuela<ref>{{cite news|date=29 December 2020|title=Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V|language=es|publisher=[[Reuters]]|url=https://www.reuters.com/article/salud-coronavirus-venezuela-rusia-idLTAKBN2931X2}}</ref>
# Vietnam<ref name="vnexpress.net">{{cite news|title=Vietnam approves Russia Covid-19 vaccine for emergency use|publisher=[[VnExpress]]|url=https://vnexpress.net/news/news/vietnam-approves-russia-covid-19-vaccine-for-emergency-use-4240528.html|access-date=2 April 2021}}</ref>
# Zimbabwe<ref name="news24.com-zimbabwe-ssv">{{cite news|date=9 March 2021|title=Covid-19: Zimbabwe authorises Sputnik V, Sinovac vaccines for emergency use|publisher=news24.com|url=https://www.news24.com/news24/africa/news/covid-19-zimbabwe-authorises-sputnik-v-sinovac-vaccines-for-emergency-use-20210309}}</ref>
<br />'''[[ISO 3166-1#Current codes|Non-country entities]]'''
* Abkhazia<ref>{{#invoke:Cite web||url=https://civil.ge/archives/417592|title = Russia's COVID Vaccine Delivered to Tskhinvali Region, Abkhazia|date = 4 May 2021}}</ref>
* South Ossetia<ref>{{#invoke:Cite web||url=https://tass.com/world/1285695|title=First batch of Sputnik V vaccine delivered to South Ossetia}}</ref>
</div>

== CoronaVac ==
<section begin="coronavacauthmap"/>
{{infobox|image={{Graph:Map|scale=80|defaultValue=gainsboro
|AD=limegreen|AF=limegreen|AG=limegreen|AL=dodgerblue|AM=dodgerblue|AO=limegreen|AR=limegreen|AT=darkgrey|AZ=dodgerblue
|BA=dodgerblue|BB=limegreen|BD=dodgerblue|BE=darkgrey|BF=limegreen|BG=darkgrey|BH=limegreen|BJ=dodgerblue|BN=limegreen|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=limegreen|BW=dodgerblue|BZ=limegreen
|CD=limegreen|CF=limegreen|CG=limegreen|CI=limegreen|CL=dodgerblue|CM=limegreen|CN=blueviolet|CO=dodgerblue|CR=limegreen|CV=limegreen|CY=darkgrey|CZ=darkgrey
|DE=darkgrey|DJ=dodgerblue|DK=darkgrey|DM=limegreen|DO=dodgerblue|DZ=limegreen
|EC=dodgerblue|EE=darkgrey|EG=dodgerblue|ES=darkgrey|ET=limegreen
|FI=darkgrey|FJ=dodgerblue|FM=limegreen|FR=darkgrey
|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=limegreen|GN=dodgerblue|GQ=dodgerblue|GR=darkgrey|GT=limegreen|GY=limegreen
|HK=dodgerblue|HN=limegreen|HR=darkgrey|HT=limegreen|HU=dodgerblue
|ID=dodgerblue|IE=darkgrey|IN=limegreen|IQ=limegreen|IR=limegreen|IS=darkgrey|IT=darkgrey
|JM=limegreen|JO=limegreen
|KE=limegreen|KG=limegreen|KH=dodgerblue|KI=limegreen|KM=limegreen|KN=limegreen|KP=limegreen|KR=limegreen|KZ=dodgerblue
|LA=dodgerblue|LB=limegreen|LC=limegreen|LI=darkgrey|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=darkgrey|LU=darkgrey|LV=darkgrey|LY=dodgerblue
|MA=limegreen|MC=limegreen|MD=dodgerblue|ME=limegreen|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=limegreen|MR=limegreen|MT=darkgrey|MU=limegreen|MV=dodgerblue|MW=limegreen|MX=dodgerblue|MY=darkred|MZ=limegreen
|NA=limegreen|NE=limegreen|NG=limegreen|NI=limegreen|NL=darkgrey|NO=darkgrey|NP=dodgerblue|NR=limegreen|NZ=limegreen
|OM=dodgerblue
|PA=dodgerblue|PE=limegreen|PG=limegreen|PH=dodgerblue|PK=dodgerblue|PL=darkgrey|PS=dodgerblue|PT=darkgrey|PY=dodgerblue
|QA=limegreen
|RO=darkgrey|RS=limegreen|RW=limegreen
|SA=dodgerblue|SB=limegreen|SD=dodgerblue|SE=darkgrey|SI=darkgrey|SK=darkgrey|SL=limegreen|SN=limegreen|SO=dodgerblue|SR=limegreen|SS=limegreen|ST=limegreen|SV=dodgerblue|SY=dodgerblue|SZ=limegreen
|TD=limegreen|TG=dodgerblue|TH=dodgerblue|TJ=dodgerblue|TL=limeblue|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TR=dodgerblue|TT=limegreen|TV=limegreen|TZ=dodgerblue
|UA=dodgerblue|UG=limegreen|UY=dodgerblue|UZ=dodgerblue
|VC=limegreen|VE=dodgerblue|VN=limegreen|VU=limegreen
|WS=limegreen
|XK=limegreen
|YE=limegreen
|ZA=dodgerblue|ZM=limegreen|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|limegreen|Eligible [[COVAX]] recipient}}
{{leftlegend|darkgrey|[[European Medicines Agency]] (EMA) review in progress<ref name="ema.europa.eu"/>
{{leftlegend|darkred|Usage stopped}}
}}
}}
<section end="coronavacauthmap"/>
[[CoronaVac]] is an [[inactivated vaccine|inactivated virus vaccine]]<ref name="NCT043835742">{{#invoke:Cite web||date=12 May 2020|title=Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)|url=https://clinicaltrials.gov/ct2/show/NCT04383574|url-status=live|archive-url=https://web.archive.org/web/20201011084809/https://clinicaltrials.gov/ct2/show/NCT04383574/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04383574}}</ref> produced by the Chinese company [[Sinovac Biotech]].<ref name="NCT043835742"/><ref name="NCname= nct04456595=2">{{#invoke:Cite web||date=2 July 2020|title=Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)|url=https://clinicaltrials.gov/ct2/show/NCT04456595|url-status=live|archive-url=https://web.archive.org/web/20201011084811/https://clinicaltrials.gov/ct2/show/NCT04456595/|archive-date=11 October 2020|access-date=3 August 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04456595}}</ref><ref name=":12">{{cite journal|last1=PT. Bio Farma|date=10 August 2020|title=A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia|url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX|journal=Registri Penyakit Indonesia|access-date=15 August 2020}}</ref> Malaysia will stop using CoronaVac once its existing contract for 12 million doses is delivered. An additional 3 million doses would be kept as a stockpile for those who were allergic to other vaccines.<ref name=":1">{{#invoke:Cite web||last=Chung|first=Nicholas|title=We'll order more Sinovac if supply issues surface, says Khairy|url=https://www.freemalaysiatoday.com/category/nation/2021/07/16/well-order-more-sinovac-if-supply-issues-surface-says-khairy/|url-status=live|website=Free Malaysia Today}}</ref>
;Full (<section begin="CoronaVac_FN"/>1<section end="CoronaVac_FN"/>)
# China<ref name="CoronaVacCN"/>

;Emergency (<section begin="CoronaVac_EN"/>60<section end="CoronaVac_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Albania<ref name=":0">{{#invoke:Cite web||last=Semini|first=Llazar|title=Albania starts mass COVID vaccinations before tourist season|url=https://abcnews.go.com/Business/wireStory/albania-starts-mass-covid-vaccinations-tourist-season-76733128|access-date=29 March 2021|website=ABC News}}</ref>
# Armenia<ref>{{#invoke:Cite web||title=В Армению отправлена китайская вакцина от COVID-19|url=https://ru.armradio.am/2021/04/30/%d0%b2-%d0%b0%d1%80%d0%bc%d0%b5%d0%bd%d0%b8%d1%8e-%d0%be%d1%82%d0%bf%d1%80%d0%b0%d0%b2%d0%bb%d0%b5%d0%bd%d0%b0-%d0%ba%d0%b8%d1%82%d0%b0%d0%b9%d1%81%d0%ba%d0%b0%d1%8f-%d0%b2%d0%b0%d0%ba%d1%86%d0%b8/|access-date=9 May 2021|website=Общественное Радио Армении|language=ru-RU}}</ref>
# Azerbaijan<ref>{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Azerbaijan kicks off COVID-19 vaccination|url=https://www.aa.com.tr/en/world/azerbaijan-kicks-off-covid-19-vaccination/2114591|access-date=7 February 2021|publisher=Anadolu Agency|name-list-style=vanc}}</ref>
# Bangladesh<ref>{{#invoke:Cite web||title=Bangladesh approves Sinovac Covid-19 vaccine for emergency use|date=6 June 2021|url=https://www.dhakatribune.com/bangladesh/2021/06/06/sinovac-covid-19-vaccine-approved-for-emergency-use|access-date=6 June 2021|publisher=[[Dhaka Tribune]]|name-list-style=vanc}}</ref>
# Benin<ref>{{#invoke:Cite web||last=Ayosso|first=Akpédjé|date=29 March 2021|title=Deux ministres vaccinés contre Covid-19|url=https://www.24haubenin.info/?Deux-ministres-vaccines-contre-Covid-19|access-date=7 April 2021|website=24haubenin.info|language=fr}}</ref>
# Bolivia<ref>{{#invoke:Cite web||title=Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19|url=https://noticias.uol.com.br/internacional/ultimas-noticias/2021/01/06/bolivia-autoriza-uso-de-vacinas-sputnik-v-e-coronavac-contra-covid-19.htm|access-date=6 January 2021|website=noticias.uol.com.br|language=pt-br}}</ref>
# Bosnia and Herzegovina<ref>{{#invoke:Cite web||last=Agency|first=Anadolu|date=28 March 2021|title=Turkey sends Chinese COVID-19 vaccines to Bosnia-Herzegovina|url=https://www.dailysabah.com/politics/diplomacy/turkey-sends-chinese-covid-19-vaccines-to-bosnia-herzegovina|access-date=14 April 2021|website=Daily Sabah}}</ref>
# Botswana<ref>{{#invoke:Cite web||title=Botswana Could Be First African Country to Vaccinate Entire Adult Population {{!}} Voice of America - English|url=https://www.voanews.com/covid-19-pandemic/botswana-could-be-first-african-country-vaccinate-entire-adult-population|access-date=21 May 2021|website=www.voanews.com}}</ref>
# Brazil<ref name="Covid-Vaccine">{{cite news|last1=McGeever|first1=Jamie|last2=Fonseca|first2=Pedro|date=17 January 2021|title=Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-brazil-idUSKBN29M0M3|access-date=17 January 2021|name-list-style=vanc}}</ref>
# Cambodia<ref>{{#invoke:Cite web||last1=Chanritheara|first1=Torn|title=Cambodia Approves AstraZeneca and Sinovac Vaccines for COVID-19 Emergency Use|url=https://cambodianess.com/article/cambodia-approves-astrazeneca-and-sinovac-vaccines-for-covid-19-emergency-use|access-date=12 February 2021|publisher=Cambodianess}}</ref>
# Chile<ref>{{#invoke:Cite web||date=20 January 2021|title=Chile aprueba el uso de emergencia de la vacuna china de Sinovac contra covid-19|url=https://www.france24.com/es/minuto-a-minuto/20210120-chile-aprueba-el-uso-de-emergencia-de-la-vacuna-china-de-sinovac-contra-covid-19|access-date=30 January 2021|publisher=France 24}}</ref>
# Colombia<ref>{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Colombia approves emergency use of CoronaVac vaccine|url=https://www.aa.com.tr/en/americas/colombia-approves-emergency-use-of-coronavac-vaccine/2134570|access-date=7 February 2021|publisher=Anadolu Agency|name-list-style=vanc}}</ref>
# Djibouti<ref>{{#invoke:Cite web||title=Djibouti Ministry of Health|url=https://twitter.com/minsantedj/status/1372948366137696270|url-status=live|access-date=30 March 2021|website=Twitter}}</ref>
# Dominican Republic<ref>{{#invoke:Cite web||title=Anticovid vaccines run out as Dominican Republic awaits arrival of more doses|url=https://dominicantoday.com/dr/covid-19/2021/03/08/anticovid-vaccines-run-out-as-dominican-republic-awaits-arrival-of-more-doses/|access-date=10 March 2021|publisher=DominicanToday}}</ref>
# East Timor<ref>{{#invoke:Cite web||last=Martins|first=Filomeno|title=Government to launch Chinese Sinovac vaccine next week {{!}} TATOLI Agência Noticiosa de Timor-Leste|url=http://www.tatoli.tl/en/2021/06/11/government-to-launch-chinese-sinovac-vaccine-next-week/|access-date=15 June 2021}}</ref>
# Ecuador<ref>{{#invoke:Cite web||title=Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister|url=https://nationalpost.com/pmn/health-pmn/ecuador-signs-agreement-with-sinovac-for-2-million-covid-19-vaccine-minister|access-date=26 February 2021|work=National Post}}</ref>
# Egypt<ref>{{#invoke:Cite web||title=Egypt approves Sinovac COVID-19 vaccine for emergency use|url=https://gulfnews.com/world/mena/egypt-approves-sinovac-covid-19-vaccine-for-emergency-use-1.1619472925063|access-date=27 April 2021|website=gulfnews.com}}</ref>
# El Salvador<ref>{{#invoke:Cite web||title=Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac|url=https://www.laprensagrafica.com/elsalvador/Llegan-a-El-Salvador-un-millon-de-dosis-de-la-vacuna-china-contra-el-covid-19-de-la-farmaceutica-Sinovac-20210328-0004.html|access-date=29 March 2021|website=Noticias de El Salvador – La Prensa Gráfica {{!}} Informate con la verdad|language=es-ES}}</ref>
# Equatorial Guinea<ref name="whotracker"/>
# Fiji<ref>{{#invoke:Cite web||title=China to donate Sinovac Vaccine to Fiji|url=https://www.fbcnews.com.fj/news/china-to-donate-sinovac-vaccine-to-fiji/|access-date=22 March 2021|website=Fiji Broadcasting Corporation}}</ref>
# Georgia<ref>{{#invoke:Cite web||title=Covid-19 vaccination with Sinovac to start on May 24 in Georgia|url=https://agenda.ge/en/news/2021/1336|access-date=21 May 2021|website=Agenda.ge}}</ref>
# Guinea<ref>{{#invoke:Cite web||title=Guinea receives purchase of 300,000 Sinovac COVID-19 vaccines|url=https://www.channelnewsasia.com/news/world/guinea-receives-purchase-of-300-000-sinovac-covid-19-vaccines-14649970|access-date=3 June 2021|website=CNA}}</ref>
# Hungary<ref name="whotracker"/>
# Indonesia<ref name="StraitsTimes20210111">{{cite news|last=Soeriaatmadja|first=Wahyudi|date=11 January 2021|title=Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy|work=[[The Straits Times]]|url=https://www.straitstimes.com/asia/se-asia/indonesia-grants-emergency-use-approval-to-sinovac-vaccine-local-trials-show-65|access-date=11 January 2021|name-list-style=vanc}}</ref><ref name="Tempo">{{cite news|date=11 January 2021|title=BPOM Grants Emergency Use Authorization for Sinovac Vaccine|work=[[Tempo (Indonesian magazine)|Tempo]]|url=https://en.tempo.co/read/1422220/bpom-grants-emergency-use-authorization-for-sinovac-vaccine|access-date=11 January 2021}}</ref>
# Kazakhstan<ref>{{#invoke:Cite web||title=В Казахстан доставили первую партию китайской вакцины CoronaVac {{!}} Kazakhstan Today|url=https://www.kt.kz/rus/covid-19/v_kazahstan_dostavili_pervuyu_partiyu_kitayskoy_vaktsiny_1377916469.html|access-date=7 June 2021|website=www.kt.kz|language=ru}}</ref>
# Laos<ref name="CoronaVacCN">{{cite news|last1=Liu|first1=Roxanne|date=6 February 2021|title=China approves Sinovac Biotech COVID-19 vaccine for general public use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-sinovac/china-approves-sinovac-biotech-covid-19-vaccine-for-general-public-use-idUSKBN2A60AY|access-date=7 February 2021|name-list-style=vanc}}</ref>
# Libya<ref>{{#invoke:Cite web||last=|date=9 May 2021|title=Libya begins administrating China's Sinovac vaccine in Tripoli|url=https://www.libyanexpress.com/libya-begins-administrating-chinas-sinovac-vaccine-in-tripoli/|access-date=21 May 2021|website=Libyan Express}}</ref>
# Malaysia<ref name=":1" />
#Malawi<ref name=":11" />
# Maldives<ref name="whotracker"/>
# Mexico<ref name="AD5 mexico">{{cite news|last1=Barrera|first1=Adriana|date=11 February 2021|title=Mexico approves China's CanSino and Sinovac COVID-19 vaccines|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-mexico-cansino/update-2-mexico-approves-chinas-cansino-and-sinovac-covid-19-vaccines-idUSL1N2KG0NO|access-date=11 February 2021}}</ref>
# Moldova<ref>{{Cite news|last=Tanas|first=Alexander|date=9 April 2021|title=Moldova to buy 400,000 doses of Sinovac COVID-19 vaccine|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-moldova-sinovac-idUKL8N2M24JT|access-date=9 May 2021}}</ref>
# Myanmar<ref>{{#invoke:Cite web||last=Fishbein|first=Emily|title=Ethnic groups step in as Myanmar's COVID response falls apart|url=https://www.aljazeera.com/news/2021/5/10/ethnic-groups-step-in-as-myanmars-covid-response-falls-apart|access-date=2021-07-23|website=Al Jazeera|language=en}}</ref>
# Nepal<ref>{{#invoke:Cite web||title=Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine|url=https://kathmandupost.com/health/2021/06/04/nepal-gives-emergency-use-approval-to-china-s-sinovac-covid-19-vaccine|access-date=7 June 2021|website=kathmandupost.com}}</ref>
# North Macedonia<ref>{{#invoke:Cite web||last=Testorides|first=Konstantin|date=27 June 2021|title=North Macedonia gets 500,000 doses of Sinovac vaccines|url=https://apnews.com/article/coronavirus-vaccine-coronavirus-pandemic-health-government-and-politics-business-1827f4b8b524449d72dd43e62a97ac63|url-status=live|access-date=28 June 2021|publisher=Associated Press}}</ref>
# Oman<ref name="oman-coronavac-sputnik">{{#invoke:Cite web||title=COVID-19: Oman approves use of Sinovac and Sputnik vaccines|url=https://gulfnews.com/world/gulf/oman/covid-19-oman-approves-use-of-sinovac-and-sputnik-vaccines-1.80173049|access-date=25 June 2021|website=gulfnews.com}}</ref>
# Pakistan<ref>{{#invoke:Cite web||title=DRAP allows emergency authorisation to fifth Covid-19 vaccine|url=https://www.thenews.com.pk/print/817278-drap-allows-emergency-authorisation-to-fifth-covid-19-vaccine|access-date=10 April 2021|website=The News International}}</ref>
# Palestine<ref name="whotracker"/>
# Panama<ref>{{cite news|date=9 April 2021|title=Panama approves emergency use of Chinese vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-04/10/c_139870805.htm|access-date=9 April 2021}}</ref>
# Paraguay<ref>{{#invoke:Cite web||title=CoronaVac, vacuna de alta eficacia|url=https://www.mspbs.gov.py/portal/22762/coronavac-vacuna-de-alta-eficacia.html|website=Ministerio de Salud Publica Y Bienestar Social (Paraguay)}}</ref>
# Philippines<ref>{{cite news|date=22 February 2021|title=Philippines approves Sinovac's COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-philippines-vaccine/philippines-approves-sinovacs-covid-19-vaccine-for-emergency-use-idUSL4N2KL0UK}}</ref>
#Saudi Arabia<ref name=":9" />
# Singapore<ref>{{cite news |last1=Baker |first1=Jalelah Abu |title=Those who opt for Sinovac, other vaccines under WHO emergency list to be considered fully vaccinated |url=https://www.channelnewsasia.com/singapore/sinovac-vaccine-covid19-sinopharm-astrazeneca-fully-vaccinated-2096576 |access-date=6 August 2021 |work=CNA |date=6 August 2021}}</ref> ''(restricted)''
# Somalia<ref name="cdctracker"/>
# South Africa<ref>{{cite news|date=3 July 2021|title=SAHPRA authorises the CoronaVac vaccine with conditions|publisher=SAHPRA|url=https://www.sahpra.org.za/press-releases/sahpra-authorises-the-coronavac-vaccine-with-conditions/}}</ref>
# Sri Lanka<ref>{{#invoke:Cite web||title=Sri Lanka approves China's Sinovac COVID-19 vaccine for emergency use|url=http://www.colombopage.com/archive_21A/Jul17_1626497465CH.php|url-status=live|access-date=2021-07-18|website=ColomboPage}}</ref>
# Sudan<ref name="cdctracker"/>
# Syria<ref name="whotracker"/>
# Tajikistan<ref>{{#invoke:Cite web||title=Китайской вакциной в Таджикистане первоначально будут прививать людей старше 60 лет {{!}} Новости Таджикистана ASIA-Plus|url=https://asiaplustj.info/ru/news/tajikistan/society/20210621/kitaiskoi-vaktsinoi-v-tadzhikistane-pervonachalno-budut-privivat-lyudei-starshe-60-let|access-date=13 July 2021|website=asiaplustj.info}}</ref>
# Tanzania<ref>{{#invoke:Cite web||last=|first=|date=13 July 2021|title=Vaccine-Holdout Tanzania Begins Inoculations With Sinovac Doses - BNN Bloomberg|url=https://www.bnnbloomberg.ca/vaccine-holdout-tanzania-begins-inoculations-with-sinovac-doses-1.1628276|url-status=live|access-date=13 July 2021|website=Bloomberg}}</ref>
# Thailand<ref>{{cite news|last1=Thepgumpanat|first1=Panarat|date=22 February 2021|title=Thailand allows emergency use of Sinovac's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand/thailand-allows-emergency-use-of-sinovacs-covid-19-vaccine-idUSKBN2AM1BX|access-date=23 February 2021}}</ref>
# Togo<ref>{{#invoke:Cite web||last=|title=Le CoronaVac pour les étudiants du public|url=https://www.republicoftogo.com/Toutes-les-rubriques/Education/Le-CoronaVac-pour-les-etudiants-du-public|access-date=23 May 2021|website=République Togolaise|language=fr}}</ref>
# Tunisia<ref>{{#invoke:Cite web||date=5 March 2021|title=Tunisia approva vaccino cinese Sinovac|url=https://www.ansa.it/sito/notizie/mondo/dalla_cina/2021/03/05/covid-tunisia-approva-vaccino-cinese-sinovac_9ba5fbb3-4ee9-48de-9327-c37a3931f5d1.html|access-date=7 March 2021|publisher=Agenzia Nazionale Stampa Associata (in Italian)|language=it}}</ref>
# Turkey<ref>{{cite news|date=11 January 2021|title=Turkey to begin COVID-19 vaccine jabs by this weekend|work=Anadolu|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-to-begin-covid-19-vaccine-jabs-by-this-weekend/2106366|access-date=11 January 2021}}</ref>
# Turkmenistan<ref>{{#invoke:Cite web||last=turkmenportal|title=В Туркменистан поступила крупная партия китайской вакцины "CoronaVac" |url=https://turkmenportal.com/blog/36504/v-turkmenistan-postupila-krupnaya-partiya-kitaiskoi-vakciny-coronavac|access-date=7 June 2021|website=Туркменистан, интернет портал о культурной, деловой и развлекательной жизни в Туркменистане|language=ru}}</ref>
# Ukraine<ref>{{cite news|last1=Zinets|first1=Natalia|date=9 March 2021|title=Ukraine approves China's Sinovac COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-ukraine-vaccine-idUSKBN2B11H6|access-date=10 March 2021|publisher=Reuters}}</ref>
# Uruguay<ref name="CoronaVacCN" />
# Uzbekistan<ref>{{#invoke:Cite web||title=Uzbekistan plans to obtain Sinovac coronavirus vaccine|url=https://akipress.com/news:658218:Uzbekistan_plans_to_obtain_Sinovac_coronavirus_vaccine/|access-date=21 May 2021|website=akipress.com}}</ref>
# Venezuela<ref>{{#invoke:Cite web||date=2021-06-30|title=COVID-19 Information|url=https://ve.usembassy.gov/covid-19-information/|access-date=2021-08-23|website=U.S. Embassy in Venezuela|language=en-US}}</ref>
# Zimbabwe<ref name="news24.com-zimbabwe-ssv" />
<!-- not counted -->
<br />'''[[ISO 3166-1#Current codes|Non-country entities]]'''
* Hong Kong<ref>{{#invoke:Cite web||date=18 February 2021|title=Use of Sinovac vaccine authorised|url=https://www.news.gov.hk/eng/2021/02/20210218/20210218_111857_034.html|access-date=19 February 2021|publisher=Government of Hong Kong}}</ref>
* Northern Cyprus<ref name=":4" />
* ''[[World Health Organization]]''<ref>{{cite news |last=Nebehay |first=Stephanie |title=WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed |url=https://www.reuters.com/article/us-health-coronavirus-who-sinovac/who-approves-sinovac-covid-vaccine-the-second-chinese-made-dose-listed-idUSKCN2DD3V5 |access-date=1 June 2021 |work=Reuters |date=1 June 2021 |location=Geneva}}</ref><ref name="WHO recommendation">{{cite web | title=WHO recommendation Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac | website=[[World Health Organization]] (WHO) | date=1 May 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-sinovac-covid-19-vaccine-vero-cell-inactivated-coronavac | access-date=1 June 2021}}</ref><ref name="WHO PR 20210601">{{cite press release | title=WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=1 June 2021}}</ref>
</div>
{{-}}

== Covaxin ==
<section begin="covaxinauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AD=silver|AF=silver|AG=silver|AL=silver|AM=silver|AO=silver|AR=dodgerblue|AZ=silver
|BA=silver|BB=silver|BD=silver|BF=silver|BH=silver|BJ=silver|BN=silver|BO=silver|BR=darkred|BS=silver|BT=silver|BW=dodgerblue|BZ=silver
|CD=silver|CF=dodgerblue|CG=silver|CI=silver|CL=silver|CM=silver|CO=silver|CR=silver|CV=silver
|DJ=silver|DM=silver|DO=silver|DZ=silver
|EC=silver|EG=silver|ET=dodgerblue
|FJ=silver|FM=silver
|GD=silver|GE=silver|GH=silver|GM=silver|GN=silver|GT=dodgerblue|GY=dodgerblue
|HN=silver|HT=silver
|ID=silver|IN=dodgerblue|IQ=silver|IR=dodgerblue
|JM=silver|JO=silver
|KE=silver|KG=silver|KH=silver|KI=silver|KM=dodgerblue|KN=silver|KP=silver|KR=silver
|LA=silver|LB=silver|LC=silver|LK=dodgerblue|LR=silver|LS=silver|LY=silver
|MA=silver|MC=silver|MD=silver|ME=silver|MH=silver|MK=silver|ML=silver|MM=dodgerblue|MN=silver|MR=silver|MU=dodgerblue|MV=silver|MW=silver|MX=dodgerblue|MY=silver|MZ=silver
|NA=silver|NE=silver|NG=silver|NI=dodgerblue|NP=dodgerblue|NR=silver|NZ=silver
|OM=silver
|PA=silver|PE=silver|PG=silver|PH=dodgerblue|PK=dodgerblue|PS=silver|PY=dodgerblue
|QA=silver
|RS=silver|RW=silver
|SA=silver|SB=silver|SD=silver|SG=silver|SL=silver|SN=silver|SO=silver|SR=silver|SS=silver|ST=silver|SV=silver|SY=silver|SZ=silver
|TD=silver|TG=silver|TJ=silver|TL=silver|TN=silver|TO=silver|TT=silver|TV=silver
|UA=silver|UG=silver|UY=silver|UZ=silver
|VC=silver|VE=dodgerblue|VN=silver|VU=silver
|WS=silver
|XK=silver
|YE=silver
|ZA=silver|ZM=silver|ZW=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|silver|Eligible [[COVAX]] recipient (ongoing assessment)<ref name="WHO status"/>}}
{{leftlegend|darkred|Suspended import}}
}}
<section end="covaxinauthmap"/>
[[Covaxin]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the Indian company [[Bharat Biotech]] and the [[Indian Council of Medical Research]].<ref name="NYT India" />
;Full (<section begin="Covaxin_EN"/>0<section end="Covaxin_EN"/>)
;Emergency (<section begin="Covaxin_EN"/>21<section end="Covaxin_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Argentina<ref>{{#invoke:Cite web||url=https://www.batimes.com.ar/news/argentina/buenos-aires-province-agrees-to-buy-10-million-doses-of-covaxin-vaccine.phtml|title=Buenos Aires Province agrees to buy 10 million doses of Covaxin vaccine|publisher=BAT Times|date=4 June 2021}}</ref>
# Botswana<ref name="cov-200421">{{#invoke:Cite web||url=https://timesofindia.indiatimes.com/india/covid-19-bharat-biotech-ramps-up-covaxin-capacity-to-700-million-doses-per-annum/articleshow/82162467.cms|title=Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum &#124; India News |website=The Times of India}}</ref>
# Brazil ''(restricted)''<ref name="g1.globo.com"/>
# Central African Republic<ref name="cdctracker"/>
# Comoros<ref name="cdctracker"/>
# Ethiopia<ref name="whotracker" />
# Guatemala<ref name="cov-200421"/>
# Guyana<ref name="cov-200421"/>
# India<ref name="NYT India" />
# Iran<ref>{{cite news |title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official |url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19 |work=IRNA English |date=17 February 2021 }}</ref>
# Mauritius<ref>{{#invoke:Cite web||title=COVID-19: COVAXIN receives approval of National COVID-19 Vaccination Committee – beSafeMoris|url=https://besafemoris.mu/general_news/covid-19-covaxin-receives-approval-of-national-covid-19-vaccination-committee/|access-date=9 April 2021}}</ref>
# Mexico<ref>{{#invoke:Cite web||url=https://www.excelsior.com.mx/nacional/mexico-autoriza-covaxin-vacuna-de-emergencia-india/1441874|title=México autoriza Covaxin, la vacuna india contra covid-19|publisher=Excelsior|date=6 April 2021}}</ref>
# Myanmar<ref>{{cite news |title=Myanmar sees over 130,000 Covid-19 recoveries, just over 7,000 still in hospital |url=https://elevenmyanmar.com/news/myanmar-sees-over-130000-covid-19-recoveries-just-over-7000-still-in-hospital |work=[[Eleven Media Group]] |date=19 February 2021}}</ref>
# Nepal<ref>{{cite news|last=Sharma|first=Gopal|date=19 March 2021|title=Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal-india-idUSKBN2BB1KN|access-date=19 March 2021}}</ref>
# Nicaragua<ref name="cov-200421"/>
# Pakistan<ref name="whotracker"/>
# Paraguay<ref name="covaxin-py">{{#invoke:Cite web||url=https://www.hindustantimes.com/india-news/covid19-india-provides-100-000-doses-of-covaxin-vaccine-to-paraguay-101617057324587.html|title=India provides 100,000 doses of Covaxin vaccine to Paraguay|work=Hindustan Times|date=30 March 2021}}</ref><ref>{{cite tweet|number=1376615865068752896|user=MaritoAbdo|title=Acaban de llegar 100.000 dosis de vacunas contra el Covid-19, provenientes de la India. La prioridad es avanzar hacia la inmunización de todo el personal de blanco y luego la población de riesgo. Gracias a la República de la India por el apoyo.|date=30 March 2021}}</ref>
# Philippines<ref>{{cite news |title=Philippine FDA issues full EUA to Bharat Biotech's Covaxin |url=https://mb.com.ph/2021/06/23/philippine-fda-issues-full-eua-to-bharat-biotechs-covaxin/ |publisher=Manila Bulletin |date=June 23, 2021}}</ref><ref>{{cite news |title=FDA grants full emergency use authorization for Covaxin |url=https://cnnphilippines.com/news/2021/6/25/COVAXIN-EUA-Philippines.html |publisher=CNN Philippines |date=June 25, 2021}}</ref>
# Sri Lanka<ref>{{cite news |title=Sri Lanka green light for Covaxin: Opens quarantine free for fully jabbed Indian tourists |url=https://m.timesofindia.com/business/international-business/sri-lanka-green-light-for-covaxin-opens-quarantine-free-for-fully-jabbed-indian-tourists/articleshow/85594554.cms |newspaper=[[The Times of India]] |date=24 August 2021}}</ref>
# Venezuela<ref name="cov-200421"/>
# Zimbabwe<ref>{{#invoke:Cite web||date=4 March 2021|title=Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine|url=https://www.hindustantimes.com/world-news/zimbabwe-approves-covaxin-first-in-africa-to-okay-india-made-covid-19-vaccine-101614859597880.html|access-date=3 July 2021|website=Hindustan Times}}</ref>
</div>
{{clear}}

== Sputnik Light ==
<section begin="sputniklightauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AO=dodgerblue
|BH=dodgerblue
|BY=dodgerblue
|CG=dodgerblue
|EG=dodgerblue
|KG=dodgerblue
|KZ=dodgerblue
|MN=dodgerblue
|MU=dodgerblue
|NI=dodgerblue
|PS=dodgerblue
|PH=dodgerblue
|RU=dodgerblue
|SY=dodgerblue
|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="sputniklightauthmap"/>
# 
[[Sputnik Light]] is a [[viral vector vaccine]],<ref name="Ryumin">{{cite news|last=Ryumin|first=Alexander|date=20 February 2021|title=Russia registers its third COVID-19 vaccine CoviVac|publisher=[[TASS]]|location=Moscow|url=https://tass.com/society/1258859|access-date=6 March 2021}}</ref> produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It actually consists of the first dose of the [[Sputnik V COVID-19 vaccine|Sputnik V vaccine]], which is based on the [[Ad26]] vector.<ref>{{cite press release |date=6 May 2021 |title=Single dose vaccine, Sputnik Light, authorized for use in Russia |url=https://rdif.ru/Eng_fullNews/6763/ |publisher=Russian Direct Investment Fund |access-date=11 May 2021}}</ref>

;Full (<section begin="Sputnik Light_FN"/>0<section end="Sputnik Light_FN"/>)

;Emergency (<section begin="Sputnik Light_EN"/>14<section end="Sputnik Light_EN"/>)
<div style="margin-top: 0.3em; column-width: 15em;">
# Angola<ref>{{cite news |title=Sputnik Light Vaccine Approved For Use In Angola |url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-light-vaccine-approved-for-use-in-angola/ |access-date=13 May 2021 |publisher=Sputnik V vaccine |date=12 May 2021}}</ref>
# Bahrain<ref>{{cite news|date=11 May 2021|title=Bahrain authorizes emergency use of one-shot Sputnik-Light COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/world/middle-east/bahrain-authorizes-emergency-use-one-shot-sputnik-light-covid-19-vaccine-2021-05-11/|access-date=12 May 2021}}</ref>
# Belarus<ref>{{cite news |title=Belarus registers Russia's Sputnik Light vaccine for use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/belarus-registers-russias-sputnik-light-vaccine-use-2021-06-03/ |access-date=4 June 2021 |date=3 June 2021}}</ref>
# Congo<ref>{{cite web |title=Single-dose Sputnik Light vaccine approved for use in the Republic of the Congo |url=https://rdif.ru/Eng_fullNews/6878/ |publisher=Russian Direct Investment Fund |website=rdif.ru |date=7 June 2021}}</ref>
# Egypt<ref>{{Cite web|title=The single-component Sputnik Light vaccine authorized in Egypt|url=https://sputnikvaccine.com/newsroom/pressreleases/the-single-component-sputnik-light-vaccine-authorized-in-egypt/|access-date=2021-10-01|website=sputnikvaccine.com}}</ref>
# Kazakhstan<ref>{{cite news |title=Kazakhstan approves Russia's single-dose Sputnik Light vaccine |url=https://www.reuters.com/world/asia-pacific/kazakhstan-approves-russias-single-dose-sputnik-light-vaccine-rdif-2021-07-15/ |access-date=15 July 2021 |work=Reuters |date=15 July 2021 |location=Moscow}}</ref>
# Kyrgyzstan<ref>{{#invoke:Cite web||title=Single-dose Sputnik Light vaccine registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-registered-in-kyrgyzstan/|access-date=25 June 2021|website=sputnikvaccine.com}}</ref>
# Mauritius<ref>{{cite news |title=Russia's Sputnik Light vaccine approved for use in Mauritius |url=https://www.reuters.com/business/healthcare-pharmaceuticals/russias-sputnik-light-vaccine-approved-use-mauritius-rdif-2021-06-02/ |access-date=4 June 2021 |work=Reuters |date=2 June 2021}}</ref>
# Mongolia<ref>{{cite press release |title=Single-dose Sputnik Light vaccine registered in Mongolia |url=https://rdif.ru/Eng_fullNews/6907/ |location=Moscow |publisher=Russian Direct Investment Fund |access-date=25 June 2021 |date=11 June 2021}}</ref>
# Nicaragua<ref>{{cite news |title=Single-dose Sputnik Light vaccine approved for use in Nicaragua |url=https://rdif.ru/Eng_fullNews/6846/ |publisher=Russian Direct Investment Fund |date=20 May 2021}}</ref>
# Palestine<ref>{{cite news |title=Russia's Sputnik Light vaccine approved for use in Palestinian territories |url=https://www.reuters.com/article/health-coronavirus-russia-israel-palesti-idUSR4N2NB01F |access-date=4 June 2021 |work=Reuters |date=31 May 2021}}</ref>
# Philippines<ref>{{cite news
|title=Philippines approves emergency use of Russia's Sputnik Light vaccine
|url=https://www.reuters.com/world/asia-pacific/philippines-approves-emergency-use-russias-sputnik-light-vaccine-2021-08-23/ |access-date=23 August 2021 |work=Reuters |date=23 August 2021}}</ref>
# Russia<ref>{{cite news |title=Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use |url=https://www.ndtv.com/world-news/russia-approves-single-dose-sputnik-light-covid-19-vaccine-for-use-2436470 |publisher=NDTV Coronavirus |date=6 May 2021}}</ref>
# Syria<ref>{{cite news |title=Batch of Russia's Sputnik Light vaccine delivered to Syria |url=https://tass.com/world/1317383 |access-date=31 July 2021 |work=TASS |date=24 July 2021 |location=Damascus}}</ref>
# Venezuela<ref>{{cite press release|title=Single-dose Sputnik Light vaccine approved for use in Venezuela |url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-approved-for-use-in-venezuela/|access-date=15 May 2021|publisher=Gamaleya Center}}</ref>
</div>
{{clear}}


== Convidecia ==
<section begin="convideciaauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AD=silver
|AF=silver
|AG=silver
|AL=silver
|AM=silver
|AO=silver
|AR=dodgerblue
|AZ=silver
|BA=silver
|BB=silver
|BD=silver
|BF=silver
|BH=silver
|BJ=silver
|BN=silver
|BO=silver
|BR=silver
|BS=silver
|BT=silver
|BW=silver
|BZ=silver
|CD=silver
|CF=silver
|CG=silver
|CI=silver
|CL=dodgerblue
|CM=silver
|CN=blueviolet
|CO=silver
|CR=silver
|CV=silver
|DJ=silver
|DM=silver
|DO=silver
|DZ=silver
|EC=dodgerblue
|EG=silver
|ET=silver
|FJ=silver
|FM=silver
|GD=silver
|GE=silver
|GH=silver
|GM=silver
|GN=silver
|GT=silver
|GY=silver
|HN=silver
|HU=dodgerblue
|HT=silver
|ID=dodgerblue
|IN=silver
|IQ=silver
|IR=silver
|JM=silver
|JO=silver
|KE=silver
|KG=silver
|KH=silver
|KI=silver
|KM=silver
|KN=silver
|KP=silver
|KR=silver
|LA=silver
|LB=silver
|LC=silver
|LK=silver
|LR=silver
|LS=silver
|LY=silver
|MA=silver
|MC=silver
|MD=dodgerblue
|ME=silver
|MH=silver
|MK=silver
|ML=silver
|MM=silver
|MN=silver
|MR=silver
|MU=silver
|MV=silver
|MW=silver
|MX=dodgerblue
|MY=dodgerblue
|MZ=silver
|NA=silver
|NE=silver
|NG=silver
|NI=silver
|NP=silver
|NR=silver
|NZ=silver
|OM=silver
|PA=silver
|PE=silver
|PG=silver
|PH=silver
|PK=dodgerblue
|PS=silver
|PY=silver
|QA=silver
|RS=silver
|RW=silver
|SA=silver
|SB=silver
|SD=silver
|SG=silver
|SL=silver
|SN=silver
|SO=silver
|SR=silver
|SS=silver
|ST=silver
|SV=silver
|SY=silver
|SZ=silver
|TD=silver
|TG=silver
|TJ=silver
|TL=silver
|TN=silver
|TO=silver
|TT=silver
|TV=silver
|UA=silver
|UG=silver
|UY=silver
|UZ=silver
|VC=silver
|VE=silver
|VN=silver
|VU=silver
|WS=silver
|XK=silver
|YE=silver
|ZA=silver
|ZM=silver
|ZW=silver
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
{{leftlegend|silver|Eligible [[COVAX]] recipient (ongoing assessment)<ref name="WHO status">{{#invoke:Cite web||title=Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process|url=https://extranet.who.int/pqweb/key-resources/documents/status-covid-19-vaccines-within-who-eulpq-evaluation-process|publisher=[[World Health Organization]] (WHO)}}</ref>}}
}}
<section end="convideciaauthmap"/>
[[Ad5-nCoV|Convidecia]] is a [[viral vector vaccine]]<ref name="zhu7-20">{{cite journal|display-authors=6|vauthors=Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W|date=August 2020|title=Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial|journal=Lancet|volume=396|issue=10249|pages=479–88|doi=10.1016/s0140-6736(20)31605-6|pmc=7836858|pmid=32702299|lay-url=https://blogs.sciencemag.org/pipeline/archives/2020/07/20/new-data-on-the-cansino-vaccine|doi-access=free|title-link=doi}}</ref> produced by the Chinese company [[CanSino Biologics]] and the Beijing Institute of Biotechnology of the [[Academy of Military Medical Sciences]].

;Full (<section begin="Convidecia_FN"/>1<section end="Convidecia_FN"/>)
# China<ref>{{cite news |title=China approves two more domestic COVID-19 vaccines for public use |url=https://www.reuters.com/article/us-health-coronavirus-china-vaccine-idUSKBN2AP1MW |access-date=16 March 2021 |publisher=Reuters |date=25 February 2021}}</ref>

;Emergency (<section begin="Convidecia_EN"/>9<section end="Convidecia_EN"/>)
# Argentina<ref>{{#invoke:Cite web||date=11 June 2021|title=Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine|url=https://www.reuters.com/world/americas/argentina-issues-emergency-approval-chinas-single-dose-cansino-covid-19-vaccine-2021-06-11/|access-date=11 June 2021|website=Reuters}}</ref>
# Chile<ref name=":7">{{#invoke:Cite web||title=ISP Approves Emergency Use And Importation Of Cansino Vaccine To Fight COVID-19|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-covid-19-de-laboratorio-cansino/|access-date=8 April 2021|website=Institute of Public Health of Chile}}</ref>
# Ecuador<ref>{{#invoke:Cite web||date=15 June 2021|title=Ecuador authorizes use of China's CanSino vaccine against COVID-19|url=https://www.reuters.com/world/americas/ecuador-authorizes-use-chinas-cansino-vaccine-against-covid-19-2021-06-15/|access-date=16 June 2021|website=Reuters}}</ref>
# Hungary<ref>{{cite web | title=China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary | publisher=MSN | date=22 March 2021 | url=https://www.msn.com/en-xl/europe/top-stories/china-s-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-in-hungary/ar-BB1eOIEV | access-date=22 March 2021}}</ref><ref name="WashPost Hungary" />
#Indonesia<ref name="auto6"/>
# Malaysia<ref>{{#invoke:Cite web||title=Govt approves Pfizer jabs for 12-year-olds and above, CanSino and Johnson & Johnson vaccines get conditional registration, says Health DG|url=https://www.thestar.com.my/news/nation/2021/06/15/govt-approves-pfizer-jabs-for-12-year-olds-and-above-conditional-approval-for-cansino-and-johnson--johnson-vaccines-says-health-dg|access-date=15 June 2021|website=The Star}}</ref>
# Mexico<ref name="AD5 mexico"/>
# Moldova<ref name="msmps.gov.md"/>
# Pakistan<ref>{{cite news | last1=Shahzad |first1=Asif |title=Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use |url=https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine/pakistan-approves-chinese-cansinobio-covid-vaccine-for-emergency-use-idUSKBN2AC1FG |publisher=Reuters |access-date=12 February 2021 |date=12 February 2021}}</ref>

{{clear}}

== Sinopharm-WIBP ==
<section begin="wibpauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|AE=dodgerblue
|CN=blueviolet
|MK=dodgerblue
|PE=dodgerblue
|PH=dodgerblue
|VE=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="wibpauthmap"/>
The [[Sinopharm WIBP COVID-19 vaccine]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the [[China National Pharmaceutical Group]] (Sinopharm) and its Wuhan Institute of Biological Products.

;Full (<section begin="Sinopharm-WIBP_FN"/>1<section end="Sinopharm-WIBP_FN"/>)
# China<ref>{{Cite news|last=Wee|first=Sui-Lee|date=25 February 2021|title=China approves two more Covid-19 vaccines.|work=The New York Times|url=https://www.nytimes.com/live/2021/02/25/world/covid-19-coronavirus|access-date=1 April 2021}}</ref>

;Emergency (<section begin="Sinopharm-WIBP_EN"/>5<section end="Sinopharm-WIBP_EN"/>)
# North Macedonia<ref name="whotracker"/>
# Peru<ref name="whotracker"/>
# Philippines<ref>{{cite news |author1=De Vera, Analou |title=FDA grants EUA to COVID-19 vaccine Sinopharm manufactured by Wuhan affiliate |url=https://mb.com.ph/2021/08/25/fda-grants-eua-to-covid-19-vaccine-sinopharm-manufactured-by-wuhan-affiliate/ |publisher=Manila Bulletin |date=August 25, 2021}}</ref>
# United Arab Emirates<ref name="NYT vaccine tracker" />
# Venezuela<ref name="whotracker"/>

{{clear}}

== Abdala ==
<section begin="abdalaauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CU=dodgerblue
|NI=dodgerblue
|VE=dodgerblue
|VN=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="abdalaauthmap"/>
[[Abdala (vaccine)|Abdala]] is a [[subunit vaccine]] developed by the [[Center for Genetic Engineering and Biotechnology]] in [[Cuba]].

;Full (<section begin="Abdala_FN"/>0<section end="Abdala_FN"/>)

;Emergency (<section begin="Abdala_EN"/>4<section end="Abdala_EN"/>)
# Cuba<ref name="Cubarollout" /><ref>{{Cite news|date=9 July 2021|title=COVID: Cuba approves emergency use of own Abdala vaccine|work=Deutsche Welle|url=https://www.dw.com/en/covid-cuba-approves-emergency-use-of-own-abdala-vaccine/a-58222105|access-date=9 July 2021}}</ref><ref>{{#invoke:Cite web||title=Aprueba el CECMED el Autorizo de Uso de Emergencia del candidato vacunal cubano ABDALA {{!}} CECMED|url=https://www.cecmed.cu/noticias/aprueba-cecmed-autorizo-uso-emergencia-candidato-vacunal-cubano-abdala|access-date=9 July 2021|website=www.cecmed.cu|language=es}}</ref>
#Nicaragua<ref>{{cite news 
|title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/ |access-date= 4 October 2021|publisher=Reuters |date=2 October 2021}}</ref>
# Venezuela<ref>{{cite news |title=Venezuela receives first shipment of Cuban coronavirus vaccine |url=https://www.reuters.com/world/americas/venezuela-receives-first-shipment-cuban-coronavirus-vaccine-2021-06-24/ |access-date=3 July 2021 |publisher=Reuters |date=25 June 2021}}</ref>
# Vietnam<ref>{{cite news |title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Abdala của Cuba|url=https://www.vietnamplus.vn/bo-y-te-phe-duyet-co-dieu-kien-vaccine-covid19-abdala-cua-cuba/741596.vnp |access-date=18 September 2021 |publisher= Vietnam News Agency|date=18 September 2021|language=vi}}</ref>
{{clear}}

== EpiVacCorona ==
<section begin="epivac-coronaauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|TM=blueviolet
|RU=dodgerblue
|BY=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="epivac-coronaauthmap"/>
[[EpiVacCorona]] is a [[peptide vaccine]] produced by the Russian [[State Research Center of Virology and Biotechnology VECTOR]]<wbr />.<ref name="NCT045275753">{{#invoke:Cite web||date=22 September 2020|title=Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)|url=https://clinicaltrials.gov/ct2/show/NCT04527575|access-date=16 November 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368988}}</ref>

;Full (<section begin="EpiVacCorona_FN"/>1<section end="EpiVacCorona_FN"/>)
# Turkmenistan<ref>{{cite news |title= Turkmenistan registers vaccines for the prevention of infectious diseases |url=https://tdh.gov.tm/en/post/25911/turkmenistan-registers-vaccines-prevention-infectious-diseases |work=Turkmenistan Today |date=29 January 2021 }}</ref><ref>{{cite news |title=Russian vaccine "EpiVacCorona" was registered in Turkmenistan |url=https://www.en24news.com/e/2021/01/russian-vaccine-epivaccorona-was-registered-in-turkmenistan.html |work=EN24 |date=29 January 2021 }}</ref>

;Emergency (<section begin="EpiVacCorona_EN"/>2<section end="EpiVacCorona_EN"/>)
# Belarus<ref>{{#invoke:Cite web||date=3 February 2021|title=Belarus receives Russia's EpiVacCorona vaccine|url=https://eng.belta.by/society/view/belarus-receives-russias-epivaccorona-vaccine-137131-2021/|access-date=5 April 2021|website=Belta}}</ref>
# Russia<ref>{{cite web | title = О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона" | website=Rospotrebnadzor |url = https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 |date=14 October 2020 |language=ru}}</ref><ref>{{cite web | title = Russia's EpiVacCorona vaccine post-registration trials started | publisher=The Pharma Letter |url = https://www.thepharmaletter.com/article/russia-s-epivaccorona-vaccine-post-registration-trials-started |date=18 November 2020 }}</ref>

{{clear}}

== Zifivax ==
<section begin="rbd-dimerauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CN=dodgerblue
|UZ=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="rbd-dimerauthmap"/>
[[ZF2001|Zifivax]] is a [[subunit vaccine]] produced by the Chinese company [[Anhui Zhifei Longcom Biopharmaceutical]].<ref name="london2">{{#invoke:Cite web||date=1 March 2021|title=COVID-19 vaccine development pipeline (Refresh URL to update)|url=https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/|access-date=10 March 2021|publisher=Vaccine Centre, London School of Hygiene and Tropical Medicine}}</ref>

;Full (<section begin="Zifivax_FN"/>0<section end="Zifivax_FN"/>)

;Emergency (<section begin="Zifivax_EN"/>2<section end="Zifivax_EN"/>)
# China<ref>{{cite news|last=Liu|first=Roxanne|date=15 March 2021|title=China IMCAS's COVID-19 vaccine obtained emergency use approval in China|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-china-vaccine-idUSL4N2LD3BZ|access-date=15 March 2021}}</ref>
# Uzbekistan<ref>{{cite news | last1=Mamatkulov |first1=Mukhammadsharif |title=Uzbekistan approves Chinese-developed COVID-19 vaccine |url=https://www.reuters.com/article/uzbekistan-china-coronavirus-vaccine/uzbekistan-approves-chinese-developed-covid-19-vaccine-idUSS0N2IK00P |publisher=Reuters |access-date=2 March 2021 |date=1 March 2021}}</ref><ref>{{cite news |title=Uzbekistan certifies Chinese vaccine to fight against COVID-19 |url=http://www.chinadaily.com.cn/a/202103/02/WS603e0477a31024ad0baac3bb.html |newspaper=[[China Daily]] |access-date=8 March 2021 |date=2 March 2021}}</ref>

{{clear}}

== Soberana 02 ==
<section begin="soberana2authmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|CU=dodgerblue
|IR=dodgerblue
|NI=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="soberana2authmap"/>
[[Soberana 02]], is a [[conjugate vaccine]] developed by Instituto Finlay de Vacunas.<ref name="finlayIran">{{cite web |title=Autorizo de emergencia SOBERANA 02 en Irán |url=https://www.finlay.edu.cu/blog/autorizo-de-emergencia-soberana-02-en-iran/ |website=finlay.edu.cu |publisher=Instituto Finlay de Vacunas |access-date=6 July 2021 |date=1 July 2021}}</ref>{{Efn|While there has been a mass innoculation campaign in Cuba under an "observational study",<ref name="Cubarollout">{{cite news|date=9 July 2021|title=Cuba approves emergency use of home-grown Covid vaccine, Latin America's first|work=Medical Xpress|url=https://medicalxpress.com/news/2021-07-cuba-emergency-home-grown-covid-vaccine.html#:~:text=Cuba%20on%20Friday%20approved%20its,first%20developed%20in%20Latin%20America.&text=Cuba%20is%20working%20on%20five,even%20before%20they%20received%20approval.|access-date=9 July 2021}}</ref> no formal [[Emergency Use Authorization|emergency authorisation]] has been given as of 9 July 2021.}}

;Full (<section begin="Soberana 02_FN"/>0<section end="Soberana 02_FN"/>)

;Emergency (<section begin="Soberana 02_EN"/>3<section end="Soberana 02_EN"/>)
# Cuba<ref>{{cite news |title=Cuba grants emergency approval to second homegrown COVID-19 vaccine |url=https://www.gmanetwork.com/news/scitech/science/800262/cuba-grants-emergency-approval-to-second-homegrown-covid-19-vaccine/story/?fbclid=IwAR1Z55319ccTk50zLyjlDixLDr3gBSef-XRaeqiaccukCop2cPAhu_NurR4 |publisher=GMA News |date=21 August 2021}}</ref>
# Nicaragua<ref>{{cite news |title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/|publisher=Reuters |date =2 October 2021}}</ref>
# Iran<ref name="finlayIran"/>

{{clear}}

== QazCovid-in ==
<section begin="covivacauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|KZ=dodgerblue
|KG=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="covivacauthmap"/>
[[QazCovid-in]], also known as QazVac, is an [[inactivated vaccine|inactivated virus vaccine]] developed by the Research Institute for Biological Safety Problems in Kazakhstan.<ref name="qazvac">{{cite web |title=A new vaccine on the scene: Kazakhstan begins rollout of homegrown QazVac |date=26 April 2021 |url=https://fortune.com/2021/04/26/new-covid-19-vaccine-kazakhstan-qazvac/ |website=Fortune}}</ref>
;Full (<section begin="QazCovid-in_FN"/>0<section end="QazCovid-in_FN"/>)

;Emergency (<section begin="QazCovid-in_EN"/>2<section end="QazCovid-in_EN"/>)
# Kazakhstan<ref name="qazvac"/>
# Kyrgyzstan<ref>{{cite news | title=Vaccination against COVID-19: QazVac registered in Kyrgyzstan
 |url=https://24.kg/english/204508_Vaccination_against_COVID-19_QazVac_registered_in_Kyrgyzstan/ |publisher=24.kg |date=19 August 2021 }}</ref><ref>{{cite news | title=Kyrgyzstan to start using Kazakh-made QazVac after expert review
 |url=https://www.eureporter.co/world/kazakhstan/2021/08/19/kyrgyzstan-to-start-using-kazakh-made-qazvac-after-expert-review/ |publisher=Eureporter |date=19 August 2021 }}</ref><ref>{{cite news | title=THE COVID-19 VACCINE QAZVAC IS FIRSTLY REGISTRATED ABROAD
 |url=https://www.biosafety.kz/en/uncategorized/%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0-qazvac-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-covid-19-%d0%bf%d0%be%d0%bb%d1%83%d1%87%d0%b8%d0%bb%d0%b0-%d0%bf%d0%b5%d1%80%d0%b2%d1%83%d1%8e-%d1%80%d0%b5%d0%b3/ |publisher=Biosafety.kz |date=18 August 2021 }}</ref>

== CoviVac ==
<section begin="covivacauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
|RU=dodgerblue
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="covivacauthmap"/>
[[CoviVac (Russia COVID-19 vaccine)|CoviVac]] is an [[inactivated vaccine|inactivated virus vaccine]]<ref name="Ryumin"/> produced by the Chumakov Centre at the [[Russian Academy of Sciences]].<ref>{{#invoke:Cite web||date=18 January 2021|title=Briefing with Deputy Prime Minister Tatyana Golikova, Health Minister Mikhail Murashko and Head of Rospotrebnadzor Anna Popova|url=http://government.ru/en/news/41342/|access-date=20 February 2021|publisher=Government of Russia}}</ref>

;Full (<section begin="CoviVac_FN"/>0<section end="CoviVac_FN"/>)

;Emergency (<section begin="CoviVac_EN"/>1<section end="CoviVac_EN"/>)
# Russia<ref>{{cite news | title=Russia approves its third COVID-19 vaccine, CoviVac |url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russia-approves-its-third-covid-19-vaccine-covivac-idUKKBN2AK07H |publisher=Reuters |date=20 February 2021 }}</ref>

{{clear}}

== Minhai ==
[[Minhai COVID-19 vaccine]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by Minhai Biotechnology Co. and [[Shenzhen Kangtai Biological Products]] Co. Ltd. in China.<ref name="MinhaiEUA">{{Cite news|author=Reuters Staff|date=14 May 2021|title=Kangtai Biological's COVID-19 vaccine gets emergency use approval in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai-idUSKBN2CV1F6|access-date=20 May 2021}}</ref>
;Full (<section begin="Minhai_FN"/>0<section end="Minhai_FN"/>)

;Emergency (<section begin="Minhai_EN"/>1<section end="Minhai_EN"/>)
# China<ref name="MinhaiEUA"/>

== COVIran Barekat ==
[[COVIran Barekat]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by Shifa Pharmed Industrial Co. in Iran.<ref name="ShifaEUA">{{#invoke:Cite web||date=14 June 2021|title=Iran issues license on its coronavirus vaccine|url=https://en.trend.az/iran/society/3439812.html|access-date=14 June 2021|website=Trend.Az}}</ref>
;Full (<section begin="COVIran Barakat_FN"/>0<section end="COVIran Barakat_FN"/>)

;Emergency (<section begin="COVIran Barekat_EN"/>1<section end="COVIran Barekat_EN"/>)
# Iran<ref name="ShifaEUA"/>

== FAKHRAVAC ==
[[FAKHRAVAC]] (or MIVAC), is an [[inactivated vaccine|inactivated virus vaccine]] developed in Iran by the [[Organization of Defensive Innovation and Research]], an organization of [[Ministry of Defence and Armed Forces Logistics (Iran)|Iran's Ministry of Defense]].<ref name="FakhraVacEUA">{{Cite web|date=2021-09-09|title=Iran Authorizes Emergency Use of Third Homegrown Vaccine - Defense news|url=https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|url-status=live|archive-url=https://web.archive.org/web/20210909123956/https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|archive-date=2021-09-09|access-date=2021-09-09|website=Tasnim News Agency|language=en}}</ref>
;Full (<section begin="FAKHRAVAC_FN"/>0<section end="FAKHRAVAC_FN"/>)

;Emergency (<section begin="FAKHRAVAC_EN"/>1<section end="FAKHRAVAC_EN"/>)
# Iran<ref name="FakhraVacEUA"/>

== Chinese Academy of Medical Sciences ==
[[Chinese Academy of Medical Sciences COVID-19 vaccine]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by [[Peking Union Medical College|Chinese Academy of Medical Sciences]].<ref name="IMBCAMSEUA">{{cite news |last1=Liu |first1=Roxanne |last2=Woo |first2=Ryan |title=China builds new plant for IMBCAMS COVID-19 vaccine -state media |url=https://www.reuters.com/world/asia-pacific/china-builds-new-plant-imbcams-covid-19-vaccine-state-media-2021-06-09/ |access-date=15 June 2021 |work=Reuters |date=9 June 2021}}</ref>
;Full (<section begin="Chinese Academy of Medical Sciences_FN"/>0<section end="Chinese Academy of Medical Sciences_FN"/>)

;Emergency (<section begin="Chinese Academy of Medical Sciences_EN"/>1<section end="Chinese Academy of Medical Sciences_EN"/>)
# China<ref name="IMBCAMSEUA"/>

== Medigen ==
[[MVC COVID-19 vaccine|MVC-COV1901]], is a [[Protein subunit|protein subunit vaccine]] developed by Medigen Vaccine Biologics and Dynavax Technologies.<ref name="MVCTW">{{cite web |title=Taiwan approves Medigen's COVID-19 vaccine candidate |url=https://www.reuters.com/world/asia-pacific/taiwan-approves-production-medigens-covid-19-vaccine-candidate-2021-07-19/ |publisher=Reuters |access-date=19 July 2021 |date=19 July 2021}}</ref>
;Full (<section begin="Medigen_FN"/>0<section end="Medigen_FN"/>)

;Emergency (<section begin="Medigen_EN"/>1<section end="Medigen_EN"/>)
# Taiwan<ref name="MVCTW"/>
== ZyCoV-D ==
[[ZyCoV-D]], is a [[DNA vaccine|DNA plasmid]] based [[COVID-19 vaccine]] developed by the Indian-based pharmaceutical company [[Cadila Healthcare]] with support from the [[Biotechnology Industry Research Assistance Council]].<ref name="zycov-d">{{cite news |title=India gives emergency approval for world's first COVID-19 DNA vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/india-approves-zydus-cadilas-covid-19-vaccine-emergency-use-2021-08-20/ |work=Reuters |date=20 August 2021 |language=en}}</ref>
;Full (<section begin="ZyCoV-D_FN"/>0<section end="ZyCoV-D_FN"/>)

;Emergency (<section begin="ZyCoV-D_EN"/>1<section end="ZyCoV-D_EN"/>)
# India<ref name="zycov-d"/>

<!--
== Novavax COVID-19 vaccine ==
<section begin="NVXauthmap"/>
{{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro
}}
|caption=
{{leftlegend|blueviolet|Full authorization}}
{{leftlegend|dodgerblue|Emergency authorization}}
}}
<section end="NVXauthmap"/>

The [[Novavax COVID-19 vaccine]], codenamed NVX-CoV2373, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), that is undergoing trials in India under the brand name Covovax. It requires two doses and is stable at 2 to 8 °C (36 to 46 °F) refrigerated temperatures.

NVX-CoV2373 has been described as both a protein [[subunit vaccine]]and a [[virus-like particle vaccine]], though the producers call it a "recombinant nanoparticle vaccine".

;Full (<section begin="Novavax_FN"/>0<section end="Novavax_FN"/>)

;Emergency (<section begin="Novavax_EN"/>0<section end="Novavax_EN"/>)

{{clear}}

-->

== Notes ==
{{reflist|group=lower-alpha}}

== References ==
{{reflist}}

{{COVID-19 pandemic}}
{{Vaccines}}
{{Portal bar|COVID-19|Medicine|Modern history|Viruses|Current events}}

[[Категори:COVID-19-дэ эсэргүү вакцина| ]]
[[Категори:Медицинскэ шэнжэлэлгэ]]
[[Категори:COVID-19-эй халдабарита үбшэнэй медицинскэ харюу]]
